<!DOCTYPE html>

<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>Rheumatoid arthritis - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Rheumatoid_arthritis","wgTitle":"Rheumatoid arthritis","wgCurRevisionId":762110407,"wgRevisionId":762110407,"wgArticleId":25875,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Uses editors parameter","CS1 maint: Multiple names: authors list","Pages using ISBN magic links","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from July 2016","Articles with unsourced statements from October 2014","Articles with unsourced statements from January 2017","Articles with unsourced statements from July 2008","Articles with unsourced statements from September 2010","Articles with unsourced statements from December 2015","Articles with unsourced statements from July 2015","Commons category with local link same as on Wikidata","Articles with DMOZ links","Wikipedia articles with GND identifiers","RTT","Connective tissue diseases","Arthritis","Autoimmune diseases","Disorders of fascia","Steroid-responsive inflammatory conditions"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Rheumatoid_arthritis","wgRelevantArticleId":25875,"wgRequestId":"WIpCXApAMFoAAK7yrWYAAAAY","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgPreferredVariant":"en","wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":true},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgWikibaseItemId":"Q187255","wgCentralAuthMobileDomain":false,"wgVisualEditorToolbarScrollOffset":0,"wgEditSubmitButtonLabelPublish":false});mw.loader.state({"ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","user.tokens":"loading","ext.cite.styles":"ready","ext.math.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","mediawiki.sectionAnchor":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready"});mw.loader.implement("user.options@0j3lz3q",function($,jQuery,require,module){mw.user.options.set({"variant":"en"});});mw.loader.implement("user.tokens@1dqfd7l",function ( $, jQuery, require, module ) {
mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});/*@nomin*/;

});mw.loader.load(["ext.cite.a11y","ext.math.scripts","mediawiki.toc","mediawiki.action.view.postEdit","site","mediawiki.page.startup","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.legacy.wikibits","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.interface","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"]);});</script>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.math.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.29.0-wmf.8" name="generator"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<link href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Rheumatoid_arthritis" rel="alternate"/>
<link href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" rel="alternate" title="Edit this page" type="application/x-wiki"/>
<link href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" rel="edit" title="Edit this page"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="copyright"/>
<link href="https://en.wikipedia.org/wiki/Rheumatoid_arthritis" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Rheumatoid_arthritis rootpage-Rheumatoid_arthritis skin-vector action-view"> <div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">
<a id="top"></a>
<div id="siteNotice"><!-- CentralNotice --></div>
<div class="mw-indicators">
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">Rheumatoid arthritis</h1>
<div class="mw-body-content" id="bodyContent">
<div id="siteSub">From Wikipedia, the free encyclopedia</div>
<div id="contentSub"></div>
<div class="mw-jump" id="jump-to-nav">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
</div>
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background:#ccc">Rheumatoid arthritis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a class="image" href="/wiki/File:Rheumatoid_Arthritis.JPG"><img alt="Rheumatoid Arthritis.JPG" data-file-height="3240" data-file-width="4320" height="188" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/250px-Rheumatoid_Arthritis.JPG" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/375px-Rheumatoid_Arthritis.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/500px-Rheumatoid_Arthritis.JPG 2x" width="250"/></a></td>
</tr>
<tr>
<td colspan="2" style="text-align:center">A hand affected by rheumatoid arthritis</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#eee;;">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Rheumatology" title="Rheumatology">Rheumatology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a class="external text" href="http://apps.who.int/classifications/icd10/browse/2016/en#/M05" rel="nofollow">M05</a>-<a class="external text" href="http://apps.who.int/classifications/icd10/browse/2016/en#/M06" rel="nofollow">M06</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=714" rel="nofollow">714</a></td>
</tr>
<tr>
<th scope="row"><a class="mw-redirect" href="/wiki/OMIM" title="OMIM">OMIM</a></th>
<td><a class="external text" href="https://omim.org/entry/180300" rel="nofollow">180300</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a class="external text" href="http://www.diseasesdatabase.com/ddb11506.htm" rel="nofollow">11506</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a class="external text" href="https://medlineplus.gov/ency/article/000431.htm" rel="nofollow">000431</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a class="external text" href="http://emedicine.medscape.com/article/331715-overview" rel="nofollow">article/331715</a> <a class="external text" href="http://emedicine.medscape.com/article/1266195-overview" rel="nofollow">article/1266195</a> <a class="external text" href="http://emedicine.medscape.com/article/305417-overview" rel="nofollow">article/305417</a> <a class="external text" href="http://emedicine.medscape.com/article/401271-overview" rel="nofollow">article/401271</a> <a class="external text" href="http://emedicine.medscape.com/article/335186-overview" rel="nofollow">article/335186</a> <a class="external text" href="http://emedicine.medscape.com/article/808419-overview" rel="nofollow">article/808419</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a class="external text" href="http://patient.info/doctor/rheumatoid-arthritis" rel="nofollow">Rheumatoid arthritis</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a class="external text" href="//www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&amp;term=D001172" rel="nofollow">D001172</a></td>
</tr>
<tr class="noprint">
<td colspan="2" style="text-align:center">
<div style="text-align: right;">[<a class="extiw" href="https://www.wikidata.org/wiki/Q187255" title="d:Q187255">edit on Wikidata</a>]</div>
</td>
</tr>
</table>
<p><b>Rheumatoid arthritis</b> (<b>RA</b>) is a long-term <a class="mw-redirect" href="/wiki/Autoimmune_disorder" title="Autoimmune disorder">autoimmune disorder</a> that primarily affects <a class="mw-redirect" href="/wiki/Synovial_joints" title="Synovial joints">joints</a>. It typically results in warm, swollen, and <a href="/wiki/Pain" title="Pain">painful</a> joints. Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. The disease may also affect other parts of the body. This may result in a <a href="/wiki/Anemia" title="Anemia">low red blood cell count</a>, <a href="/wiki/Pleurisy" title="Pleurisy">inflammation around the lungs</a>, and <a href="/wiki/Pericarditis" title="Pericarditis">inflammation around the heart</a>. Fever and low energy may also be present.<sup class="reference" id="cite_ref-NIH2014_1-0"><a href="#cite_note-NIH2014-1">[1]</a></sup> Often, symptoms come on gradually over weeks to months.<sup class="reference" id="cite_ref-Majithia2007_2-0"><a href="#cite_note-Majithia2007-2">[2]</a></sup></p>
<p>While the cause of rheumatoid arthritis is not clear, it is believed to involve a combination of <a href="/wiki/Genetics" title="Genetics">genetic</a> and environmental factors. The underlying mechanism involves the body's <a href="/wiki/Immune_system" title="Immune system">immune system</a> attacking the joints. This results in inflammation and thickening of the <a class="mw-redirect" href="/wiki/Synovium" title="Synovium">joint capsule</a>. It also affects the underlying <a href="/wiki/Bone" title="Bone">bone</a> and <a href="/wiki/Cartilage" title="Cartilage">cartilage</a>.<sup class="reference" id="cite_ref-NIH2014_1-1"><a href="#cite_note-NIH2014-1">[1]</a></sup> The diagnosis is made mostly on the basis of a person's signs and symptoms.<sup class="reference" id="cite_ref-Majithia2007_2-1"><a href="#cite_note-Majithia2007-2">[2]</a></sup> <a href="/wiki/Medical_imaging" title="Medical imaging">X-rays</a> and laboratory testing may support a diagnosis or exclude other diseases with similar symptoms.<sup class="reference" id="cite_ref-NIH2014_1-2"><a href="#cite_note-NIH2014-1">[1]</a></sup> Other diseases that may present similarly include <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a>, <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a>, and <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a> among others.<sup class="reference" id="cite_ref-Majithia2007_2-2"><a href="#cite_note-Majithia2007-2">[2]</a></sup></p>
<p>The goal of treatment is to reduce pain, decrease inflammation, and improve a person's overall functioning. This may be helped by balancing rest and exercise, the use of <a class="mw-redirect" href="/wiki/Orthoses" title="Orthoses">splints and braces</a>, or the use of assistive devices. <a class="mw-redirect" href="/wiki/Analgesics" title="Analgesics">Pain medications</a>, <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a>, and <a class="mw-redirect" href="/wiki/NSAIDs" title="NSAIDs">NSAIDs</a> are frequently used to help with symptoms. A group of medications called <a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">disease-modifying antirheumatic drugs</a> (DMARDs), such as <a href="/wiki/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a> and <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>, may be used to try to slow the progression of disease.<sup class="reference" id="cite_ref-NIH2014_1-3"><a href="#cite_note-NIH2014-1">[1]</a></sup> Biological DMARDs may be used when disease does not respond to other treatments.<sup class="reference" id="cite_ref-Lancet2010_3-0"><a href="#cite_note-Lancet2010-3">[3]</a></sup> However, they may have a greater rate of adverse effects.<sup class="reference" id="cite_ref-4"><a href="#cite_note-4">[4]</a></sup> Surgery to repair, <a href="/wiki/Joint_replacement" title="Joint replacement">replace</a>, or <a href="/wiki/Arthrodesis" title="Arthrodesis">fuse</a> joints may help in certain situations.<sup class="reference" id="cite_ref-NIH2014_1-4"><a href="#cite_note-NIH2014-1">[1]</a></sup> Most <a class="mw-redirect" href="/wiki/Complementary_and_alternative_medicine" title="Complementary and alternative medicine">alternative medicine treatments</a> are not supported by evidence.<sup class="reference" id="cite_ref-Ef2010_5-0"><a href="#cite_note-Ef2010-5">[5]</a></sup><sup class="reference" id="cite_ref-NCCIH_6-0"><a href="#cite_note-NCCIH-6">[6]</a></sup></p>
<p>RA affects between 0.5 and 1% of adults in the <a class="mw-redirect" href="/wiki/Developed_world" title="Developed world">developed world</a> with between 5 and 50 per 100,000 people newly developing the condition each year.<sup class="reference" id="cite_ref-Lancet2010_3-1"><a href="#cite_note-Lancet2010-3">[3]</a></sup> Onset is most frequent during middle age and women are affected 2.5 times as frequently as men.<sup class="reference" id="cite_ref-NIH2014_1-5"><a href="#cite_note-NIH2014-1">[1]</a></sup> In 2013, it resulted in 38,000 deaths up from 28,000 deaths in 1990.<sup class="reference" id="cite_ref-GDB2013_7-0"><a href="#cite_note-GDB2013-7">[7]</a></sup> The first recognized description of RA was made in 1800 by Dr. <a href="/wiki/Augustin_Jacob_Landr%C3%A9-Beauvais" title="Augustin Jacob Landré-Beauvais">Augustin Jacob Landré-Beauvais</a> (1772–1840) of Paris.<sup class="reference" id="cite_ref-Landre1800_8-0"><a href="#cite_note-Landre1800-8">[8]</a></sup> The term <i>rheumatoid arthritis</i> is based on the Greek for watery and inflamed joints.<sup class="reference" id="cite_ref-Paget2002_9-0"><a href="#cite_note-Paget2002-9">[9]</a></sup></p>
<div class="toclimit-3">
<div class="toc" id="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Joints"><span class="tocnumber">1.1</span> <span class="toctext">Joints</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Skin"><span class="tocnumber">1.2</span> <span class="toctext">Skin</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Lungs"><span class="tocnumber">1.3</span> <span class="toctext">Lungs</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Kidneys"><span class="tocnumber">1.4</span> <span class="toctext">Kidneys</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Heart_and_blood_vessels"><span class="tocnumber">1.5</span> <span class="toctext">Heart and blood vessels</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Other"><span class="tocnumber">1.6</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Imaging"><span class="tocnumber">4.1</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Blood_tests"><span class="tocnumber">4.2</span> <span class="toctext">Blood tests</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Classification_Criteria"><span class="tocnumber">4.3</span> <span class="toctext">Classification Criteria</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Differential_diagnoses"><span class="tocnumber">4.4</span> <span class="toctext">Differential diagnoses</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Monitoring_progression"><span class="tocnumber">4.5</span> <span class="toctext">Monitoring progression</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Prevention"><span class="tocnumber">5</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Lifestyle"><span class="tocnumber">6.1</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Disease_modifying_agents"><span class="tocnumber">6.2</span> <span class="toctext">Disease modifying agents</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Anti-inflammatory_agents"><span class="tocnumber">6.3</span> <span class="toctext">Anti-inflammatory agents</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Surgery"><span class="tocnumber">6.4</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Alternative_medicine"><span class="tocnumber">6.5</span> <span class="toctext">Alternative medicine</span></a>
<ul>
<li class="toclevel-3 tocsection-23"><a href="#Dietary_supplements"><span class="tocnumber">6.5.1</span> <span class="toctext">Dietary supplements</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-24"><a href="#Pregnancy"><span class="tocnumber">6.6</span> <span class="toctext">Pregnancy</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Vaccinations"><span class="tocnumber">6.7</span> <span class="toctext">Vaccinations</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-26"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-27"><a href="#Prognostic_factors"><span class="tocnumber">7.1</span> <span class="toctext">Prognostic factors</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Mortality"><span class="tocnumber">7.2</span> <span class="toctext">Mortality</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-29"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-31"><a href="#Etymology"><span class="tocnumber">9.1</span> <span class="toctext">Etymology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-32"><a href="#Research"><span class="tocnumber">10</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-34"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>RA primarily affects <a class="mw-redirect" href="/wiki/Joints" title="Joints">joints</a>, but it also affects other <a href="/wiki/Organ_(anatomy)" title="Organ (anatomy)">organs</a> in more than 15–25% of individuals.<sup class="reference" id="cite_ref-pmid12860726_10-0"><a href="#cite_note-pmid12860726-10">[10]</a></sup></p>
<h3><span class="mw-headline" id="Joints">Joints</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=2" title="Edit section: Joints">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Rheumatoid_arthritis_joint.gif"><img alt="" class="thumbimage" data-file-height="559" data-file-width="288" height="427" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Rheumatoid_arthritis_joint.gif/220px-Rheumatoid_arthritis_joint.gif" srcset="//upload.wikimedia.org/wikipedia/commons/7/7e/Rheumatoid_arthritis_joint.gif 1.5x" width="220"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:Rheumatoid_arthritis_joint.gif" title="Enlarge"></a></div>
A diagram showing how rheumatoid arthritis affects a joint</div>
</div>
</div>
<p><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a> of joints involves <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> of the <a href="/wiki/Synovial_membrane" title="Synovial membrane">synovial membrane</a>. Joints become swollen, tender and warm, and stiffness limits their movement. With time, multiple joints are affected (<a href="/wiki/Polyarthritis" title="Polyarthritis">polyarthritis</a>). Most commonly involved are the small joints of the <a href="/wiki/Hand" title="Hand">hands</a>, <a href="/wiki/Foot" title="Foot">feet</a> and <a class="mw-redirect" href="/wiki/Cervical_spine" title="Cervical spine">cervical spine</a>, but larger joints like the shoulder and knee can also be involved.<sup class="reference" id="cite_ref-DAVIDSONS2010_11-0"><a href="#cite_note-DAVIDSONS2010-11">[11]</a></sup><sup class="reference" style="white-space:nowrap;">:1089</sup> Synovitis can lead to <a href="/wiki/Tether_(cell_biology)" title="Tether (cell biology)">tethering</a> of tissue with loss of movement and erosion of the joint surface causing deformity and loss of function.<sup class="reference" id="cite_ref-Majithia2007_2-3"><a href="#cite_note-Majithia2007-2">[2]</a></sup></p>
<p>RA typically manifests with signs of <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>, with the affected joints being swollen, warm, painful and stiff, particularly early in the morning on waking or following prolonged inactivity. Increased stiffness early in the morning is often a prominent feature of the disease and typically lasts for more than an hour. Gentle movements may relieve symptoms in early stages of the disease. These signs help distinguish rheumatoid from non-inflammatory problems of the joints, such as <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a>. In arthritis of non-inflammatory causes, signs of inflammation and early morning stiffness are less prominent with stiffness typically less than one hour, and movements induce pain caused by mechanical arthritis.<sup class="reference" id="cite_ref-12"><a href="#cite_note-12">[12]</a></sup> The pain associated with RA is induced at the site of inflammation and classified as <a class="mw-redirect" href="/wiki/Nociceptive" title="Nociceptive">nociceptive</a> as opposed to <a class="mw-redirect" href="/wiki/Neuropathic" title="Neuropathic">neuropathic</a>.<sup class="reference" id="cite_ref-13"><a href="#cite_note-13">[13]</a></sup> The joints are often affected in a fairly symmetrical fashion, although this is not specific, and the initial presentation may be asymmetrical.<sup class="reference" id="cite_ref-DAVIDSONS2010_11-1"><a href="#cite_note-DAVIDSONS2010-11">[11]</a></sup><sup class="reference" style="white-space:nowrap;">:1089</sup></p>
<p>As the pathology progresses the inflammatory activity leads to tendon tethering and erosion and destruction of the joint surface, which impairs range of movement and leads to deformity. The fingers may suffer from almost any deformity depending on which joints are most involved. Specific deformities, which also occur in <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a>, include <a href="/wiki/Ulnar_deviation" title="Ulnar deviation">ulnar deviation</a>, <a href="/wiki/Boutonniere_deformity" title="Boutonniere deformity">boutonniere deformity</a> (also "buttonhole deformity", flexion of proximal interphalangeal joint and extension of distal interphalangeal joint), <a href="/wiki/Swan_neck_deformity" title="Swan neck deformity">swan neck deformity</a> (hyperextension at proximal interphalangeal joint and flexion at distal interphalangeal joint) and "Z-thumb." "Z-thumb" or "Z-deformity" consists of <a class="mw-redirect" href="/wiki/Hyperextension" title="Hyperextension">hyperextension</a> of the <a class="mw-redirect" href="/wiki/Interphalangeal_articulations_of_hand" title="Interphalangeal articulations of hand">interphalangeal joint</a>, fixed <a class="mw-redirect" href="/wiki/Flexion" title="Flexion">flexion</a> and <a href="/wiki/Subluxation" title="Subluxation">subluxation</a> of the <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joint</a> and gives a "Z" appearance to the thumb.<sup class="reference" id="cite_ref-DAVIDSONS2010_11-2"><a href="#cite_note-DAVIDSONS2010-11">[11]</a></sup><sup class="reference" style="white-space:nowrap;">:1089</sup> The <a href="/wiki/Hammer_toe" title="Hammer toe">hammer toe</a> deformity may be seen. In the worst case, joints are known as <a href="/wiki/Arthritis_mutilans" title="Arthritis mutilans">arthritis mutilans</a> due to the mutilating nature of the deformities.<sup class="reference" id="cite_ref-McGraw_Hill_14-0"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup> "Spindling of fingers" of hand occurs due to swelling of the PIP but not DIP joints. "Piano key movement" of the <a href="/wiki/Ulnar_styloid_process" title="Ulnar styloid process">ulnar styloid</a> occurs due to inflammation around the ulnar styloid and tenosynovitis of <a href="/wiki/Extensor_carpi_ulnaris_muscle" title="Extensor carpi ulnaris muscle">extensor carpi ulnaris</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2016)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Skin">Skin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=3" title="Edit section: Skin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/Rheumatoid_nodule" title="Rheumatoid nodule">rheumatoid nodule</a>, which is sometimes in the <a class="mw-redirect" href="/wiki/Cutaneous" title="Cutaneous">skin</a>, is the most common non joint feature.<sup class="reference" id="cite_ref-Tur2013_15-0"><a href="#cite_note-Tur2013-15">[15]</a></sup> They occur in 30% of people who have RA.<sup class="reference" id="cite_ref-Tur2013_15-1"><a href="#cite_note-Tur2013-15">[15]</a></sup> It is a type of inflammatory reaction known to pathologists as a "<a class="mw-redirect" href="/wiki/Necrotizing" title="Necrotizing">necrotizing</a> <a href="/wiki/Granuloma" title="Granuloma">granuloma</a>". The <a href="/wiki/Initial" title="Initial">initial</a> pathologic process in nodule formation is unknown but may be essentially the same as the synovitis, since similar structural features occur in both. The nodule has a central area of <a href="/wiki/Fibrinoid_necrosis" title="Fibrinoid necrosis">fibrinoid necrosis</a> that may be <a href="/wiki/Fissure" title="Fissure">fissured</a> and which corresponds to the <a href="/wiki/Fibrin" title="Fibrin">fibrin</a>-rich necrotic material found in and around an affected synovial space. Surrounding the necrosis is a layer of <a class="new" href="/w/index.php?title=Palisading&amp;action=edit&amp;redlink=1" title="Palisading (page does not exist)">palisading</a> <a class="mw-redirect" href="/wiki/Macrophages" title="Macrophages">macrophages</a> and <a class="mw-redirect" href="/wiki/Fibroblasts" title="Fibroblasts">fibroblasts</a>, corresponding to the <a class="new" href="/w/index.php?title=Intimal_layer&amp;action=edit&amp;redlink=1" title="Intimal layer (page does not exist)">intimal layer</a> in synovium and a cuff of <a href="/wiki/Connective_tissue" title="Connective tissue">connective tissue</a> containing clusters of <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a> and <a href="/wiki/Plasma_cell" title="Plasma cell">plasma cells</a>, corresponding to the <a class="new" href="/w/index.php?title=Subintimal_zone&amp;action=edit&amp;redlink=1" title="Subintimal zone (page does not exist)">subintimal zone</a> in synovitis. The typical rheumatoid nodule may be a few millimetres to a few centimetres in diameter and is usually found over bony prominences, such as the <a href="/wiki/Olecranon" title="Olecranon">elbow</a>, the <a class="mw-redirect" href="/wiki/Calcaneal_tuberosity" title="Calcaneal tuberosity">heel</a>, the <a class="mw-redirect" href="/wiki/Metacarpophalangeal_joints" title="Metacarpophalangeal joints">knuckles</a>, or other areas that sustain repeated mechanical stress. Nodules are associated with a positive RF (<a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a>) <a href="/wiki/Titer" title="Titer">titer</a>, ACPA, and severe erosive arthritis. Rarely, these can occur in internal organs or at diverse sites on the body.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup>.</p>
<p>Several forms of <a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a> occur in RA, but are mostly seen with long-standing and untreated disease. The most common presentation is due to involvement of small- and medium-sized vessels. Rheumatoid vasculitis can thus commonly present with skin ulceration and vasculitic nerve infarction known as <a class="mw-redirect" href="/wiki/Mononeuritis_multiplex" title="Mononeuritis multiplex">mononeuritis multiplex</a>.<sup class="reference" id="cite_ref-16"><a href="#cite_note-16">[16]</a></sup></p>
<p>Other, rather rare, skin associated symptoms include <a href="/wiki/Pyoderma_gangrenosum" title="Pyoderma gangrenosum">pyoderma gangrenosum</a>, <a class="mw-redirect" href="/wiki/Sweet%27s_syndrome" title="Sweet's syndrome">Sweet's syndrome</a>, drug reactions, <a href="/wiki/Erythema_nodosum" title="Erythema nodosum">erythema nodosum</a>, lobe <a href="/wiki/Panniculitis" title="Panniculitis">panniculitis</a>, <a href="/wiki/Atrophy" title="Atrophy">atrophy</a> of finger skin, <a href="/wiki/Palmar_erythema" title="Palmar erythema">palmar erythema</a>, and skin fragility (often worsened by corticosteroid use).<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup>.</p>
<h3><span class="mw-headline" id="Lungs">Lungs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=4" title="Edit section: Lungs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Fibrosis" title="Fibrosis">Fibrosis</a> of the <a class="mw-redirect" href="/wiki/Lungs" title="Lungs">lungs</a> is a recognized complication of rheumatoid arthritis. It is also a rare but well-recognized consequence of therapy (for example with <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> and <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>). <a href="/wiki/Caplan%27s_syndrome" title="Caplan's syndrome">Caplan's syndrome</a> describes lung nodules in individuals with RA and additional exposure to <a href="/wiki/Coal" title="Coal">coal</a> dust. <a class="mw-redirect" href="/wiki/Exsudate" title="Exsudate">Exsudative</a> <a href="/wiki/Pleural_effusion" title="Pleural effusion">Pleural effusions</a> are also associated with RA.<sup class="reference" id="cite_ref-17"><a href="#cite_note-17">[17]</a></sup><sup class="reference" id="cite_ref-18"><a href="#cite_note-18">[18]</a></sup></p>
<h3><span class="mw-headline" id="Kidneys">Kidneys</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=5" title="Edit section: Kidneys">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Renal <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> can occur as a consequence of untreated chronic inflammation.<sup class="reference" id="cite_ref-19"><a href="#cite_note-19">[19]</a></sup> Treatment with <a href="/wiki/Penicillamine" title="Penicillamine">penicillamine</a> and <a href="/wiki/Gold_salts" title="Gold salts">gold salts</a> are recognized causes of <a class="mw-redirect" href="/wiki/Membranous_nephropathy" title="Membranous nephropathy">membranous nephropathy</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Heart_and_blood_vessels">Heart and blood vessels</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=6" title="Edit section: Heart and blood vessels">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>People with RA are more prone to <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, and risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (heart attack) and <a href="/wiki/Stroke" title="Stroke">stroke</a> is markedly increased.<sup class="reference" id="cite_ref-20"><a href="#cite_note-20">[20]</a></sup><sup class="reference" id="cite_ref-21"><a href="#cite_note-21">[21]</a></sup><sup class="reference" id="cite_ref-22"><a href="#cite_note-22">[22]</a></sup> Other possible complications that may arise include: <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Endocarditis" title="Endocarditis">endocarditis</a>, left ventricular failure, valvulitis and <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a>.<sup class="reference" id="cite_ref-Gupta_23-0"><a href="#cite_note-Gupta-23">[23]</a></sup> Many people with RA do not experience the same chest pain that others feel when they have angina or myocardial infarction. To reduce cardiovascular risk, it is crucial to maintain optimal control of the <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> caused by RA (which may be involved in causing the cardiovascular risk), and to use exercise and medications appropriately to reduce other cardiovascular risk factors such as blood lipids and blood pressure. Doctors who treat people with RA should be sensitive to cardiovascular risk when prescribing anti-inflammatory medications, and may want to consider prescribing routine use of low doses of aspirin if the gastrointestinal effects are tolerable.<sup class="reference" id="cite_ref-Gupta_23-1"><a href="#cite_note-Gupta-23">[23]</a></sup></p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=7" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<dl>
<dt>Eyes</dt>
<dd>The eye can be directly affected in the form of <a href="/wiki/Episcleritis" title="Episcleritis">episcleritis</a> or <a href="/wiki/Scleritis" title="Scleritis">scleritis</a>. Scleritis when severe can very rarely progress to perforating <a class="new" href="/w/index.php?title=Scleromalacia&amp;action=edit&amp;redlink=1" title="Scleromalacia (page does not exist)">scleromalacia</a>. Rather more common is the indirect effect of <a class="mw-redirect" href="/wiki/Keratoconjunctivitis_sicca" title="Keratoconjunctivitis sicca">keratoconjunctivitis sicca</a>, which is a dryness of eyes and mouth caused by <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocyte</a> infiltration of <a href="/wiki/Lacrimal_gland" title="Lacrimal gland">lacrimal</a> and <a href="/wiki/Salivary_gland" title="Salivary gland">salivary glands</a>. When severe, dryness of the cornea can lead to <a href="/wiki/Keratitis" title="Keratitis">keratitis</a> and loss of vision. Preventive treatment of severe dryness with measures such as <a href="/wiki/Nasolacrimal_duct" title="Nasolacrimal duct">nasolacrimal duct</a> blockage is important.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup></dd>
</dl>
<dl>
<dt>Liver</dt>
<dd>Liver problems in people with rheumatoid arthritis may be due to the underlying disease process or as a result of the medications used to treat the disease.<sup class="reference" id="cite_ref-Selmi2011_24-0"><a href="#cite_note-Selmi2011-24">[24]</a></sup> A coexisting autoimmune liver disease, such as <a class="mw-redirect" href="/wiki/Primary_biliary_cirrhosis" title="Primary biliary cirrhosis">primary biliary cirrhosis</a> or <a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">autoimmune hepatitis</a> may also cause problems.<sup class="reference" id="cite_ref-Selmi2011_24-1"><a href="#cite_note-Selmi2011-24">[24]</a></sup></dd>
</dl>
<dl>
<dt>Blood</dt>
<dd><a href="/wiki/Anemia" title="Anemia">Anemia</a> is by far the most common abnormality of the blood cells which can be caused by a variety of mechanisms. The chronic inflammation caused by RA leads to raised <a href="/wiki/Hepcidin" title="Hepcidin">hepcidin</a> levels, leading to <a href="/wiki/Anemia_of_chronic_disease" title="Anemia of chronic disease">anemia of chronic disease</a> where iron is poorly absorbed and also sequestered into <a class="mw-redirect" href="/wiki/Macrophages" title="Macrophages">macrophages</a>. RA may also cause a <a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">warm autoimmune hemolytic anemia</a>.<sup class="reference" id="cite_ref-25"><a href="#cite_note-25">[25]</a></sup> The red cells are of normal size and color (normocytic and normochromic). A <a href="/wiki/Neutropenia" title="Neutropenia">low white blood cell count</a> usually only occurs in people with <a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a> with an enlarged liver and spleen. The mechanism of neutropenia is complex. An <a href="/wiki/Thrombocytosis" title="Thrombocytosis">increased platelet count</a> occurs when inflammation is uncontrolled.</dd>
</dl>
<dl>
<dt>Neurological</dt>
<dd><a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">Peripheral neuropathy</a> and <a class="mw-redirect" href="/wiki/Mononeuritis_multiplex" title="Mononeuritis multiplex">mononeuritis multiplex</a> may occur. The most common problem is <a href="/wiki/Carpal_tunnel_syndrome" title="Carpal tunnel syndrome">carpal tunnel syndrome</a> caused by compression of the median nerve by swelling around the wrist. <a href="/wiki/Atlanto-axial_joint" title="Atlanto-axial joint">Atlanto-axial</a> <a href="/wiki/Subluxation" title="Subluxation">subluxation</a> can occur, owing to erosion of the <a class="mw-redirect" href="/wiki/Odontoid_process" title="Odontoid process">odontoid process</a> and/or <a class="mw-disambig" href="/wiki/Transverse_ligament" title="Transverse ligament">transverse ligaments</a> in the <a class="mw-redirect" href="/wiki/Cervical_spine" title="Cervical spine">cervical spine</a>'s connection to the skull. Such an erosion (&gt;3mm) can give rise to <a class="mw-redirect" href="/wiki/Vertebrae" title="Vertebrae">vertebrae</a> slipping over one another and compressing the spinal cord. Clumsiness is initially experienced, but without due care, this can progress to <a class="mw-redirect" href="/wiki/Quadriplegia" title="Quadriplegia">quadriplegia</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup></dd>
</dl>
<dl>
<dt>Constitutional symptoms</dt>
<dd><a href="/wiki/Constitutional_symptoms" title="Constitutional symptoms">Constitutional symptoms</a> including <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a>, low grade <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Malaise" title="Malaise">malaise</a>, <a class="mw-redirect" href="/wiki/Morning_stiffness" title="Morning stiffness">morning stiffness</a>, <a class="mw-redirect" href="/wiki/Loss_of_appetite" title="Loss of appetite">loss of appetite</a> and <a class="mw-redirect" href="/wiki/Loss_of_weight" title="Loss of weight">loss of weight</a> are common systemic manifestations seen in people with active RA.</dd>
</dl>
<dl>
<dt>Bones</dt>
<dd>Local <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> occurs in RA around inflamed joints. It is postulated to be partially caused by inflammatory <a class="mw-redirect" href="/wiki/Cytokines" title="Cytokines">cytokines</a>. More general osteoporosis is probably contributed to by immobility, systemic cytokine effects, local cytokine release in bone marrow and corticosteroid therapy.</dd>
</dl>
<dl>
<dt>Cancer</dt>
<dd>The incidence of <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> is increased in RA, although it is uncommon.<sup class="reference" id="cite_ref-26"><a href="#cite_note-26">[26]</a></sup><sup class="reference" id="cite_ref-27"><a href="#cite_note-27">[27]</a></sup></dd>
</dl>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=8" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>RA is a chronic autoimmune disorder the causes of which are not completely understood. It is a systemic (whole body) disorder principally affecting synovial tissues. There is no evidence that physical and emotional effects or stress could be a trigger for the disease. The many negative findings suggest that either the trigger varies, or that it might, in fact, be a chance event inherent with the immune response.<sup class="reference" id="cite_ref-28"><a href="#cite_note-28">[28]</a></sup></p>
<p>Half of the risk for RA is believed to be genetic.<sup class="reference" id="cite_ref-Lancet2010_3-2"><a href="#cite_note-Lancet2010-3">[3]</a></sup> It is strongly associated with the inherited tissue type <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> (MHC) antigen <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a>-DRB1 (most specifically the shared epitope alleles, including *0401 and *0404, although this difference based in race and ethnicity), and the genes <a href="/wiki/PTPN22" title="PTPN22">PTPN22</a> and <a href="/wiki/PADI4" title="PADI4">PADI4</a>—hence family history is an important risk factor.<sup class="reference" id="cite_ref-29"><a href="#cite_note-29">[29]</a></sup><sup class="reference" id="cite_ref-30"><a href="#cite_note-30">[30]</a></sup> Inheriting the PTPN22 gene has been shown to double a person's susceptibility to RA. PADI4, the gene encoding one of the human citrullinating enzymes, has been identified as a major risk factor in people of Asian descent, but not in those of European descent.<sup class="reference" id="cite_ref-31"><a href="#cite_note-31">[31]</a></sup> First-degree relatives prevalence rate is 2–3% and disease <a class="mw-redirect" href="/wiki/Genetic_concordance" title="Genetic concordance">genetic concordance</a> in <a class="mw-redirect" href="/wiki/Monozygotic_twins" title="Monozygotic twins">monozygotic twins</a> is approximately 15–20%.<sup class="reference" id="cite_ref-32"><a href="#cite_note-32">[32]</a></sup><sup class="reference" id="cite_ref-33"><a href="#cite_note-33">[33]</a></sup></p>
<p><a href="/wiki/Tobacco_smoking" title="Tobacco smoking">Smoking</a> may be the most significant non-genetic risk factor<sup class="reference" id="cite_ref-Lancet2010_3-3"><a href="#cite_note-Lancet2010-3">[3]</a></sup> for RA in Caucasian populations, with RA being up to three times more common in smokers than non-smokers, particularly in men, heavy smokers, and those who are rheumatoid factor positive.<sup class="reference" id="cite_ref-Sugiyama2010_34-0"><a href="#cite_note-Sugiyama2010-34">[34]</a></sup> Modest alcohol consumption may be protective.<sup class="reference" id="cite_ref-35"><a href="#cite_note-35">[35]</a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=9" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Both genetic, as well as environmental factors, are implicated in the pathophysiology of the disease. Smoking is the main environmental risk to RA.<sup class="reference" id="cite_ref-Lancet2010_3-4"><a href="#cite_note-Lancet2010-3">[3]</a></sup> 50% of the risk of having RA is attributable to genetic factors.<sup class="reference" id="cite_ref-Lancet2010_3-5"><a href="#cite_note-Lancet2010-3">[3]</a></sup> No infectious agent has been consistently linked with RA and there is no evidence of disease clustering to indicate its infectious etiology.<sup class="reference" id="cite_ref-Elsevier_36-0"><a href="#cite_note-Elsevier-36">[36]</a></sup> <a href="/wiki/HLA-DR4" title="HLA-DR4">HLA-DR4</a> is the major genetic factor implicated – but its relative importance varies across ethnic groups.<sup class="reference" id="cite_ref-Elsevier_36-1"><a href="#cite_note-Elsevier-36">[36]</a></sup><sup class="reference" id="cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-0"><a href="#cite_note-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209-37">[37]</a></sup> Related allotypes of <a class="mw-redirect" href="/wiki/MHC_Class_II" title="MHC Class II">MHC Class II</a> and the <a href="/wiki/T_cell" title="T cell">T cell</a>-associated protein <a href="/wiki/PTPN22" title="PTPN22">PTPN22</a> has also been found associated in many studies.<sup class="reference" id="cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-1"><a href="#cite_note-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209-37">[37]</a></sup></p>
<p>RA primarily starts as a state of persistent cellular activation leading to autoimmunity and immune complexes in both joints and other, organs where it manifests. The initial site of disease is the synovial membrane, where swelling and congestion leads to infiltration by immune cells. The various phases of progression of RA are:<sup class="reference" id="cite_ref-McGraw_Hill_14-1"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<ul>
<li>Initiation phase, due to non-specific inflammation.</li>
<li>Amplification phase, due to <a href="/wiki/T_cell" title="T cell">T cell</a> activation</li>
<li>Chronic inflammatory phase with tissue injury, due to <a class="mw-redirect" href="/wiki/Cytokines" title="Cytokines">cytokines</a> <a class="mw-redirect" href="/wiki/Interleukin_1" title="Interleukin 1">IL–1</a>, <a class="mw-redirect" href="/wiki/TNF-alpha" title="TNF-alpha">TNF-alpha</a> and <a href="/wiki/Interleukin_6" title="Interleukin 6">IL–6</a>.</li>
</ul>
<p>The factors that allow an abnormal immune response, once initiated, to become permanent and chronic, are becoming more clearly understood. The genetic association with HLA-DR4, as well as the newly discovered associations with the gene <a href="/wiki/PTPN22" title="PTPN22">PTPN22</a> and with two additional genes,<sup class="reference" id="cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-2"><a href="#cite_note-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209-37">[37]</a></sup> all implicate altered thresholds in regulation of the adaptive immune response. It has also become clear from recent studies that these genetic factors may interact with the most clearly defined environmental risk factor for RA, namely cigarette smoking.<sup class="reference" id="cite_ref-Sugiyama2010_34-1"><a href="#cite_note-Sugiyama2010-34">[34]</a></sup><sup class="reference" id="cite_ref-38"><a href="#cite_note-38">[38]</a></sup> Other environmental factors also appear to modulate the risk of acquiring RA, and hormonal factors in the individual may explain some features of the disease, such as the higher occurrence in women, the not-infrequent onset after childbirth, and the (slight) modulation of disease risk by hormonal medications. Exactly how altered regulatory thresholds allow the triggering of a specific autoimmune response remains uncertain. However, one possibility is that negative feedback mechanisms that normally maintain tolerance of self are overtaken by aberrant positive feedback mechanisms for certain antigens such as IgG Fc (bound by RF) and citrullinated fibrinogen (bound by ACPA) (see the entry on <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a>).The debate on the relative roles of immune complexes and T cell products in inflammation in RA has continued for 30 years. There is little doubt that both B and T cells are essential to the disease. However, there is good evidence for neither cell being necessary at the site of inflammation. This tends to favor immune complexes (based on antibody synthesized elsewhere) as the initiators, even if not the sole perpetuators of inflammation.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup> The presence of autoantibodies to IgGFc, known as <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factors</a> (RF), and <a class="mw-redirect" href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">antibodies to citrullinated peptides</a> (ACPA) is an integral part of RA disease process. As is the case with many other autoimmune diseases, people with RA have abnormally glycosylated antibodies.<sup class="reference" id="cite_ref-immune_glycan_39-0"><a href="#cite_note-immune_glycan-39">[39]</a></sup> It is believed that these glycan (oligosaccharide) alterations promote joint inflammation.<sup class="reference" id="cite_ref-immune_glycan_39-1"><a href="#cite_note-immune_glycan-39">[39]</a></sup></p>
<p>Once the abnormal immune response has become established (which may take several years before any symptoms occur), plasma cells derived from B lymphocytes produce rheumatoid factors and ACPA of the IgG and IgM classes in large quantities. These are not deposited in the way that they are in systemic lupus. Rather, they activate macrophages through Fc receptor and complement binding, which seems to play an important role in the intense inflammatory response present in RA.<sup class="reference" id="cite_ref-40"><a href="#cite_note-40">[40]</a></sup> Binding of an autoreactive antibody to the Fc receptors is mediated through the antibody's N-glycans, which are altered to promote inflammation in people with RA.<sup class="reference" id="cite_ref-immune_glycan_39-2"><a href="#cite_note-immune_glycan-39">[39]</a></sup> This contributes to inflammation of the synovium, in terms of edema, vasodilation and infiltration by activated T-cells (mainly CD4 in nodular aggregates and CD8 in diffuse infiltrates). Synovial macrophages and dendritic cells further function as antigen presenting cells by expressing MHC class II molecules, leading to an established local immune reaction in the tissue. The disease progresses in concert with the formation of granulation tissue at the edges of the synovial lining (<a href="/wiki/Pannus" title="Pannus">pannus</a>) with extensive angiogenesis and production of enzymes that cause tissue damage. Modern pharmacological treatments of RA target these mediators. Once the inflammatory reaction is established, the synovium thickens, the cartilage and the underlying bone begins to disintegrate and evidence of joint destruction accrues.</p>
<p><a class="mw-redirect" href="/wiki/Tumor_necrosis_factors" title="Tumor necrosis factors">TNF</a> (alpha) plays a major role in the pathogenesis of RA. There are several theories on how TNF release happens in disease process. If TNF release is stimulated by B cell products in the form of RF or ACPA -containing immune complexes, through activation of immunoglobulin <a href="/wiki/Fc_receptor" title="Fc receptor">Fc receptors</a>, then RA can be seen as a form of <a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III hypersensitivity</a>.<sup class="reference" id="cite_ref-41"><a href="#cite_note-41">[41]</a></sup><sup class="reference" id="cite_ref-42"><a href="#cite_note-42">[42]</a></sup> If TNF release is stimulated by T cell products such as <a class="mw-redirect" href="/wiki/Interleukin-17" title="Interleukin-17">interleukin-17</a> it might be considered closer to <a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">type IV hypersensitivity</a> although this terminology may be getting somewhat dated and unhelpful.<sup class="reference" id="cite_ref-43"><a href="#cite_note-43">[43]</a></sup></p>
<p>Although TNF appears to be the dominant, other <a class="mw-redirect" href="/wiki/Cytokines" title="Cytokines">cytokines</a> (chemical mediators) are likely to be involved in inflammation in RA. Blockade of TNF does not benefit all persons or all tissues (lung disease and nodules may get worse). Blockade of IL-1, <a href="/wiki/Interleukin_15" title="Interleukin 15">IL-15</a> and <a href="/wiki/Interleukin_6" title="Interleukin 6">IL-6</a> also have beneficial effects and <a href="/wiki/Interleukin_17" title="Interleukin 17">IL-17</a> may be important.<sup class="reference" id="cite_ref-44"><a href="#cite_note-44">[44]</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup> Constitutional symptoms such as fever, malaise, loss of appetite and weight loss are also caused by cytokines released into the blood stream. As with most autoimmune diseases, it is important to distinguish between the cause(s) that trigger the process and those that may permit it to persist and progress.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=10" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=11" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:RheumatoideArthritisAP.jpg"><img alt="" class="thumbimage" data-file-height="3436" data-file-width="2100" height="360" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/220px-RheumatoideArthritisAP.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/330px-RheumatoideArthritisAP.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/440px-RheumatoideArthritisAP.jpg 2x" width="220"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:RheumatoideArthritisAP.jpg" title="Enlarge"></a></div>
X-ray of the hand in rheumatoid arthritis.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Inflamatory_arthritis2010.JPG"><img alt="" class="thumbimage" data-file-height="3072" data-file-width="2304" height="293" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/220px-Inflamatory_arthritis2010.JPG" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/330px-Inflamatory_arthritis2010.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/440px-Inflamatory_arthritis2010.JPG 2x" width="220"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:Inflamatory_arthritis2010.JPG" title="Enlarge"></a></div>
Appearance of synovial fluid from a joint with inflammatory arthritis.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a class="image" href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif"><img alt="" class="thumbimage" data-file-height="1452" data-file-width="1004" height="318" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/220px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/330px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/440px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif 2x" width="220"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" title="Enlarge"></a></div>
Signs of destruction and inflammation on <a href="/wiki/Medical_ultrasound" title="Medical ultrasound">ultrasonography</a> and <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> in the second <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joint</a> in established RA. Thin arrows indicate an erosive change; thick arrows indicate <a href="/wiki/Synovitis" title="Synovitis">synovitis</a>. Ultrasonography (left side of image) in the (a) longitudinal and (b) the transverse planes shows both signs of destruction and inflammation. Axial T1-weighted magnetic resonance images were obtained (c) before and (d) after contrast administration, also demonstrating synovitis. Additionally, a coronal T1-weighted magnetic resonance image (e) before contrast administration visualizes the same bone erosion as shown in panels c and d.</div>
</div>
</div>
<p><a href="/wiki/X-ray" title="X-ray">X-rays</a> of the hands and feet are generally performed in people with many joints affected. In RA, there may be no changes in the early stages of the disease or the x-ray may demonstrate juxta-articular osteopenia, soft tissue swelling, and loss of joint space. As the disease advances, there may be bony erosions and subluxation. X-rays of other joints may be taken if symptoms of pain or swelling occur in those joints.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup></p>
<p>Other medical imaging techniques such as magnetic resonance imaging (MRI) and ultrasound are also used in RA.<sup class="reference" id="cite_ref-McGraw_Hill_14-2"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<p>There have been technical advances in ultrasonography. High-frequency transducers (10 MHz or higher) have improved the spatial resolution of ultrasound images; these images can depict 20% more erosions than conventional radiography. Also, color Doppler and power Doppler ultrasound, which show vascular signals of active synovitis depending on the degree of inflammation, are useful in assessing synovial inflammation. This is important, since in the early stages of RA, the synovium is primarily affected, and synovitis seems to be the best predictive marker of future joint damage.<sup class="reference" id="cite_ref-45"><a href="#cite_note-45">[45]</a></sup></p>
<h3><span class="mw-headline" id="Blood_tests">Blood tests</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=12" title="Edit section: Blood tests">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>When RA is clinically suspected, testing for the presence of <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a> (RF, a non-specific <a href="/wiki/Antibody" title="Antibody">antibody</a>) and (<a class="mw-redirect" href="/wiki/Anti-citrullinated_protein_antibodies" title="Anti-citrullinated protein antibodies">ACPAs</a>, measured as anti-CCP antibodies) may be required.<sup class="reference" id="cite_ref-46"><a href="#cite_note-46">[46]</a></sup> A negative RF or CCP antibody does not rule out RA; rather, the arthritis is called <i><a class="mw-redirect" href="/wiki/Seronegative" title="Seronegative">seronegative</a></i>. This is the case in about 15-25% of people with RA.<sup class="reference" id="cite_ref-Nishimura_47-0"><a href="#cite_note-Nishimura-47">[47]</a></sup><sup class="reference" id="cite_ref-48"><a href="#cite_note-48">[48]</a></sup> During the first year of illness, rheumatoid factor is more likely to be negative with some individuals converting to seropositive status over time. RF is also seen in other illnesses, for example <a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a>, <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a>, <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a>, chronic infections and in approximately 10% of the healthy population, therefore the test is not very specific.<sup class="reference" id="cite_ref-McGraw_Hill_14-3"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<p>Because of this low <a class="mw-redirect" href="/wiki/Specificity_(tests)" title="Specificity (tests)">specificity</a>, new serological tests have been developed, which test for the presence of the anti-citrullinated protein antibodies (<a class="mw-redirect" href="/wiki/Anti-citrullinated_protein_antibodies" title="Anti-citrullinated protein antibodies">ACPAs</a>) (clinically tested using the CCP assay). Like RF, these tests are positive in only a proportion (61-75%) of all RA cases, with a specificity of around 95%.<sup class="reference" id="cite_ref-49"><a href="#cite_note-49">[49]</a></sup> As with RF, there is evidence for ACPAs being present in many cases even before onset of clinical disease.<sup class="reference" id="cite_ref-McGraw_Hill_14-4"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<p>The by far most common clinical test for ACPAs is the anti-CCP (<a class="mw-redirect" href="/wiki/Cyclic_citrullinated_peptide" title="Cyclic citrullinated peptide">cyclic citrullinated peptide</a>) ELISA. Recently a serological <a href="/wiki/Point-of-care_testing" title="Point-of-care testing">point-of-care test</a> (POCT) for the early detection of RA has been developed. This assay combines the detection of rheumatoid factor and anti-MCV for diagnosis of RA and shows a sensitivity of 72% and specificity of 99.7%.<sup class="reference" id="cite_ref-50"><a href="#cite_note-50">[50]</a></sup><sup class="reference" id="cite_ref-51"><a href="#cite_note-51">[51]</a></sup></p>
<p>Also, several other blood tests are usually done to allow for other causes of arthritis, such as <a href="/wiki/Lupus_erythematosus" title="Lupus erythematosus">lupus erythematosus</a>. The <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR), <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, <a class="mw-redirect" href="/wiki/Full_blood_count" title="Full blood count">full blood count</a>, <a class="mw-redirect" href="/wiki/Kidney_function" title="Kidney function">kidney function</a>, <a class="mw-redirect" href="/wiki/Liver_enzyme" title="Liver enzyme">liver enzymes</a> and other immunological tests (e.g., <a class="mw-redirect" href="/wiki/Antinuclear_antibody" title="Antinuclear antibody">antinuclear antibody</a>/ANA) are all performed at this stage. Elevated <a href="/wiki/Ferritin" title="Ferritin">ferritin</a> levels can reveal <a class="mw-redirect" href="/wiki/Hemochromatosis" title="Hemochromatosis">hemochromatosis</a>, a mimic of RA, or be a sign of <a href="/wiki/Adult-onset_Still%27s_disease" title="Adult-onset Still's disease">Still's disease</a>, a seronegative, usually juvenile, variant of rheumatoid arthritis.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2008)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Classification_Criteria">Classification Criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=13" title="Edit section: Classification Criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2010 the <i>2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria</i> were introduced.<sup class="reference" id="cite_ref-acr-eular_52-0"><a href="#cite_note-acr-eular-52">[52]</a></sup><sup class="reference" id="cite_ref-53"><a href="#cite_note-53">[53]</a></sup> The new criterion is not a diagnostic criterion but a classification criterion to identify disease with a high likelihood of developing a chronic form.<sup class="reference" id="cite_ref-McGraw_Hill_14-5"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup> However a score of 6 or greater unequivocally classifies a person with a diagnosis of rheumatoid arthritis.</p>
<p>These new classification criteria overruled the "old" ACR criteria of 1987 and are adapted for early RA diagnosis. The "new" classification criteria, jointly published by the <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> (ACR) and the <a href="/wiki/European_League_Against_Rheumatism" title="European League Against Rheumatism">European League Against Rheumatism</a> (EULAR) establish a point value between 0 and 10. Four areas are covered in the diagnosis:<sup class="reference" id="cite_ref-acr-eular_52-1"><a href="#cite_note-acr-eular-52">[52]</a></sup></p>
<ul>
<li>joint involvement, designating the <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joints</a>, <a class="mw-redirect" href="/wiki/Proximal_interphalangeal_joint" title="Proximal interphalangeal joint">proximal interphalangeal joints</a>, the <a class="mw-redirect" href="/wiki/Interphalangeal_articulations_of_hand" title="Interphalangeal articulations of hand">interphalangeal joint</a> of the thumb, second through fifth <a class="mw-redirect" href="/wiki/Metatarsophalangeal_joint" title="Metatarsophalangeal joint">metatarsophalangeal joint</a> and <a href="/wiki/Wrist" title="Wrist">wrist</a> as <i>small joints</i>, and <a href="/wiki/Shoulder" title="Shoulder">shoulders</a>, <a href="/wiki/Elbow" title="Elbow">elbows</a>, <a class="mw-redirect" href="/wiki/Hip_joint" title="Hip joint">hip joints</a>, <a href="/wiki/Knee" title="Knee">knees</a>, and <a href="/wiki/Ankle" title="Ankle">ankles</a> as <i>large joints</i>:
<ul>
<li>Involvement of 1 large joint gives 0 points</li>
<li>Involvement of 2–10 large joints gives 1 point</li>
<li>Involvement of 1–3 small joints (with or without involvement of large joints) gives 2 points</li>
<li>Involvement of 4–10 small joints (with or without involvement of large joints) gives 3 points</li>
<li>Involvement of more than 10 joints (with involvement of at least 1 small joint) gives 5 points</li>
</ul>
</li>
<li>serological parameters – including the <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a> as well as <a class="mw-redirect" href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">ACPA</a> – "ACPA" stands for "anti-citrullinated protein antibody":
<ul>
<li>Negative RF <i>and</i> negative ACPA gives 0 points</li>
<li>Low-positive RF <i>or</i> low-positive ACPA gives 2 points</li>
<li>High-positive RF <i>or</i> high-positive ACPA gives 3 points</li>
</ul>
</li>
<li>acute phase reactants: 1 point for elevated erythrocyte sedimentation rate, <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">ESR</a>, or elevated <a href="/wiki/C-reactive_protein" title="C-reactive protein">CRP</a> value (c-reactive protein)</li>
<li>duration of <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>: 1 point for symptoms lasting six weeks or longer</li>
</ul>
<p>The new criteria accommodate to the growing understanding of RA and the improvements in diagnosing RA and disease treatment. In the "new" criteria serology and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diagnostics</a> carries major weight, as ACPA detection is appropriate to diagnose the disease in an early state, before joints destructions occur. Destruction of the joints viewed in radiological images was a significant point of the ACR criteria from 1987.<sup class="reference" id="cite_ref-54"><a href="#cite_note-54">[54]</a></sup> This criterion no longer is regarded to be relevant, as this is just the type of damage that treatment is meant to avoid.</p>
<p>In clinical practice, the following criteria apply:<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2010)">citation needed</span></a></i>]</sup></p>
<ul>
<li>two or more swollen joints</li>
<li>morning stiffness lasting more than one hour for at least six weeks</li>
<li>the detection of <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factors</a> or <a href="/wiki/Autoantibody" title="Autoantibody">autoantibodies</a> against <a class="mw-redirect" href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">ACPA</a> such as autoantibodies to <a class="mw-redirect" href="/wiki/Anti-MCV" title="Anti-MCV">mutated citrullinated vimentin</a> can confirm the suspicion of RA. A negative autoantibody result does not exclude a diagnosis of RA.</li>
</ul>
<h3><span class="mw-headline" id="Differential_diagnoses">Differential diagnoses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=14" title="Edit section: Differential diagnoses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several other medical conditions can resemble RA, and usually need to be distinguished from it at the time of diagnosis:<sup class="reference" id="cite_ref-Merckmanual_55-0"><a href="#cite_note-Merckmanual-55">[55]</a></sup><sup class="reference" id="cite_ref-56"><a href="#cite_note-56">[56]</a></sup></p>
<ul>
<li>Crystal induced arthritis (<a href="/wiki/Gout" title="Gout">gout</a>, and <a class="mw-redirect" href="/wiki/Pseudogout" title="Pseudogout">pseudogout</a>) – usually involves particular joints (knee, MTP1, heels) and can be distinguished with an aspiration of joint fluid if in doubt. Redness, asymmetric distribution of affected joints, pain occurs at night and the starting pain is less than an hour with gout.</li>
<li><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a> – distinguished with <a href="/wiki/X-ray" title="X-ray">X-rays</a> of the affected joints and blood tests, age (mostly older persons), starting pain less than an hour, asymmetric distribution of affected joints and pain worsens when using joint for longer periods.</li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a> (SLE) – distinguished by specific clinical symptoms and blood tests (antibodies against double-stranded DNA)</li>
<li>One of the several types of <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a> resembles RA – nail changes and skin symptoms distinguish between them</li>
<li><a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a> causes erosive arthritis and may closely resemble RA – it may be distinguished by blood test in endemic areas</li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (previously Reiter's disease) – asymmetrically involves heel, <a class="mw-redirect" href="/wiki/Sacroiliac" title="Sacroiliac">sacroiliac</a> joints and large joints of the leg. It is usually associated with <a href="/wiki/Urethritis" title="Urethritis">urethritis</a>, <a href="/wiki/Conjunctivitis" title="Conjunctivitis">conjunctivitis</a>, <a class="mw-redirect" href="/wiki/Iritis" title="Iritis">iritis</a>, painless buccal ulcers, and <a class="mw-redirect" href="/wiki/Keratoderma_blennorrhagica" title="Keratoderma blennorrhagica">keratoderma blennorrhagica</a>.</li>
<li><a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a> – this involves the spine, although an RA-like symmetrical small-joint polyarthritis may occur in the context of this condition.</li>
<li><a href="/wiki/Hepatitis_C" title="Hepatitis C">Hepatitis C</a> – RA-like symmetrical small-joint polyarthritis may occur in the context of this condition. Hepatitis C may also induce Rheumatoid Factor auto-antibodies</li>
</ul>
<p>Rarer causes that usually behave differently but may cause joint pains:<sup class="reference" id="cite_ref-Merckmanual_55-1"><a href="#cite_note-Merckmanual-55">[55]</a></sup></p>
<ul>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a>, amyloidosis, and <a href="/wiki/Whipple%27s_disease" title="Whipple's disease">Whipple's disease</a> can also resemble RA.</li>
<li><a class="mw-redirect" href="/wiki/Hemochromatosis" title="Hemochromatosis">Hemochromatosis</a> may cause hand joint arthritis.</li>
<li>Acute rheumatic fever can be differentiated from RA by a migratory pattern of joint involvement and evidence of antecedent <a class="mw-redirect" href="/wiki/Streptococcal" title="Streptococcal">streptococcal</a> infection. Bacterial arthritis (such as by <i><a href="/wiki/Streptococcus" title="Streptococcus">Streptococcus</a></i>) is usually asymmetric, while RA usually involves both sides of the body symmetrically.</li>
<li><a class="mw-redirect" href="/wiki/Gonococcal" title="Gonococcal">Gonococcal</a> arthritis (another bacterial arthritis) is also initially migratory and can involve <a class="mw-redirect" href="/wiki/Tendons" title="Tendons">tendons</a> around the wrists and ankles.</li>
</ul>
<p>Some patients are in a situation of undifferentiation (i.e. none of the above criteria is positive), even if synovitis is witnessed and assessed with ultrasound imaging.</p>
<h3><span class="mw-headline" id="Monitoring_progression">Monitoring progression</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=15" title="Edit section: Monitoring progression">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There are many tools available for monitoring remission in rheumatoid arthritis.</p>
<dl>
<dt>DAS28</dt>
<dd><i>Disease Activity Score of 28 joints</i> (<span id="DAS28">DAS28</span>) is widely used as an indicator of RA disease activity and response to treatment, but is not always a reliable indicator of treatment effect.<sup class="reference" id="cite_ref-57"><a href="#cite_note-57">[57]</a></sup> The joints included in DAS28 are (<a class="mw-redirect" href="/wiki/Bilateral_symmetry" title="Bilateral symmetry">bilaterally</a>): <a class="mw-redirect" href="/wiki/Proximal_interphalangeal_joint" title="Proximal interphalangeal joint">proximal interphalangeal joints</a> (10 joints), <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joints</a> (10), <a href="/wiki/Wrist" title="Wrist">wrists</a> (2), <a href="/wiki/Elbow" title="Elbow">elbows</a> (2), <a href="/wiki/Shoulder" title="Shoulder">shoulders</a> (2) and <a href="/wiki/Knee" title="Knee">knees</a> (2). When looking at these joints, both the number of joints with tenderness upon touching (TEN28) and swelling (SW28) are counted. In addition, the <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR) is measured. Also, the affected person makes a subjective assessment (SA) of disease activity during the preceding 7 days on a scale between 0 and 100, where 0 is "no activity" and 100 is "highest activity possible". With these parameters, DAS28 is calculated as:<sup class="reference" id="cite_ref-Prevoo1995_58-0"><a href="#cite_note-Prevoo1995-58">[58]</a></sup></dd>
</dl>
<p><span><span class="mwe-math-mathml-inline mwe-math-mathml-a11y" style="display: none;"><math xmlns="http://www.w3.org/1998/Math/MathML">
<semantics>
<mrow class="MJX-TeXAtom-ORD">
<mstyle displaystyle="true" scriptlevel="0">
<mi>D</mi>
<mi>A</mi>
<mi>S</mi>
<mn>28</mn>
<mo>=</mo>
<mn>0.56</mn>
<mo>×<!-- × --></mo>
<mrow class="MJX-TeXAtom-ORD">
<msqrt>
<mi>T</mi>
<mi>E</mi>
<mi>N</mi>
<mn>28</mn>
</msqrt>
</mrow>
<mo>+</mo>
<mn>0.28</mn>
<mo>×<!-- × --></mo>
<mrow class="MJX-TeXAtom-ORD">
<msqrt>
<mi>S</mi>
<mi>W</mi>
<mn>28</mn>
</msqrt>
</mrow>
<mo>+</mo>
<mn>0.70</mn>
<mo>×<!-- × --></mo>
<mi>ln</mi>
<mo>⁡<!-- ⁡ --></mo>
<mo stretchy="false">(</mo>
<mi>E</mi>
<mi>S</mi>
<mi>R</mi>
<mo stretchy="false">)</mo>
<mo>+</mo>
<mn>0.014</mn>
<mo>×<!-- × --></mo>
<mi>S</mi>
<mi>A</mi>
</mstyle>
</mrow>
<annotation encoding="application/x-tex">{\displaystyle DAS28=0.56\times {\sqrt {TEN28}}+0.28\times {\sqrt {SW28}}+0.70\times \ln(ESR)+0.014\times SA}</annotation>
</semantics>
</math></span><img alt="DAS28=0.56\times {\sqrt {TEN28}}+0.28\times {\sqrt {SW28}}+0.70\times \ln(ESR)+0.014\times SA" aria-hidden="true" class="mwe-math-fallback-image-inline" src="https://wikimedia.org/api/rest_v1/media/math/render/svg/72f2d725a63dc89947190fb31d949be971a86f0f" style="vertical-align: -0.838ex; width:78.656ex; height:3.176ex;"/></span></p>
<p>From this, the disease activity of the affected person can be classified as follows:<sup class="reference" id="cite_ref-Prevoo1995_58-1"><a href="#cite_note-Prevoo1995-58">[58]</a></sup></p>
<table class="wikitable">
<tr>
<th colspan="2" rowspan="2">Current<br/>
DAS28</th>
<th colspan="3">DAS28 decrease from initial value</th>
</tr>
<tr>
<td><a class="mw-redirect" href="/wiki/More_than" title="More than">&gt;</a> 1.2</td>
<td>&gt; 0.6 but <a class="mw-redirect" href="/wiki/Less_than_or_equal_to" title="Less than or equal to">≤</a> 1.2</td>
<td>≤ 0.6</td>
</tr>
<tr>
<td><a class="mw-redirect" href="/wiki/Less_than_or_equal_to" title="Less than or equal to">≤</a> 3.2</td>
<td>Inactive</td>
<td>Good improvement</td>
<td>Moderate improvement</td>
<td>No improvement</td>
</tr>
<tr>
<td><a class="mw-redirect" href="/wiki/More_than" title="More than">&gt;</a> 3.2 but ≤ 5.1</td>
<td>Moderate</td>
<td>Moderate improvement</td>
<td>Moderate improvement</td>
<td>No improvement</td>
</tr>
<tr>
<td>&gt; 5.1</td>
<td>Very active</td>
<td>Moderate improvement</td>
<td>No improvement</td>
<td>No improvement</td>
</tr>
</table>
<p>One major limitation of use of the DAS28 score in clinical setting is low-grade synovitis may be missed.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2015)">citation needed</span></a></i>]</sup></p>
<dl>
<dt>Other</dt>
<dd>Other tools to monitor remission in rheumatoid arthritis are: ACR-EULAR Provisional Definition of Remission of Rheumatoid arthritis, <a class="new" href="/w/index.php?title=Simplified_Disease_Activity_Index&amp;action=edit&amp;redlink=1" title="Simplified Disease Activity Index (page does not exist)">Simplified Disease Activity Index</a> (SDAI) and <a class="new" href="/w/index.php?title=Clinical_Disease_Activity_Index&amp;action=edit&amp;redlink=1" title="Clinical Disease Activity Index (page does not exist)">Clinical Disease Activity Index</a> (CDAI).<sup class="reference" id="cite_ref-59"><a href="#cite_note-59">[59]</a></sup> Some scores are also available that do not require the input from a healthcare professional and thus allow self-monitoring by the person, like HAQ-DI.<sup class="reference" id="cite_ref-60"><a href="#cite_note-60">[60]</a></sup></dd>
</dl>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=16" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no known prevention for the condition other than the reduction of risk factors.<sup class="reference" id="cite_ref-Healthline_61-0"><a href="#cite_note-Healthline-61">[61]</a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=17" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no cure for RA, but treatments can improve symptoms and slow the progress of the disease. Disease-modifying treatment has the best results when it is started early and aggressively.<sup class="reference" id="cite_ref-ACR2008_62-0"><a href="#cite_note-ACR2008-62">[62]</a></sup></p>
<p>The goals of treatment are to minimize symptoms such as pain and swelling, to prevent bone deformity (for example, bone erosions visible in X-rays), and to maintain day-to-day functioning.<sup class="reference" id="cite_ref-Wasserman_63-0"><a href="#cite_note-Wasserman-63">[63]</a></sup> This can often be achieved using two main classes of medications: analgesics such as NSAIDs, and <a class="mw-redirect" href="/wiki/Disease-modifying_antirheumatic_drugs" title="Disease-modifying antirheumatic drugs">disease-modifying antirheumatic drugs</a> (DMARDs).<sup class="reference" id="cite_ref-NICEguidelines_64-0"><a href="#cite_note-NICEguidelines-64">[64]</a></sup> RA should generally be treated with at least one specific anti-rheumatic medication.<sup class="reference" id="cite_ref-ACR2008_62-1"><a href="#cite_note-ACR2008-62">[62]</a></sup> The use of <a class="mw-redirect" href="/wiki/Benzodiazepines" title="Benzodiazepines">benzodiazepines</a> (such as <a href="/wiki/Diazepam" title="Diazepam">diazepam</a>) to treat the pain is not recommended as it does not appear to help and is associated with risks.<sup class="reference" id="cite_ref-65"><a href="#cite_note-65">[65]</a></sup> <a class="mw-redirect" href="/wiki/Analgesics" title="Analgesics">Analgesics</a>, other than NSAIDs, offer lesser, but some benefit with respect to pain whilst not causing the same level of gastrointestinal irritation.<sup class="reference" id="cite_ref-Lancet2010_3-6"><a href="#cite_note-Lancet2010-3">[3]</a></sup></p>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=18" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Regular exercise is recommended as both safe and useful to maintain muscles strength and overall physical function.<sup class="reference" id="cite_ref-66"><a href="#cite_note-66">[66]</a></sup> It is uncertain if specific dietary measures have an effect.<sup class="reference" id="cite_ref-67"><a href="#cite_note-67">[67]</a></sup> Physical activity is beneficial for persons with Rheumatoid arthritis complaining of fatigue.<sup class="reference" id="cite_ref-68"><a href="#cite_note-68">[68]</a></sup> Occupational therapy has a positive role to play in improving functional ability of persons with rheumatoid arthritis.<sup class="reference" id="cite_ref-69"><a href="#cite_note-69">[69]</a></sup></p>
<h3><span class="mw-headline" id="Disease_modifying_agents">Disease modifying agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=19" title="Edit section: Disease modifying agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a class="mw-redirect" href="/wiki/Disease-modifying_antirheumatic_drugs" title="Disease-modifying antirheumatic drugs">Disease-modifying antirheumatic drugs</a> (DMARDs) are the primary treatment for RA.<sup class="reference" id="cite_ref-Lancet2010_3-7"><a href="#cite_note-Lancet2010-3">[3]</a></sup> They are a diverse collection of drugs, grouped by use and convention. They have been found to improve symptoms, decrease joint damage, and improve overall functional abilities.<sup class="reference" id="cite_ref-Lancet2010_3-8"><a href="#cite_note-Lancet2010-3">[3]</a></sup> DMARDs should be started early in the disease as they result in disease remission in approximately half of people and improved outcomes overall.<sup class="reference" id="cite_ref-70"><a href="#cite_note-70">[70]</a></sup> The following drugs are considered as DMARDs: <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>, <a href="/wiki/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a>, <a href="/wiki/Sulfasalazine" title="Sulfasalazine">sulfasalazine</a>, <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>, TNF-alpha inhibitors (<a href="/wiki/Certolizumab_pegol" title="Certolizumab pegol">certolizumab</a>, <a href="/wiki/Infliximab" title="Infliximab">infliximab</a> and <a href="/wiki/Etanercept" title="Etanercept">etanercept</a>), <a href="/wiki/Abatacept" title="Abatacept">abatacept</a>, and <a href="/wiki/Anakinra" title="Anakinra">anakinra</a>. <a href="/wiki/Rituximab" title="Rituximab">Rituximab</a> and <a href="/wiki/Tocilizumab" title="Tocilizumab">tocilizumab</a> are monoclonal antibodies and are also DMARDs.</p>
<p>The most commonly used agent is methotrexate with other frequently used agents including sulfasalazine and leflunomide. <a href="/wiki/Sodium_aurothiomalate" title="Sodium aurothiomalate">Sodium aurothiomalate</a> (gold) and <a class="mw-redirect" href="/wiki/Cyclosporin" title="Cyclosporin">cyclosporin</a> are less commonly used due to more common adverse effects. Agents may be used in combinations.<sup class="reference" id="cite_ref-Lancet2010_3-9"><a href="#cite_note-Lancet2010-3">[3]</a></sup> Methotrexate is the most important and useful DMARD and is usually the first treatment.<sup class="reference" id="cite_ref-Wasserman_63-1"><a href="#cite_note-Wasserman-63">[63]</a></sup><sup class="reference" id="cite_ref-NICEguidelines_64-1"><a href="#cite_note-NICEguidelines-64">[64]</a></sup><sup class="reference" id="cite_ref-chapter94_71-0"><a href="#cite_note-chapter94-71">[71]</a></sup> Adverse effects should be monitored regularly with toxicity including gastrointestinal, hematologic, pulmonary, and hepatic.<sup class="reference" id="cite_ref-chapter94_71-1"><a href="#cite_note-chapter94-71">[71]</a></sup> Side effects such as nausea, vomiting or abdominal pain can be reduced by taking folic acid.<sup class="reference" id="cite_ref-72"><a href="#cite_note-72">[72]</a></sup> The most common undesirable effect is that it increases liver enzymes in almost 15% of people.<sup class="reference" id="cite_ref-chapter94_71-2"><a href="#cite_note-chapter94-71">[71]</a></sup> It is thus recommended that those who consistently demonstrate abnormal levels of liver enzymes or have a history of liver disease or alcohol use undergo liver biopsies.<sup class="reference" id="cite_ref-ACR2002_73-0"><a href="#cite_note-ACR2002-73">[73]</a></sup></p>
<p>Biological agents should generally only be used if methotrexate and other conventional agents are not effective after a trial of three months.<sup class="reference" id="cite_ref-74"><a href="#cite_note-74">[74]</a></sup> They are associated with a higher rate of serious infections as compared to other DMARDs.<sup class="reference" id="cite_ref-75"><a href="#cite_note-75">[75]</a></sup> These agents used to treat rheumatoid arthritis include: <a href="/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha">tumor necrosis factor alpha</a> (TNFα) blockers<sup class="reference" id="cite_ref-Lancet2010_3-10"><a href="#cite_note-Lancet2010-3">[3]</a></sup> such as <a href="/wiki/Infliximab" title="Infliximab">infliximab</a>; <a class="mw-redirect" href="/wiki/Interleukin_1" title="Interleukin 1">interleukin 1</a> blockers such as <a href="/wiki/Anakinra" title="Anakinra">anakinra</a>, <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibodies</a> against <a href="/wiki/B_cell" title="B cell">B cells</a> such as <a href="/wiki/Rituximab" title="Rituximab">rituximab</a> and tocilizumab,<sup class="reference" id="cite_ref-76"><a href="#cite_note-76">[76]</a></sup> <a href="/wiki/T_cell" title="T cell">T cell</a> costimulation blocker such as abatacept among others. They are often used in combination with either methotrexate or leflunomide.<sup class="reference" id="cite_ref-Lancet2010_3-11"><a href="#cite_note-Lancet2010-3">[3]</a></sup> In those who are well controlled on TNF blockers decreasing the dose does not appear to affect overall function.<sup class="reference" id="cite_ref-77"><a href="#cite_note-77">[77]</a></sup> Persons should be screened for <a href="/wiki/Latent_tuberculosis" title="Latent tuberculosis">latent tuberculosis</a> before starting any <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF blockers</a> therapy to avoid reactivation.<sup class="reference" id="cite_ref-McGraw_Hill_14-6"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<p>TNF blockers and methotrexate appear to have similar effectiveness when used alone and better results are obtained when used together. TNF blockers appear to have equivalent effectiveness with <a href="/wiki/Etanercept" title="Etanercept">etanercept</a> appearing to be the safest.<sup class="reference" id="cite_ref-78"><a href="#cite_note-78">[78]</a></sup> Abatacept appears effective for RA with 20% more people improving with treatment than without but long term safety studies are yet unavailable.<sup class="reference" id="cite_ref-79"><a href="#cite_note-79">[79]</a></sup> However, there is a lack of evidence to distinguish between the biologics available for RA.<sup class="reference" id="cite_ref-80"><a href="#cite_note-80">[80]</a></sup> Issues with the biologics include their high cost and association with infections including <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a>.<sup class="reference" id="cite_ref-Lancet2010_3-12"><a href="#cite_note-Lancet2010-3">[3]</a></sup></p>
<h3><span class="mw-headline" id="Anti-inflammatory_agents">Anti-inflammatory agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=20" title="Edit section: Anti-inflammatory agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a class="mw-redirect" href="/wiki/NSAIDs" title="NSAIDs">NSAIDs</a> reduce both pain and stiffness in those with RA.<sup class="reference" id="cite_ref-Lancet2010_3-13"><a href="#cite_note-Lancet2010-3">[3]</a></sup> Generally they appear to have no effect on people's long term disease course and thus are no longer first line agents.<sup class="reference" id="cite_ref-Lancet2010_3-14"><a href="#cite_note-Lancet2010-3">[3]</a></sup><sup class="reference" id="cite_ref-81"><a href="#cite_note-81">[81]</a></sup> NSAIDs should be used with caution in those with <a class="mw-redirect" href="/wiki/Gastrointestinal_problem" title="Gastrointestinal problem">gastrointestinal</a>, <a class="mw-redirect" href="/wiki/Cardiovascular" title="Cardiovascular">cardiovascular</a>, or kidney problems.<sup class="reference" id="cite_ref-82"><a href="#cite_note-82">[82]</a></sup><sup class="reference" id="cite_ref-pmid22141388_83-0"><a href="#cite_note-pmid22141388-83">[83]</a></sup><sup class="reference" id="cite_ref-84"><a href="#cite_note-84">[84]</a></sup> Use of methotrexate together with NSAIDS is safe, if adequate monitoring is done.<sup class="reference" id="cite_ref-85"><a href="#cite_note-85">[85]</a></sup></p>
<p><a href="/wiki/COX-2_inhibitor" title="COX-2 inhibitor">COX-2 inhibitors</a>, such as <a href="/wiki/Celecoxib" title="Celecoxib">celecoxib</a>, and NSAIDs are equally effective.<sup class="reference" id="cite_ref-Job2008_86-0"><a href="#cite_note-Job2008-86">[86]</a></sup> They have a similar gastrointestinal risk as an NSAIDs plus a <a class="mw-redirect" href="/wiki/Proton_pump_inhibitor" title="Proton pump inhibitor">proton pump inhibitor</a>.<sup class="reference" id="cite_ref-87"><a href="#cite_note-87">[87]</a></sup> In the elderly there is less gastrointestinal intolerance to celecoxib than to NSAIDs alone.<sup class="reference" id="cite_ref-88"><a href="#cite_note-88">[88]</a></sup> There however is an increased risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> with COX-2 inhibitors.<sup class="reference" id="cite_ref-Job2008_86-1"><a href="#cite_note-Job2008-86">[86]</a></sup> Anti-ulcer medications are not recommended routinely but only in those high risk of gastrointestinal problems.<sup class="reference" id="cite_ref-89"><a href="#cite_note-89">[89]</a></sup></p>
<p><a class="mw-redirect" href="/wiki/Glucocorticoids" title="Glucocorticoids">Glucocorticoids</a> can be used in the short term for flare-ups, while waiting for slow-onset drugs to take effect.<sup class="reference" id="cite_ref-Lancet2010_3-15"><a href="#cite_note-Lancet2010-3">[3]</a></sup> Injection of glucocorticoids into individual joints is also effective.<sup class="reference" id="cite_ref-Lancet2010_3-16"><a href="#cite_note-Lancet2010-3">[3]</a></sup> While long-term use reduces joint damage it also results in osteoporosis and susceptibility to infections, and thus is not recommended.<sup class="reference" id="cite_ref-Lancet2010_3-17"><a href="#cite_note-Lancet2010-3">[3]</a></sup></p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=21" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In early phases of the disease, an arthroscopic or open <a href="/wiki/Synovectomy" title="Synovectomy">synovectomy</a> may be performed. It consists of the removal of the inflamed <a class="mw-redirect" href="/wiki/Synovia" title="Synovia">synovia</a> and prevents a quick destruction of the affected joints. Severely affected joints may require <a href="/wiki/Joint_replacement" title="Joint replacement">joint replacement</a> surgery, such as knee replacement.<sup class="reference" id="cite_ref-Lancet2010_3-18"><a href="#cite_note-Lancet2010-3">[3]</a></sup> Postoperatively, <a class="mw-redirect" href="/wiki/Physiotherapy" title="Physiotherapy">physiotherapy</a> is always necessary.</p>
<h3><span class="mw-headline" id="Alternative_medicine">Alternative medicine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=22" title="Edit section: Alternative medicine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In general, there is not enough evidence to support any complementary health approaches for RA, with safety concerns for some of them. Some mind and body practices and dietary supplements may help people with symptoms and therefore may be beneficial additions to conventional treatments, but there is not enough evidence to draw conclusions.<sup class="reference" id="cite_ref-NCCIH_6-1"><a href="#cite_note-NCCIH-6">[6]</a></sup> A <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> of <a class="mw-redirect" href="/wiki/Complementary_and_alternative_medicine" title="Complementary and alternative medicine">CAM</a> modalities (excluding fish oil) found that " The available evidence does not support their current use in the management of RA.".<sup class="reference" id="cite_ref-Macfarlane_90-0"><a href="#cite_note-Macfarlane-90">[90]</a></sup> Studies showing beneficial effects in RA on a wide variety of CAM modalities are often affected by <a href="/wiki/Publication_bias" title="Publication bias">publication bias</a> and are generally not high quality evidence such as <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trials</a> (RCTs).<sup class="reference" id="cite_ref-Ef2010_5-1"><a href="#cite_note-Ef2010-5">[5]</a></sup></p>
<p>A 2005 Cochrane review states that <a href="/wiki/Low_level_laser_therapy" title="Low level laser therapy">low level laser therapy</a> can be tried to improve pain and morning stiffness due to rheumatoid arthritis as there are few side-effects.<sup class="reference" id="cite_ref-91"><a href="#cite_note-91">[91]</a></sup></p>
<p>There is some evidence that <a class="mw-redirect" href="/wiki/Tai_Chi" title="Tai Chi">Tai Chi</a> improves the range of motion of a joint in persons with rheumatoid arthritis.<sup class="reference" id="cite_ref-92"><a href="#cite_note-92">[92]</a></sup> The evidence for acupuncture is inconclusive<sup class="reference" id="cite_ref-93"><a href="#cite_note-93">[93]</a></sup> with it appearing to be equivalent to sham acupuncture.<sup class="reference" id="cite_ref-94"><a href="#cite_note-94">[94]</a></sup></p>
<h4><span class="mw-headline" id="Dietary_supplements">Dietary supplements</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=23" title="Edit section: Dietary supplements">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<dl>
<dt>Omega-3</dt>
<dd>Some evidence supports omega-3 fatty acids and <a class="mw-redirect" href="/wiki/Gamma-linolenic_acid" title="Gamma-linolenic acid">gamma-linolenic acid</a> in RA.<sup class="reference" id="cite_ref-95"><a href="#cite_note-95">[95]</a></sup> The benefit from omega-3 appears modest but consistent,<sup class="reference" id="cite_ref-96"><a href="#cite_note-96">[96]</a></sup> though the current evidence is not strong enough to determine that supplementation with <a href="/wiki/Omega-3_fatty_acid" title="Omega-3 fatty acid">omega-3 polyunsaturated fatty acids</a> (found in fish oil) is an effective treatment for RA.<sup class="reference" id="cite_ref-97"><a href="#cite_note-97">[97]</a></sup> Gamma-linolenic acid, which may reduce pain, tender joint count and stiffness, is generally safe.<sup class="reference" id="cite_ref-98"><a href="#cite_note-98">[98]</a></sup></dd>
</dl>
<dl>
<dt>Herbal</dt>
<dd>The <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> states that no herbal medicines have health claims supported by high-quality evidence and thus they do not recommend their use.<sup class="reference" id="cite_ref-ACRCAM_99-0"><a href="#cite_note-ACRCAM-99">[99]</a></sup> There is no scientific basis to suggest that herbal supplements advertised as "natural" are safer for use than conventional medications as both are chemicals. Herbal medications, although labelled "natural", may be toxic or fatal if consumed.<sup class="reference" id="cite_ref-ACRCAM_99-1"><a href="#cite_note-ACRCAM-99">[99]</a></sup></dd>
</dl>
<p>Due to the false belief that herbal supplements are always safe, there is sometimes a hesitancy to report their use which may increase the risk of adverse reaction.<sup class="reference" id="cite_ref-Ef2010_5-2"><a href="#cite_note-Ef2010-5">[5]</a></sup></p>
<p>The following are under investigation for treatments for RA, based on preliminary promising results (not recommended for clinical use yet): <a href="/wiki/Boswellic_acid" title="Boswellic acid">boswellic acid</a>,<sup class="reference" id="cite_ref-100"><a href="#cite_note-100">[100]</a></sup> <a href="/wiki/Curcumin" title="Curcumin">curcumin</a>,<sup class="reference" id="cite_ref-101"><a href="#cite_note-101">[101]</a></sup> <a href="/wiki/Harpagophytum" title="Harpagophytum">devil's claw</a>,<sup class="reference" id="cite_ref-102"><a href="#cite_note-102">[102]</a></sup><sup class="reference" id="cite_ref-pmid17627199_103-0"><a href="#cite_note-pmid17627199-103">[103]</a></sup> <a href="/wiki/Euonymus_alatus" title="Euonymus alatus">Euonymus alatus</a>,<sup class="reference" id="cite_ref-104"><a href="#cite_note-104">[104]</a></sup> and <a href="/wiki/Tripterygium_wilfordii" title="Tripterygium wilfordii">thunder god vine (<i>Tripterygium wilfordii</i>)</a>.<sup class="reference" id="cite_ref-pmid21365177_105-0"><a href="#cite_note-pmid21365177-105">[105]</a></sup> <a href="/wiki/National_Center_for_Complementary_and_Integrative_Health" title="National Center for Complementary and Integrative Health">NCCIH</a> has noted that, "In particular, the herb thunder god vine (Tripterygium wilfordii) can have serious side effects."<sup class="reference" id="cite_ref-NCCIH_6-2"><a href="#cite_note-NCCIH-6">[6]</a></sup></p>
<p>There is conflicting evidence on the role of <a href="/wiki/Erythropoiesis" title="Erythropoiesis">erythropoiesis</a>-stimulating agents for treatment of anemia in persons with rheumatoid arthritis.<sup class="reference" id="cite_ref-106"><a href="#cite_note-106">[106]</a></sup></p>
<h3><span class="mw-headline" id="Pregnancy">Pregnancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=24" title="Edit section: Pregnancy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>More than 75% of people with rheumatoid arthritis have symptoms improve during pregnancy but might have worsenings after delivery.<sup class="reference" id="cite_ref-McGraw_Hill_14-7"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup> <a href="/wiki/Methotrexate" title="Methotrexate">Methotrexate</a> and <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a> are teratogenic (harmful to foetus) and not used in pregnancy. It is recommended women of childbearing age should use contraceptives to avoid pregnancy and to discontinue its use if pregnancy is planned.<sup class="reference" id="cite_ref-Wasserman_63-2"><a href="#cite_note-Wasserman-63">[63]</a></sup><sup class="reference" id="cite_ref-chapter94_71-3"><a href="#cite_note-chapter94-71">[71]</a></sup> Low dose of <a href="/wiki/Prednisolone" title="Prednisolone">prednisolone</a>, <a href="/wiki/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a> and <a href="/wiki/Sulfasalazine" title="Sulfasalazine">sulfasalazine</a> are considered safe in pregnant persons with rheumatoid arthritis.</p>
<h3><span class="mw-headline" id="Vaccinations">Vaccinations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=25" title="Edit section: Vaccinations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>People with RA have an increased risk of infections and mortality and recommended vaccinations can reduce these risks.<sup class="reference" id="cite_ref-107"><a href="#cite_note-107">[107]</a></sup> The inactivated <a href="/wiki/Influenza_vaccine" title="Influenza vaccine">influenza vaccine</a> should be received annually.<sup class="reference" id="cite_ref-108"><a href="#cite_note-108">[108]</a></sup> The <a href="/wiki/Pneumococcal_vaccine" title="Pneumococcal vaccine">pneumococcal vaccine</a> should be administered twice for people under the age 65 and once for those over 65.<sup class="reference" id="cite_ref-109"><a href="#cite_note-109">[109]</a></sup> Lastly, the live-attenuated <a href="/wiki/Zoster_vaccine" title="Zoster vaccine">zoster vaccine</a> should be administered once after the age 60, but is not recommended in people on a <a href="/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha">tumor necrosis factor alpha</a> blocker.<sup class="reference" id="cite_ref-110"><a href="#cite_note-110">[110]</a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=26" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:292px;"><a class="image" href="/wiki/File:Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg"><img alt="" class="thumbimage" data-file-height="415" data-file-width="940" height="128" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/290px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/435px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/580px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png 2x" width="290"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg" title="Enlarge"></a></div>
<a href="/wiki/Disability-adjusted_life_year" title="Disability-adjusted life year">Disability-adjusted life year</a> for RA per 100,000 inhabitants in 2004.<sup class="reference" id="cite_ref-111"><a href="#cite_note-111">[111]</a></sup>
<div class="div-col columns column-count column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;"> </span> no data</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;"> </span> &lt;40</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;"> </span> 40–50</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;"> </span> 50–60</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;"> </span> 60–70</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;"> </span> 70–80</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;"> </span> 80–90</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;"> </span> 90–100</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;"> </span> 100–110</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;"> </span> 110–120</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;"> </span> 120–130</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;"> </span> 130–140</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;"> </span> &gt;140</div>
</div>
</div>
</div>
</div>
<p>The course of the disease varies greatly. Some people have mild short-term symptoms, but in most the disease is progressive for life. Around 20%–30% will have subcutaneous nodules (known as <a href="/wiki/Rheumatoid_nodule" title="Rheumatoid nodule">rheumatoid nodules</a>); this is associated with a poor prognosis.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2014)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Prognostic_factors">Prognostic factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=27" title="Edit section: Prognostic factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Poor prognostic factors include,</p>
<ul>
<li>Persistent synovitis</li>
<li>Early erosive disease</li>
<li>Extra-articular findings (including subcutaneous rheumatoid nodules)</li>
<li>Positive serum RF findings</li>
<li>Positive serum anti-CCP autoantibodies</li>
<li>Carriership of HLA-DR4 "Shared Epitope" alleles</li>
<li>Family history of RA</li>
<li>Poor functional status</li>
<li>Socioeconomic factors</li>
<li>Elevated acute phase response (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP])</li>
<li>Increased clinical severity.</li>
</ul>
<h3><span class="mw-headline" id="Mortality">Mortality</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=28" title="Edit section: Mortality">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>RA reduces lifespan on average from three to twelve years.<sup class="reference" id="cite_ref-Wasserman_63-3"><a href="#cite_note-Wasserman-63">[63]</a></sup> According to the UK's National Rheumatoid Arthritis Society, Young age at onset, long disease duration, the concurrent presence of other health problems (called co-morbidity), and characteristics of severe RA—such as poor functional ability or overall health status, a lot of joint damage on x-rays, the need for hospitalisation or involvement of organs other than the joints—have been shown to associate with higher mortality".<sup class="reference" id="cite_ref-112"><a href="#cite_note-112">[112]</a></sup> Positive responses to treatment may indicate a better prognosis. A 2005 study by the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a> noted that RA sufferers suffer a doubled risk of heart disease,<sup class="reference" id="cite_ref-113"><a href="#cite_note-113">[113]</a></sup> independent of other risk factors such as <a class="mw-redirect" href="/wiki/Diabetes" title="Diabetes">diabetes</a>, alcohol abuse, and elevated <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>, blood pressure and <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a>. The mechanism by which RA causes this increased risk remains unknown; the presence of chronic inflammation has been proposed as a contributing factor.<sup class="reference" id="cite_ref-114"><a href="#cite_note-114">[114]</a></sup> It is possible that the use of new biologic drug therapies extend the lifespan of people with RA and reduce the risk and progression of atherosclerosis.<sup class="reference" id="cite_ref-pmid20678592_115-0"><a href="#cite_note-pmid20678592-115">[115]</a></sup> This is based on cohort and registry studies, and still remains hypothetical. It is still uncertain whether biologics improve vascular function in RA or not. There was an increase in total cholesterol and HDLc levels and no improvement of the atherogenic index.<sup class="reference" id="cite_ref-biologics_cv_effects.2F_cancer_116-0"><a href="#cite_note-biologics_cv_effects.2F_cancer-116">[116]</a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=29" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:292px;"><a class="image" href="/wiki/File:Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg"><img alt="" class="thumbimage" data-file-height="415" data-file-width="940" height="128" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg/290px-Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg/435px-Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg/580px-Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg.png 2x" width="290"/></a>
<div class="thumbcaption">
<div class="magnify"><a class="internal" href="/wiki/File:Rheumatoid_arthritis_world_map-Deaths_per_million_persons-WHO2012.svg" title="Enlarge"></a></div>
Deaths from rheumatoid arthritis per million persons in 2012
<div class="refbegin columns references-column-count references-column-count-3" style="-moz-column-count: 3; -webkit-column-count: 3; column-count: 3;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff20; color:black; font-size:100%; text-align:center;"> </span> 0–0</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffe820; color:black; font-size:100%; text-align:center;"> </span> 1–1</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffd820; color:black; font-size:100%; text-align:center;"> </span> 2–3</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc020; color:black; font-size:100%; text-align:center;"> </span> 4–5</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffa020; color:black; font-size:100%; text-align:center;"> </span> 6–6</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a20; color:black; font-size:100%; text-align:center;"> </span> 7–8</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #f08015; color:black; font-size:100%; text-align:center;"> </span> 9–9</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #e06815; color:black; font-size:100%; text-align:center;"> </span> 10–12</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d85010; color:black; font-size:100%; text-align:center;"> </span> 13–20</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d02010; color:black; font-size:100%; text-align:center;"> </span> 21–55</div>
</div>
</div>
</div>
</div>
<p>RA affects between 0.5 and 1% of adults in the developed world with between 5 and 50 per 100,000 people newly developing the condition each year.<sup class="reference" id="cite_ref-Lancet2010_3-19"><a href="#cite_note-Lancet2010-3">[3]</a></sup> In 2010 it resulted in about 49,000 deaths globally.<sup class="reference" id="cite_ref-Loz2012_117-0"><a href="#cite_note-Loz2012-117">[117]</a></sup></p>
<p>Onset is uncommon under the age of 15 and from then on the incidence rises with age until the age of 80. Women are affected three to five times as often as men.<sup class="reference" id="cite_ref-McGraw_Hill_14-8"><a href="#cite_note-McGraw_Hill-14">[14]</a></sup></p>
<p>The age at which the disease most commonly starts is in women between 40 and 50 years of age, and for men somewhat later.<sup class="reference" id="cite_ref-118"><a href="#cite_note-118">[118]</a></sup> RA is a chronic disease, and although rarely, a spontaneous remission may occur, the natural course is almost invariably one of the persistent symptoms, waxing and waning in intensity, and a progressive deterioration of joint structures leading to deformations and disability.</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=30" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first known traces of arthritis date back at least as far as 4500 BC. A text dated 123 AD first describes symptoms very similar to RA.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2015)">citation needed</span></a></i>]</sup> It was noted in skeletal remains of Native Americans found in Tennessee.<sup class="reference" id="cite_ref-119"><a href="#cite_note-119">[119]</a></sup> In Europe, the disease is vanishingly rare before the 17th century.<sup class="reference" id="cite_ref-120"><a href="#cite_note-120">[120]</a></sup> The first recognized description of RA in modern medicine was in 1800 by the French physician <a href="/wiki/Augustin_Jacob_Landr%C3%A9-Beauvais" title="Augustin Jacob Landré-Beauvais">Dr Augustin Jacob Landré-Beauvais</a> (1772–1840) who was based in the famed <a href="/wiki/Piti%C3%A9-Salp%C3%AAtri%C3%A8re_Hospital" title="Pitié-Salpêtrière Hospital">Salpêtrière Hospital</a> in Paris.<sup class="reference" id="cite_ref-Landre1800_8-1"><a href="#cite_note-Landre1800-8">[8]</a></sup> The name "rheumatoid arthritis" itself was coined in 1859 by British rheumatologist Dr <a href="/wiki/Alfred_Baring_Garrod" title="Alfred Baring Garrod">Alfred Baring Garrod</a>.<sup class="reference" id="cite_ref-121"><a href="#cite_note-121">[121]</a></sup></p>
<p>An anomaly has been noticed from the investigation of Pre-Columbian bones. The bones from the Tennessee site show no signs of tuberculosis even though it was prevalent at the time throughout the Americas.<sup class="reference" id="cite_ref-pmid14528501_122-0"><a href="#cite_note-pmid14528501-122">[122]</a></sup></p>
<p>The art of <a href="/wiki/Peter_Paul_Rubens" title="Peter Paul Rubens">Peter Paul Rubens</a> may possibly depict the effects of RA. In his later paintings, his rendered hands show, in the opinion of some physicians, increasing deformity consistent with the symptoms of the disease.<sup class="reference" id="cite_ref-pmid7005475_123-0"><a href="#cite_note-pmid7005475-123">[123]</a></sup><sup class="reference" id="cite_ref-124"><a href="#cite_note-124">[124]</a></sup> RA appears to some to have been depicted in 16th-century paintings.<sup class="reference" id="cite_ref-125"><a href="#cite_note-125">[125]</a></sup> However, it is generally recognized in art historical circles that the painting of hands in the 16th and 17th century followed certain stylized conventions, most clearly seen in the Mannerist movement. It was conventional, for instance, to show the upheld right hand of Christ in what now appears a deformed posture. These conventions are easily misinterpreted as portrayals of disease.</p>
<p>Historic treatments for RA have also included: <a href="/wiki/RICE_(medicine)" title="RICE (medicine)">rest, ice, compression and elevation</a>, <a href="/wiki/Apple" title="Apple">apple</a> diet, <a href="/wiki/Nutmeg" title="Nutmeg">nutmeg</a>, some light exercise every now and then, <a href="/wiki/Urtica" title="Urtica">nettles</a>, <a href="/wiki/Bee" title="Bee">bee</a> venom, <a href="/wiki/Copper" title="Copper">copper</a> bracelets, <a href="/wiki/Rhubarb_diet" title="Rhubarb diet">rhubarb diet</a>, extractions of teeth, <a href="/wiki/Fasting" title="Fasting">fasting</a>, <a href="/wiki/Honey" title="Honey">honey</a>, <a href="/wiki/Vitamin" title="Vitamin">vitamins</a>, <a href="/wiki/Insulin" title="Insulin">insulin</a>, <a href="/wiki/Magnet" title="Magnet">magnets</a>, and <a href="/wiki/Electroconvulsive_therapy" title="Electroconvulsive therapy">electroconvulsive therapy</a> (ECT).<sup class="reference" id="cite_ref-126"><a href="#cite_note-126">[126]</a></sup> The <a href="/wiki/Prosorba_column" title="Prosorba column">Prosorba column</a> blood filtering device (removing <a class="mw-redirect" href="/wiki/IgG" title="IgG">IgG</a>) was approved by the FDA in 1999 for treatment of RA<sup class="reference" id="cite_ref-127"><a href="#cite_note-127">[127]</a></sup> However it was discontinued at the end of 2006.<sup class="reference" id="cite_ref-128"><a href="#cite_note-128">[128]</a></sup></p>
<h3><span class="mw-headline" id="Etymology">Etymology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=31" title="Edit section: Etymology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Rheumatoid arthritis is derived from the Greek word <i>ῥεύμα-rheuma (nom.), ῥεύματος-rheumatos (gen.)</i> ("flow, current"). The suffix -<i>oid</i> ("resembling") gives the translation as <i>joint inflammation that resembles rheumatic fever</i>. Rhuma which means watery discharge might refer to the fact that the joints are swollen or that the disease may be made worse by wet weather.<sup class="reference" id="cite_ref-Paget2002_9-1"><a href="#cite_note-Paget2002-9">[9]</a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=32" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The cause of RA has been a subject of intensive research.</p>
<p>One theory is that infections may provoke the autoimmune response characteristic of rheumatoid arthritis. One example of this theory is that unique bacterial species associated with periodontitis may initiate an autoimmune response in genetically susceptible individuals by <a href="/wiki/Citrullination" title="Citrullination">citrullinating</a> self-proteins, thus leading to the production of ACPAs.<sup class="reference" id="cite_ref-129"><a href="#cite_note-129">[129]</a></sup><sup class="reference" id="cite_ref-130"><a href="#cite_note-130">[130]</a></sup> Meta-analysis found an association between periodontal disease and RA, but the mechanism of this association remains unclear.<sup class="reference" id="cite_ref-131"><a href="#cite_note-131">[131]</a></sup><sup class="reference" id="cite_ref-132"><a href="#cite_note-132">[132]</a></sup></p>
<p><a href="/wiki/Vitamin_D_deficiency" title="Vitamin D deficiency">Vitamin D deficiency</a> is more common in people with rheumatoid arthritis than in the general population.<sup class="reference" id="cite_ref-pmid23370372_133-0"><a href="#cite_note-pmid23370372-133">[133]</a></sup><sup class="reference" id="cite_ref-Wen2011_134-0"><a href="#cite_note-Wen2011-134">[134]</a></sup> However, whether vitamin D deficiency is a cause or a consequence of the disease remains unclear.<sup class="reference" id="cite_ref-pmid21067953_135-0"><a href="#cite_note-pmid21067953-135">[135]</a></sup> 1α,25-dihydroxyvitamin D3 (1,25D), an active metabolite of vitamin D, affects bone metabolism indirectly through control of calcium and phosphate homeostasis. Interaction between 1,25D and the vitamin D receptor (VDR) affects the production of RANKL and delays osteoclastogenesis.<sup class="reference" id="cite_ref-136"><a href="#cite_note-136">[136]</a></sup> Some trials have found a decreased risk for RA with vitamin D supplementation while others have not.<sup class="reference" id="cite_ref-Wen2011_134-1"><a href="#cite_note-Wen2011-134">[134]</a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=33" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-NIH2014-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH2014_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH2014_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH2014_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NIH2014_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NIH2014_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NIH2014_1-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.niams.nih.gov/health_info/Rheumatic_Disease/default.asp" rel="nofollow">"Handout on Health: Rheumatoid Arthritis"</a>. <i>National Institute of Arthritis and Musculoskeletal and Skin Diseases</i>. August 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">July 2,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Handout+on+Health%3A+Rheumatoid+Arthritis&amp;rft.date=2014-08&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.niams.nih.gov%2Fhealth_info%2FRheumatic_Disease%2Fdefault.asp&amp;rft.jtitle=National+Institute+of+Arthritis+and+Musculoskeletal+and+Skin+Diseases&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Majithia2007-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Majithia2007_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Majithia2007_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Majithia2007_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Majithia2007_2-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Majithia V, Geraci SA (2007). "Rheumatoid arthritis: diagnosis and management". <i>Am. J. Med</i>. <b>120</b> (11): 936–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.amjmed.2007.04.005" rel="nofollow">10.1016/j.amjmed.2007.04.005</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17976416" rel="nofollow">17976416</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis%3A+diagnosis+and+management&amp;rft.aufirst=V&amp;rft.au=Geraci%2C+SA&amp;rft.aulast=Majithia&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2007.04.005&amp;rft_id=info%3Apmid%2F17976416&amp;rft.issue=11&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=936-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Lancet2010-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2010_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Lancet2010_3-19"><sup><i><b>t</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Scott DL, Wolfe F, Huizinga TW (Sep 25, 2010). "Rheumatoid arthritis". <i>Lancet</i>. <b>376</b> (9746): 1094–108. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2810%2960826-4" rel="nofollow">10.1016/S0140-6736(10)60826-4</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20870100" rel="nofollow">20870100</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis&amp;rft.aufirst=DL&amp;rft.au=Huizinga%2C+TW&amp;rft.aulast=Scott&amp;rft.au=Wolfe%2C+F&amp;rft.date=2010-09-25&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2960826-4&amp;rft_id=info%3Apmid%2F20870100&amp;rft.issue=9746&amp;rft.jtitle=Lancet&amp;rft.pages=1094-108&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=376"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation journal">Singh, JA; Wells, GA; Christensen, R; Tanjong Ghogomu, E; Maxwell, L; Macdonald, JK; Filippini, G; Skoetz, N; Francis, D; Lopes, LC; Guyatt, GH; Schmitt, J; La Mantia, L; Weberschock, T; Roos, JF; Siebert, H; Hershan, S; Lunn, MP; Tugwell, P; Buchbinder, R (16 February 2011). "Adverse effects of biologics: a network meta-analysis and Cochrane overview.". <i>The Cochrane database of systematic reviews</i> (2): CD008794. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008794.pub2" rel="nofollow">10.1002/14651858.CD008794.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21328309" rel="nofollow">21328309</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Adverse+effects+of+biologics%3A+a+network+meta-analysis+and+Cochrane+overview.&amp;rft.au=Buchbinder%2C+R&amp;rft.au=Christensen%2C+R&amp;rft.au=Filippini%2C+G&amp;rft.aufirst=JA&amp;rft.au=Francis%2C+D&amp;rft.au=Guyatt%2C+GH&amp;rft.au=Hershan%2C+S&amp;rft.au=La+Mantia%2C+L&amp;rft.aulast=Singh&amp;rft.au=Lopes%2C+LC&amp;rft.au=Lunn%2C+MP&amp;rft.au=Macdonald%2C+JK&amp;rft.au=Maxwell%2C+L&amp;rft.au=Roos%2C+JF&amp;rft.au=Schmitt%2C+J&amp;rft.au=Siebert%2C+H&amp;rft.au=Skoetz%2C+N&amp;rft.au=Tanjong+Ghogomu%2C+E&amp;rft.au=Tugwell%2C+P&amp;rft.au=Weberschock%2C+T&amp;rft.au=Wells%2C+GA&amp;rft.date=2011-02-16&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008794.pub2&amp;rft_id=info%3Apmid%2F21328309&amp;rft.issue=2&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD008794&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Ef2010-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ef2010_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ef2010_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ef2010_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Efthimiou P, Kukar M (2010). "Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities". <i>Rheumatology international</i>. <b>30</b> (5): 571–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1007%2Fs00296-009-1206-y" rel="nofollow">10.1007/s00296-009-1206-y</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19876631" rel="nofollow">19876631</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Complementary+and+alternative+medicine+use+in+rheumatoid+arthritis%3A+proposed+mechanism+of+action+and+efficacy+of+commonly+used+modalities&amp;rft.aufirst=P&amp;rft.au=Kukar%2C+M&amp;rft.aulast=Efthimiou&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00296-009-1206-y&amp;rft_id=info%3Apmid%2F19876631&amp;rft.issue=5&amp;rft.jtitle=Rheumatology+international&amp;rft.pages=571-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-NCCIH-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCCIH_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCCIH_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCCIH_6-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://nccih.nih.gov/health/RA/getthefacts.htm" rel="nofollow">"Rheumatoid Arthritis and Complementary Health Approaches"</a>. National Center for Complementary and Integrative Health<span class="reference-accessdate">. Retrieved <span class="nowrap">July 1,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Rheumatoid+Arthritis+and+Complementary+Health+Approaches&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fnccih.nih.gov%2Fhealth%2FRA%2Fgetthefacts.htm&amp;rft.pub=National+Center+for+Complementary+and+Integrative+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-GDB2013-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-GDB2013_7-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4340604" rel="nofollow">"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013."</a>. <i>Lancet</i>. <b>385</b> (9963): 117–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2814%2961682-2" rel="nofollow">10.1016/S0140-6736(14)61682-2</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4340604" rel="nofollow">4340604</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25530442" rel="nofollow">25530442</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Global%2C+regional%2C+and+national+age-sex+specific+all-cause+and+cause-specific+mortality+for+240+causes+of+death%2C+1990%932013%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2013.&amp;rft.aufirst=Collaborators&amp;rft.aulast=GBD+2013+Mortality+and+Causes+of+Death&amp;rft.date=2014-12-17&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4340604&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4340604&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2814%2961682-2&amp;rft_id=info%3Apmid%2F25530442&amp;rft.issue=9963&amp;rft.jtitle=Lancet&amp;rft.pages=117-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=385"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Landre1800-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Landre1800_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Landre1800_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Landré-Beauvais AJ (1800). <i>La goutte asthénique primitive (doctoral thesis)</i>. Paris.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.btitle=La+goutte+asth%C3%A9nique+primitive+%28doctoral+thesis%29&amp;rft.date=1800&amp;rft.genre=book&amp;rft.place=Paris&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span> reproduced in <cite class="citation journal">Landré-Beauvais AJ (2001). "The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800". <i>Joint Bone spine</i>. <b>68</b> (2): 130–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FS1297-319X%2800%2900247-5" rel="nofollow">10.1016/S1297-319X(00)00247-5</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11324929" rel="nofollow">11324929</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+first+description+of+rheumatoid+arthritis.+Unabridged+text+of+the+doctoral+dissertation+presented+in+1800&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1297-319X%2800%2900247-5&amp;rft_id=info%3Apmid%2F11324929&amp;rft.issue=2&amp;rft.jtitle=Joint+Bone+spine&amp;rft.pages=130-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Paget2002-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Paget2002_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Paget2002_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Paget, Stephen A.; Lockshin, Michael D.; Loebl, Suzanne (2002). <a class="external text" href="https://books.google.com/books?id=akacOyQrnKkC&amp;pg=PA32" rel="nofollow"><i>The Hospital for Special Surgery Rheumatoid Arthritis Handbook Everything You Need to Know.</i></a> New York: John Wiley &amp; Sons. p. 32. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780471223344" title="Special:BookSources/9780471223344">9780471223344</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.aufirst=Stephen+A.&amp;rft.aulast=Paget&amp;rft.au=Lockshin%2C+Michael+D.&amp;rft.au=Loebl%2C+Suzanne&amp;rft.btitle=The+Hospital+for+Special+Surgery+Rheumatoid+Arthritis+Handbook+Everything+You+Need+to+Know.&amp;rft.date=2002&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DakacOyQrnKkC%26pg%3DPA32&amp;rft.isbn=9780471223344&amp;rft.pages=32&amp;rft.place=New+York&amp;rft.pub=John+Wiley+%26+Sons&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid12860726-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12860726_10-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1754626" rel="nofollow">"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years"</a>. <i>Ann. Rheum. Dis</i>. <b>62</b> (8): 722–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.62.8.722" rel="nofollow">10.1136/ard.62.8.722</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1754626" rel="nofollow">1754626</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12860726" rel="nofollow">12860726</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Extra-articular+disease+manifestations+in+rheumatoid+arthritis%3A+incidence+trends+and+risk+factors+over+46+years&amp;rft.au=Crowson%2C+CS&amp;rft.aufirst=C&amp;rft.au=Gabriel%2C+SE&amp;rft.aulast=Turesson&amp;rft.au=Matteson%2C+EL&amp;rft.au=O%27Fallon%2C+WM&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1754626&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1754626&amp;rft_id=info%3Adoi%2F10.1136%2Fard.62.8.722&amp;rft_id=info%3Apmid%2F12860726&amp;rft.issue=8&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=722-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=62"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-DAVIDSONS2010-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-DAVIDSONS2010_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DAVIDSONS2010_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-DAVIDSONS2010_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Nicki R. Colledge, Brian R. Walker, Stuart H. Ralston, eds. (2010). <i>Davidson's principles and practice of medicine.</i> (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7020-3084-0" title="Special:BookSources/978-0-7020-3084-0">978-0-7020-3084-0</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Davidson%27s+principles+and+practice+of+medicine.&amp;rft.date=2010&amp;rft.edition=21st&amp;rft.genre=book&amp;rft.isbn=978-0-7020-3084-0&amp;rft.place=Edinburgh&amp;rft.pub=Churchill+Livingstone%2FElsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Uses editors parameter (<a href="/wiki/Category:CS1_maint:_Uses_editors_parameter" title="Category:CS1 maint: Uses editors parameter">link</a>)</span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20100527035630/http://pn.lifehugger.com/doc/459/An_approach_to_Early_Arthritis" rel="nofollow">"An approach to Early Arthritis"</a>. Pn.lifehugger.com. 12 January 2009. Archived from <a class="external text" href="http://pn.lifehugger.com/doc/459/An_approach_to_Early_Arthritis" rel="nofollow">the original</a> on May 27, 2010.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=An+approach+to+Early+Arthritis&amp;rft.date=2009-01-12&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fpn.lifehugger.com%2Fdoc%2F459%2FAn_approach_to_Early_Arthritis&amp;rft.pub=Pn.lifehugger.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gaffo A, Saag KG, Curtis JR (2006). "Treatment of rheumatoid arthritis". <i>Am J Health Syst Pharm</i>. <b>63</b> (24): 2451–2465. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.2146%2Fajhp050514" rel="nofollow">10.2146/ajhp050514</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17158693" rel="nofollow">17158693</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Treatment+of+rheumatoid+arthritis&amp;rft.au=Curtis%2C+JR&amp;rft.aufirst=A&amp;rft.aulast=Gaffo&amp;rft.au=Saag%2C+KG&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2146%2Fajhp050514&amp;rft_id=info%3Apmid%2F17158693&amp;rft.issue=24&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.pages=2451-2465&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-McGraw_Hill-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-McGraw_Hill_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-McGraw_Hill_14-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Shah, Ankur. <i>Harrison's Principle of Internal Medicine</i> (18th ed.). United States: McGraw Hill. p. 2738. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-07174889-6" title="Special:BookSources/978-0-07174889-6">978-0-07174889-6</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.aufirst=Ankur&amp;rft.aulast=Shah&amp;rft.btitle=Harrison%27s+Principle+of+Internal+Medicine&amp;rft.edition=18th&amp;rft.genre=book&amp;rft.isbn=978-0-07174889-6&amp;rft.pages=2738&amp;rft.place=United+States&amp;rft.pub=McGraw+Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Tur2013-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tur2013_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tur2013_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Turesson, C (May 2013). "Extra-articular rheumatoid arthritis.". <i>Current opinion in rheumatology</i>. <b>25</b> (3): 360–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2Fbor.0b013e32835f693f" rel="nofollow">10.1097/bor.0b013e32835f693f</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23425964" rel="nofollow">23425964</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Extra-articular+rheumatoid+arthritis.&amp;rft.aufirst=C&amp;rft.aulast=Turesson&amp;rft.date=2013-05&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2Fbor.0b013e32835f693f&amp;rft_id=info%3Apmid%2F23425964&amp;rft.issue=3&amp;rft.jtitle=Current+opinion+in+rheumatology&amp;rft.pages=360-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation journal">Genta, Marcia S.; Genta, Robert M.; Gabay, Cem (2006-10-01). <a class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/17023257" rel="nofollow">"Systemic rheumatoid vasculitis: a review"</a>. <i>Seminars in Arthritis and Rheumatism</i>. <b>36</b> (2): 88–98. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.semarthrit.2006.04.006" rel="nofollow">10.1016/j.semarthrit.2006.04.006</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0049-0172" rel="nofollow">0049-0172</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17023257" rel="nofollow">17023257</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Systemic+rheumatoid+vasculitis%3A+a+review&amp;rft.aufirst=Marcia+S.&amp;rft.au=Gabay%2C+Cem&amp;rft.au=Genta%2C+Robert+M.&amp;rft.aulast=Genta&amp;rft.date=2006-10-01&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F17023257&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2006.04.006&amp;rft_id=info%3Apmid%2F17023257&amp;rft.issn=0049-0172&amp;rft.issue=2&amp;rft.jtitle=Seminars+in+Arthritis+and+Rheumatism&amp;rft.pages=88-98&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kim, Eunice J.; Collard, Harold R.; King, Talmadge E. (2009-11-01). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818853" rel="nofollow">"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern"</a>. <i>Chest</i>. <b>136</b> (5): 1397–1405. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1378%2Fchest.09-0444" rel="nofollow">10.1378/chest.09-0444</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1931-3543" rel="nofollow">1931-3543</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818853" rel="nofollow">2818853</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19892679" rel="nofollow">19892679</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis-associated+interstitial+lung+disease%3A+the+relevance+of+histopathologic+and+radiographic+pattern&amp;rft.au=Collard%2C+Harold+R.&amp;rft.aufirst=Eunice+J.&amp;rft.au=King%2C+Talmadge+E.&amp;rft.aulast=Kim&amp;rft.date=2009-11-01&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2818853&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2818853&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.09-0444&amp;rft_id=info%3Apmid%2F19892679&amp;rft.issn=1931-3543&amp;rft.issue=5&amp;rft.jtitle=Chest&amp;rft.pages=1397-1405&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=136"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation journal">Balbir-Gurman, Alexandra; Yigla, Mordechai; Nahir, Abraham Menahem; Braun-Moscovici, Yolanda (2006-06-01). <a class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/16765714" rel="nofollow">"Rheumatoid pleural effusion"</a>. <i>Seminars in Arthritis and Rheumatism</i>. <b>35</b> (6): 368–378. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.semarthrit.2006.03.002" rel="nofollow">10.1016/j.semarthrit.2006.03.002</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0049-0172" rel="nofollow">0049-0172</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16765714" rel="nofollow">16765714</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+pleural+effusion&amp;rft.au=Braun-Moscovici%2C+Yolanda&amp;rft.aufirst=Alexandra&amp;rft.aulast=Balbir-Gurman&amp;rft.au=Nahir%2C+Abraham+Menahem&amp;rft.au=Yigla%2C+Mordechai&amp;rft.date=2006-06-01&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F16765714&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2006.03.002&amp;rft_id=info%3Apmid%2F16765714&amp;rft.issn=0049-0172&amp;rft.issue=6&amp;rft.jtitle=Seminars+in+Arthritis+and+Rheumatism&amp;rft.pages=368-378&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=35"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation journal">de Groot K (August 2007). "[Renal manifestations in rheumatic diseases]". <i>Internist (Berl)</i>. <b>48</b> (8): 779–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1007%2Fs00108-007-1887-9" rel="nofollow">10.1007/s00108-007-1887-9</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17571244" rel="nofollow">17571244</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=%5BRenal+manifestations+in+rheumatic+diseases%5D&amp;rft.au=de+Groot+K&amp;rft.date=2007-08&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00108-007-1887-9&amp;rft_id=info%3Apmid%2F17571244&amp;rft.issue=8&amp;rft.jtitle=Internist+%28Berl%29&amp;rft.pages=779-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation journal">Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (April 1994). "The mortality of rheumatoid arthritis". <i>Arthritis Rheum</i>. <b>37</b> (4): 481–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.1780370408" rel="nofollow">10.1002/art.1780370408</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8147925" rel="nofollow">8147925</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+mortality+of+rheumatoid+arthritis&amp;rft.au=Bloch%2C+DA&amp;rft.au=Cathey%2C+MA&amp;rft.aufirst=F&amp;rft.au=Fries%2C+JF&amp;rft.au=Haga%2C+M&amp;rft.au=Kleinheksel%2C+SM&amp;rft.aulast=Wolfe&amp;rft.au=Mitchell%2C+DM&amp;rft.au=Sibley%2C+JT&amp;rft.au=Spitz%2C+PW&amp;rft.au=Williams%2C+CA&amp;rft.date=1994-04&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780370408&amp;rft_id=info%3Apmid%2F8147925&amp;rft.issue=4&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=481-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation journal">Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008). "Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies". <i>Arthritis Rheum</i>. <b>59</b> (12): 1690–1697. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.24092" rel="nofollow">10.1002/art.24092</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19035419" rel="nofollow">19035419</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Risk+of+cardiovascular+mortality+in+patients+with+rheumatoid+arthritis%3A+a+meta-analysis+of+observational+studies&amp;rft.au=Avi%C3%B1a-Zubieta+JA%2C+Choi+HK%2C+Sadatsafavi+M%2C+Etminan+M%2C+Esdaile+JM%2C+Lacaille+D&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.24092&amp;rft_id=info%3Apmid%2F19035419&amp;rft.issue=12&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=1690-1697&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation journal">Alenghat, Francis J. (2016-02-04). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4740809" rel="nofollow">"The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors"</a>. <i>Scientific Reports</i>. <b>6</b>: 20303. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1038%2Fsrep20303" rel="nofollow">10.1038/srep20303</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4740809" rel="nofollow">4740809</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/26842423" rel="nofollow">26842423</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+Prevalence+of+Atherosclerosis+in+Those+with+Inflammatory+Connective+Tissue+Disease+by+Race%2C+Age%2C+and+Traditional+Risk+Factors&amp;rft.aufirst=Francis+J.&amp;rft.aulast=Alenghat&amp;rft.date=2016-02-04&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4740809&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4740809&amp;rft_id=info%3Adoi%2F10.1038%2Fsrep20303&amp;rft_id=info%3Apmid%2F26842423&amp;rft.jtitle=Scientific+Reports&amp;rft.pages=20303&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Gupta-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gupta_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gupta_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Gupta A, Fomberstein B (2009). <a class="external text" href="http://www.musculoskeletalnetwork.com/rheumatoid-arthritis/content/article/1145622/1433094" rel="nofollow">"Evaluating cardiovascular risk in rheumatoid arthritis"</a>. <i>Journal of Musculoskeletal Medicine</i>. <b>26</b> (8): 481–94.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Evaluating+cardiovascular+risk+in+rheumatoid+arthritis&amp;rft.aufirst=A&amp;rft.au=Fomberstein%2C+B&amp;rft.aulast=Gupta&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.musculoskeletalnetwork.com%2Frheumatoid-arthritis%2Fcontent%2Farticle%2F1145622%2F1433094&amp;rft.issue=8&amp;rft.jtitle=Journal+of+Musculoskeletal+Medicine&amp;rft.pages=481-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Selmi2011-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-Selmi2011_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Selmi2011_24-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Selmi, Carlo; Santis, Maria De; Gershwin, M Eric (2011). "Liver involvement in subjects with rheumatic disease". <i><a href="/wiki/Arthritis_Research_%26_Therapy" title="Arthritis Research &amp; Therapy">Arthritis Research &amp; Therapy</a></i>. BioMed Central. <b>13</b> (3): 226. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1186%2Far3319" rel="nofollow">10.1186/ar3319</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21722332" rel="nofollow">21722332</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Liver+involvement+in+subjects+with+rheumatic+disease&amp;rft.aufirst=Carlo&amp;rft.au=Gershwin%2C+M+Eric&amp;rft.aulast=Selmi&amp;rft.au=Santis%2C+Maria+De&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1186%2Far3319&amp;rft_id=info%3Apmid%2F21722332&amp;rft.issue=3&amp;rft.jtitle=Arthritis+Research+%26+Therapy&amp;rft.pages=226&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text">Citation: H. Rehman : Hemolytic Anemia following Mycoplasma Infection. The Internet Journal of Hematology. 2008 Volume 4 Number 1 <a class="external autonumber" href="http://www.ispub.com/journal/the_internet_journal_of_hematology/volume_4_number_1_22/article/hemolytic_anemia_following_mycoplasma_infection.html" rel="nofollow">[1]</a></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation journal">Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L (2006). "Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis". <i>Arthritis &amp; Rheumatism</i>. <b>54</b> (3): 692–701. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.21675" rel="nofollow">10.1002/art.21675</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16508929" rel="nofollow">16508929</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Association+of+chronic+inflammation%2C+not+its+treatment%2C+with+increased+lymphoma+risk+in+rheumatoid+arthritis&amp;rft.au=Askling%2C+J&amp;rft.au=Backlin%2C+C&amp;rft.au=Catrina%2C+AI&amp;rft.au=Ekbom%2C+A&amp;rft.au=Feltelius%2C+N&amp;rft.aufirst=E&amp;rft.au=Granath%2C+F&amp;rft.au=Iliadou%2C+A&amp;rft.au=Klareskog%2C+L&amp;rft.aulast=Baecklund&amp;rft.au=Rosenquist%2C+R&amp;rft.au=Sundstr%C3%B6m%2C+C&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.21675&amp;rft_id=info%3Apmid%2F16508929&amp;rft.issue=3&amp;rft.jtitle=Arthritis+%26+Rheumatism&amp;rft.pages=692-701&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation journal">Franklin J, Lunt M, Bunn D, Symmons D, Silman A (2006). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1798140" rel="nofollow">"Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis"</a>. <i>Annals of the Rheumatic Diseases</i>. <b>65</b> (5): 617–622. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.2005.044784" rel="nofollow">10.1136/ard.2005.044784</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1798140" rel="nofollow">1798140</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16249224" rel="nofollow">16249224</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Incidence+of+lymphoma+in+a+large+primary+care+derived+cohort+of+cases+of+inflammatory+polyarthritis&amp;rft.au=Bunn%2C+D&amp;rft.aufirst=J&amp;rft.aulast=Franklin&amp;rft.au=Lunt%2C+M&amp;rft.au=Silman%2C+A&amp;rft.au=Symmons%2C+D&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1798140&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1798140&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2005.044784&amp;rft_id=info%3Apmid%2F16249224&amp;rft.issue=5&amp;rft.jtitle=Annals+of+the+Rheumatic+Diseases&amp;rft.pages=617-622&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation journal">Edwards JC, Cambridge G, Abrahams VM (1999). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2326840" rel="nofollow">"Do self-perpetuating B lymphocytes drive human autoimmune disease?"</a>. <i>Immunology</i>. <b>97</b> (2): 188–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2567.1999.00772.x" rel="nofollow">10.1046/j.1365-2567.1999.00772.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2326840" rel="nofollow">2326840</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10447731" rel="nofollow">10447731</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Do+self-perpetuating+B+lymphocytes+drive+human+autoimmune+disease%3F&amp;rft.au=Abrahams%2C+VM&amp;rft.au=Cambridge%2C+G&amp;rft.aufirst=JC&amp;rft.aulast=Edwards&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2326840&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2326840&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2567.1999.00772.x&amp;rft_id=info%3Apmid%2F10447731&amp;rft.issue=2&amp;rft.jtitle=Immunology&amp;rft.pages=188-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation journal">Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR, Li W, Tan AK, Bonnard C, Ong RT, Thalamuthu A, Pettersson S, Liu C, Tian C, Chen WV, Carulli JP, Beckman EM, Altshuler D, Alfredsson L, Criswell LA, Amos CI, Seldin MF, Kastner DL, Klareskog L, Gregersen PK (20 September 2007). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867" rel="nofollow">"TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study"</a>. <i>The New England Journal of Medicine</i>. <b>357</b> (12): 1199–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1056%2FNEJMoa073491" rel="nofollow">10.1056/NEJMoa073491</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867" rel="nofollow">2636867</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17804836" rel="nofollow">17804836</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=TRAF1%93C5+as+a+Risk+Locus+for+Rheumatoid+Arthritis+%94+A+Genomewide+Study&amp;rft.au=Alfredsson%2C+L&amp;rft.au=Altshuler%2C+D&amp;rft.au=Amos%2C+CI&amp;rft.au=Beckman%2C+EM&amp;rft.au=Bonnard%2C+C&amp;rft.au=Carulli%2C+JP&amp;rft.au=Chandrasekaran%2C+A&amp;rft.au=Chen%2C+WV&amp;rft.au=Criswell%2C+LA&amp;rft.au=Davies%2C+LR&amp;rft.au=Ding%2C+B&amp;rft.aufirst=RM&amp;rft.au=Gregersen%2C+PK&amp;rft.au=Kastner%2C+DL&amp;rft.au=Khalili%2C+H&amp;rft.au=Klareskog%2C+L&amp;rft.aulast=Plenge&amp;rft.au=Lee%2C+AT&amp;rft.au=Li%2C+W&amp;rft.au=Liew%2C+A&amp;rft.au=Liu%2C+C&amp;rft.au=Ong%2C+RT&amp;rft.au=Padyukov%2C+L&amp;rft.au=Pettersson%2C+S&amp;rft.au=Remmers%2C+EF&amp;rft.au=Seielstad%2C+M&amp;rft.au=Seldin%2C+MF&amp;rft.au=Tan%2C+AK&amp;rft.au=Thalamuthu%2C+A&amp;rft.au=Tian%2C+C&amp;rft.date=2007-09-20&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa073491&amp;rft_id=info%3Apmid%2F17804836&amp;rft.issue=12&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=1199-209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation journal">Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (Aug 2010). "Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil". <i>Rheumatology (Oxford)</i>. <b>49</b> (8): 1590–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2Fkeq134" rel="nofollow">10.1093/rheumatology/keq134</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20457731" rel="nofollow">20457731</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Anti-cyclic+citrullinated+peptide+antibodies+and+rheumatoid+factor+in+rheumatoid+arthritis+patients+and+relatives+from+Brazil&amp;rft.au=de+Messias+Reason%2C+IT&amp;rft.aufirst=I&amp;rft.aulast=Goeldner&amp;rft.au=Nisihara%2C+RM&amp;rft.au=Silva%2C+MB&amp;rft.au=Skare%2C+TL&amp;rft.au=Utiyama%2C+SR&amp;rft.date=2010-08&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkeq134&amp;rft_id=info%3Apmid%2F20457731&amp;rft.issue=8&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=1590-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.arthritis.org/genetics-ra.php" rel="nofollow">"The Genetics Behind Rheumatoid Arthritis"</a>. Arthritis Foundation<span class="reference-accessdate">. Retrieved <span class="nowrap">December 17,</span> 2012</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=The+Genetics+Behind+Rheumatoid+Arthritis&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.arthritis.org%2Fgenetics-ra.php&amp;rft.pub=Arthritis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><cite class="citation journal">Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WE (1993). "Twin concordance rates for rheumatoid arthritis: Results from a nationwide study". <i>British journal of rheumatology</i>. <b>32</b> (10): 903–907. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2F32.10.903" rel="nofollow">10.1093/rheumatology/32.10.903</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8402000" rel="nofollow">8402000</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Twin+concordance+rates+for+rheumatoid+arthritis%3A+Results+from+a+nationwide+study&amp;rft.au=Carthy%2C+D&amp;rft.au=Farhan%2C+A&amp;rft.aufirst=AJ&amp;rft.au=Holligan%2C+S&amp;rft.aulast=Silman&amp;rft.au=MacGregor%2C+AJ&amp;rft.au=Ollier%2C+WE&amp;rft.au=Thomson%2C+W&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2F32.10.903&amp;rft_id=info%3Apmid%2F8402000&amp;rft.issue=10&amp;rft.jtitle=British+journal+of+rheumatology&amp;rft.pages=903-907&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation journal">Bellamy N, Duffy D, Martin N, Mathews J (1992). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1005687" rel="nofollow">"Rheumatoid arthritis in twins: A study of aetiopathogenesis based on the Australian Twin Registry"</a>. <i>Annals of the rheumatic diseases</i>. <b>51</b> (5): 588–593. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.51.5.588" rel="nofollow">10.1136/ard.51.5.588</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1005687" rel="nofollow">1005687</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1616321" rel="nofollow">1616321</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis+in+twins%3A+A+study+of+aetiopathogenesis+based+on+the+Australian+Twin+Registry&amp;rft.au=Duffy%2C+D&amp;rft.aufirst=N&amp;rft.aulast=Bellamy&amp;rft.au=Martin%2C+N&amp;rft.au=Mathews%2C+J&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1005687&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1005687&amp;rft_id=info%3Adoi%2F10.1136%2Fard.51.5.588&amp;rft_id=info%3Apmid%2F1616321&amp;rft.issue=5&amp;rft.jtitle=Annals+of+the+rheumatic+diseases&amp;rft.pages=588-593&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Sugiyama2010-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sugiyama2010_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sugiyama2010_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S (2010). "Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies". <i>Ann. Rheum. Dis</i>. <b>69</b> (1): 70–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.2008.096487" rel="nofollow">10.1136/ard.2008.096487</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19174392" rel="nofollow">19174392</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Impact+of+smoking+as+a+risk+factor+for+developing+rheumatoid+arthritis%3A+a+meta-analysis+of+observational+studies&amp;rft.aufirst=D&amp;rft.au=Kumagai%2C+S&amp;rft.aulast=Sugiyama&amp;rft.au=Morinobu%2C+A&amp;rft.au=Nakazawa%2C+T&amp;rft.au=Nishimura%2C+K&amp;rft.au=Tamaki%2C+K&amp;rft.au=Tsuji%2C+G&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2008.096487&amp;rft_id=info%3Apmid%2F19174392&amp;rft.issue=1&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=70-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation journal">Liao KP, Alfredsson L, Karlson EW (May 2009). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2898190" rel="nofollow">"Environmental influences on risk for rheumatoid arthritis"</a>. <i>Current Opinion in Rheumatology</i>. <b>21</b> (3): 279–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2FBOR.0b013e32832a2e16" rel="nofollow">10.1097/BOR.0b013e32832a2e16</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2898190" rel="nofollow">2898190</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19318947" rel="nofollow">19318947</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Environmental+influences+on+risk+for+rheumatoid+arthritis&amp;rft.au=Alfredsson%2C+L&amp;rft.aufirst=KP&amp;rft.au=Karlson%2C+EW&amp;rft.aulast=Liao&amp;rft.date=2009-05&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2898190&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2898190&amp;rft_id=info%3Adoi%2F10.1097%2FBOR.0b013e32832a2e16&amp;rft_id=info%3Apmid%2F19318947&amp;rft.issue=3&amp;rft.jtitle=Current+Opinion+in+Rheumatology&amp;rft.pages=279-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Elsevier-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elsevier_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elsevier_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Doherty, M; Lanyon, P; Ralston, SH. <i>Musculosketal Disorders-Davidson's Principle of Internal Medicine</i> (20th ed.). Elsevier. pp. 1100–1106.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.aufirst=M&amp;rft.au=Lanyon%2C+P&amp;rft.aulast=Doherty&amp;rft.au=Ralston%2C+SH&amp;rft.btitle=Musculosketal+Disorders-Davidson%27s+Principle+of+Internal+Medicine&amp;rft.edition=20th&amp;rft.genre=book&amp;rft.pages=1100-1106&amp;rft.pub=Elsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Plenge_RM.2C_Seielstad_M.2C_Padyukov_L.2C_Lee_AT.2C_Remmers_EF.2C_Ding_B.2C_Liew_A.2C_Khalili_H.2C_Chandrasekaran_A.2C_Davies_LR.2C_Li_W.2C_Tan_AK.2C_Bonnard_C.2C_Ong_RT.2C_Thalamuthu_A.2C_Pettersson_S.2C_Liu_C.2C_Tian_C.2C_Chen_WV.2C_Carulli_JP.2C_Beckman_EM.2C_Altshuler_D.2C_Alfredsson_L.2C_Criswell_LA.2C_Amos_CI.2C_Seldin_MF.2C_Kastner_DL.2C_Klareskog_L.2C_Gregersen_PK_2007_1199.E2.80.93209_37-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR, Li W, Tan AK, Bonnard C, Ong RT, Thalamuthu A, Pettersson S, Liu C, Tian C, Chen WV, Carulli JP, Beckman EM, Altshuler D, Alfredsson L, Criswell LA, Amos CI, Seldin MF, Kastner DL, Klareskog L, Gregersen PK (2007). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867" rel="nofollow">"TRAF1-C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study"</a>. <i>N. Engl. J. Med</i>. <b>357</b> (12): 1199–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1056%2FNEJMoa073491" rel="nofollow">10.1056/NEJMoa073491</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867" rel="nofollow">2636867</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17804836" rel="nofollow">17804836</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=TRAF1-C5+as+a+Risk+Locus+for+Rheumatoid+Arthritis+%94+A+Genomewide+Study&amp;rft.au=Alfredsson%2C+L&amp;rft.au=Altshuler%2C+D&amp;rft.au=Amos%2C+CI&amp;rft.au=Beckman%2C+EM&amp;rft.au=Bonnard%2C+C&amp;rft.au=Carulli%2C+JP&amp;rft.au=Chandrasekaran%2C+A&amp;rft.au=Chen%2C+WV&amp;rft.au=Criswell%2C+LA&amp;rft.au=Davies%2C+LR&amp;rft.au=Ding%2C+B&amp;rft.aufirst=RM&amp;rft.au=Gregersen%2C+PK&amp;rft.au=Kastner%2C+DL&amp;rft.au=Khalili%2C+H&amp;rft.au=Klareskog%2C+L&amp;rft.aulast=Plenge&amp;rft.au=Lee%2C+AT&amp;rft.au=Li%2C+W&amp;rft.au=Liew%2C+A&amp;rft.au=Liu%2C+C&amp;rft.au=Ong%2C+RT&amp;rft.au=Padyukov%2C+L&amp;rft.au=Pettersson%2C+S&amp;rft.au=Remmers%2C+EF&amp;rft.au=Seielstad%2C+M&amp;rft.au=Seldin%2C+MF&amp;rft.au=Tan%2C+AK&amp;rft.au=Thalamuthu%2C+A&amp;rft.au=Tian%2C+C&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa073491&amp;rft_id=info%3Apmid%2F17804836&amp;rft.issue=12&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1199-209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation journal">Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004). "A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis". <i>Arthritis Rheum</i>. <b>50</b> (10): 3085–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.20553" rel="nofollow">10.1002/art.20553</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15476204" rel="nofollow">15476204</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+gene-environment+interaction+between+smoking+and+shared+epitope+genes+in+HLA-DR+provides+a+high+risk+of+seropositive+rheumatoid+arthritis&amp;rft.au=Alfredsson%2C+L&amp;rft.aufirst=L&amp;rft.au=Klareskog%2C+L&amp;rft.aulast=Padyukov&amp;rft.au=Silva%2C+C&amp;rft.au=Stolt%2C+P&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.20553&amp;rft_id=info%3Apmid%2F15476204&amp;rft.issue=10&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=3085-92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-immune_glycan-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-immune_glycan_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-immune_glycan_39-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-immune_glycan_39-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Maverakis E, Kim K, Shimoda M, Gershwin M, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB (2015). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4340844" rel="nofollow">"Glycans in the immune system and The Altered Glycan Theory of Autoimmunity"</a>. <i>J Autoimmun</i>. <b>57</b> (6): 1–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.jaut.2014.12.002" rel="nofollow">10.1016/j.jaut.2014.12.002</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4340844" rel="nofollow">4340844</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25578468" rel="nofollow">25578468</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Glycans+in+the+immune+system+and+The+Altered+Glycan+Theory+of+Autoimmunity&amp;rft.aufirst=E&amp;rft.au=Gershwin%2C+M&amp;rft.au=Kim%2C+K&amp;rft.aulast=Maverakis&amp;rft.au=Lebrilla%2C+CB&amp;rft.au=Patel%2C+F&amp;rft.au=Raychaudhuri%2C+S&amp;rft.au=Ruhaak%2C+LR&amp;rft.au=Shimoda%2C+M&amp;rft.au=Wilken%2C+R&amp;rft.date=2015&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4340844&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4340844&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaut.2014.12.002&amp;rft_id=info%3Apmid%2F25578468&amp;rft.issue=6&amp;rft.jtitle=J+Autoimmun&amp;rft.pages=1-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation journal">Boldt AB, Goeldner I, de Messias-Reason IJ. "Relevance of the lectin pathway of complement in rheumatic diseases". <i>Adv Clin Chem</i>. <b>56</b>: 105–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FB978-0-12-394317-0.00012-1" rel="nofollow">10.1016/B978-0-12-394317-0.00012-1</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22397030" rel="nofollow">22397030</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Relevance+of+the+lectin+pathway+of+complement+in+rheumatic+diseases&amp;rft.au=Boldt+AB%2C+Goeldner+I%2C+de+Messias-Reason+IJ&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-394317-0.00012-1&amp;rft_id=info%3Apmid%2F22397030&amp;rft.jtitle=Adv+Clin+Chem&amp;rft.pages=105-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20060807074858/http://www.path.sunysb.edu/coursemat/hbp310immun.htm" rel="nofollow">"HBP310 Immunology"</a>. <i>SUNY Stony Brook Pathology Department</i>. Archived from <a class="external text" href="http://www.path.sunysb.edu/coursemat/hbp310immun.htm" rel="nofollow">the original</a> on August 7, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">September 20,</span> 2008</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=HBP310+Immunology&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.path.sunysb.edu%2Fcoursemat%2Fhbp310immun.htm&amp;rft.jtitle=SUNY+Stony+Brook+Pathology+Department&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web">Ghaffar, Abdul. <a class="external text" href="http://www.microbiologybook.org/book/immunol-sta.htm" rel="nofollow">"Hypersensitivity States"</a>. <i>University of South Carolina School of Medicine</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 29,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Hypersensitivity+States&amp;rft.au=Ghaffar%2C+Abdul&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.microbiologybook.org%2Fbook%2Fimmunol-sta.htm&amp;rft.jtitle=University+of+South+Carolina+School+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation web">Holmes, N. (1999). <a class="external text" href="https://web.archive.org/web/20060206220202/http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" rel="nofollow">"Lecture 14: Hypersensitivity"</a>. <i>Immunology Division, Department of Pathology, University of Cambridge</i>. Archived from <a class="external text" href="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html" rel="nofollow">the original</a> on February 6, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">September 20,</span> 2008</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Lecture+14%3A+Hypersensitivity&amp;rft.au=Holmes%2C+N.&amp;rft.date=1999&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww-immuno.path.cam.ac.uk%2F~immuno%2Fpart1%2Flec13%2Flec13_97.html&amp;rft.jtitle=Immunology+Division%2C+Department+of+Pathology%2C+University+of+Cambridge&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gaffen, Sarah L. (2017-01-22). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2811488" rel="nofollow">"Role of IL-17 in the Pathogenesis of Rheumatoid Arthritis"</a>. <i>Current rheumatology reports</i>. <b>11</b> (5): 365–370. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1523-3774" rel="nofollow">1523-3774</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2811488" rel="nofollow">2811488</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19772832" rel="nofollow">19772832</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Role+of+IL-17+in+the+Pathogenesis+of+Rheumatoid+Arthritis&amp;rft.aufirst=Sarah+L.&amp;rft.aulast=Gaffen&amp;rft.date=2017-01-22&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811488&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2811488&amp;rft_id=info%3Apmid%2F19772832&amp;rft.issn=1523-3774&amp;rft.issue=5&amp;rft.jtitle=Current+rheumatology+reports&amp;rft.pages=365-370&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text">Schueller-Weidekamm C. <a class="external text" href="http://www.diagnosticimaging.com/ultrasound/content/article/113619/1561958" rel="nofollow">Modern ultrasound methods yield stronger arthritis work-up</a>. Diagnostic Imaging. May 2010:20–22.</span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation journal">Westwood OM, Nelson PN, Hay FC (2006). "Rheumatoid factors: what's new?". <i>Rheumatology (Oxford)</i>. <b>45</b> (4): 379–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2Fkei228" rel="nofollow">10.1093/rheumatology/kei228</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16418203" rel="nofollow">16418203</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+factors%3A+what%27s+new%3F&amp;rft.aufirst=OM&amp;rft.au=Hay%2C+FC&amp;rft.aulast=Westwood&amp;rft.au=Nelson%2C+PN&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkei228&amp;rft_id=info%3Apmid%2F16418203&amp;rft.issue=4&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=379-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Nishimura-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nishimura_47-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007). "Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis". <i>Ann. Intern. Med</i>. <b>146</b> (11): 797–808. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.7326%2F0003-4819-146-11-200706050-00008" rel="nofollow">10.7326/0003-4819-146-11-200706050-00008</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17548411" rel="nofollow">17548411</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Meta-analysis%3A+diagnostic+accuracy+of+anti-cyclic+citrullinated+peptide+antibody+and+rheumatoid+factor+for+rheumatoid+arthritis&amp;rft.aufirst=K&amp;rft.au=Kamae%2C+I&amp;rft.au=Kawano%2C+S&amp;rft.au=Kogata%2C+Y&amp;rft.au=Koshiba%2C+M&amp;rft.au=Kumagai%2C+S&amp;rft.au=Kuntz%2C+KM&amp;rft.aulast=Nishimura&amp;rft.au=Morinobu%2C+A&amp;rft.au=Nakazawa%2C+T&amp;rft.au=Saigo%2C+K&amp;rft.au=Sugiyama%2C+D&amp;rft.au=Tsuji%2C+G&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-146-11-200706050-00008&amp;rft_id=info%3Apmid%2F17548411&amp;rft.issue=11&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=797-808&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nishimura K; Sugiyama D; Kogata Y; Tsuji, G; Nakazawa, T; Kawano, S; Saigo, K; Morinobu, A; et al. (2007). "Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis". <i>Ann. Intern. Med</i>. <b>146</b> (11): 797–808. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.7326%2F0003-4819-146-11-200706050-00008" rel="nofollow">10.7326/0003-4819-146-11-200706050-00008</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17548411" rel="nofollow">17548411</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Meta-analysis%3A+diagnostic+accuracy+of+anti-cyclic+citrullinated+peptide+antibody+and+rheumatoid+factor+for+rheumatoid+arthritis&amp;rft.au=Kamae%2C+I&amp;rft.au=Kawano%2C+S&amp;rft.au=Kogata+Y&amp;rft.au=Koshiba%2C+M&amp;rft.au=Kumagai%2C+S&amp;rft.au=Kuntz%2C+K.+M.&amp;rft.au=Morinobu%2C+A&amp;rft.au=Nakazawa%2C+T&amp;rft.au=Nishimura+K&amp;rft.au=Saigo%2C+K&amp;rft.au=Sugiyama+D&amp;rft.au=Tsuji%2C+G&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-146-11-200706050-00008&amp;rft_id=info%3Apmid%2F17548411&amp;rft.issue=11&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=797-808&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation journal">van Venrooij, Walther J.; van Beers, Joyce J. B. C.; Pruijn, Ger J. M. (2011-06-07). <a class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/21647203" rel="nofollow">"Anti-CCP antibodies: the past, the present and the future"</a>. <i>Nature Reviews. Rheumatology</i>. <b>7</b> (7): 391–398. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1038%2Fnrrheum.2011.76" rel="nofollow">10.1038/nrrheum.2011.76</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1759-4804" rel="nofollow">1759-4804</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21647203" rel="nofollow">21647203</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Anti-CCP+antibodies%3A+the+past%2C+the+present+and+the+future&amp;rft.aufirst=Walther+J.&amp;rft.aulast=van+Venrooij&amp;rft.au=Pruijn%2C+Ger+J.+M.&amp;rft.au=van+Beers%2C+Joyce+J.+B.+C.&amp;rft.date=2011-06-07&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F21647203&amp;rft_id=info%3Adoi%2F10.1038%2Fnrrheum.2011.76&amp;rft_id=info%3Apmid%2F21647203&amp;rft.issn=1759-4804&amp;rft.issue=7&amp;rft.jtitle=Nature+Reviews.+Rheumatology&amp;rft.pages=391-398&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation journal">Renger F, Bang H, Fredenhagen G, Natusch A, Backhaus M, Feist E, Egerer K, Burmester GR. <a class="external text" href="http://acr.confex.com/acr/2008/webprogram/Paper2009.html" rel="nofollow">"Anti-MCV Antibody Test for the Diagnosis of Rheumatoid Arthritis Using a POCT-Immunoassay"</a>. <i>American College of Rheumatology, 2008 Annual Scientific Meeting, poster presentation</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Anti-MCV+Antibody+Test+for+the+Diagnosis+of+Rheumatoid+Arthritis+Using+a+POCT-Immunoassay&amp;rft.au=Backhaus%2C+M&amp;rft.au=Bang%2C+H&amp;rft.au=Burmester%2C+GR&amp;rft.au=Egerer%2C+K&amp;rft.au=Feist%2C+E&amp;rft.aufirst=F&amp;rft.au=Fredenhagen%2C+G&amp;rft.aulast=Renger&amp;rft.au=Natusch%2C+A&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Facr.confex.com%2Facr%2F2008%2Fwebprogram%2FPaper2009.html&amp;rft.jtitle=American+College+of+Rheumatology%2C+2008+Annual+Scientific+Meeting%2C+poster+presentation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><cite class="citation journal">Luime JJ, Colin EM, Hazes JM, Lubberts E (2009). "Does anti-MCV has additional value as serological marker in the diagnostic and prognostic work-up of patients with rheumatoid arthritis? A systematic review". <i>Ann Rheum Dis</i>. <b>69</b> (2): 337–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.2008.103283" rel="nofollow">10.1136/ard.2008.103283</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19289382" rel="nofollow">19289382</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Does+anti-MCV+has+additional+value+as+serological+marker+in+the+diagnostic+and+prognostic+work-up+of+patients+with+rheumatoid+arthritis%3F+A+systematic+review&amp;rft.au=Colin%2C+EM&amp;rft.aufirst=JJ&amp;rft.au=Hazes%2C+JM&amp;rft.aulast=Luime&amp;rft.au=Lubberts%2C+E&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2008.103283&amp;rft_id=info%3Apmid%2F19289382&amp;rft.issue=2&amp;rft.jtitle=Ann+Rheum+Dis&amp;rft.pages=337-44&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-acr-eular-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-acr-eular_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-acr-eular_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010). <a class="external text" href="https://web.archive.org/web/20100821113205/http://www.rheumatology.org/practice/clinical/classification/ra/2010_revised_criteria_classification_ra.pdf" rel="nofollow">"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative"</a> <span style="font-size:85%;">(PDF)</span>. <i>Ann. Rheum. Dis</i>. <b>69</b> (9): 1580–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fard.2010.138461" rel="nofollow">10.1136/ard.2010.138461</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20699241" rel="nofollow">20699241</a>. Archived from <a class="external text" href="http://www.rheumatology.org/practice/clinical/classification/ra/2010_revised_criteria_classification_ra.pdf" rel="nofollow">the original</a> <span style="font-size:85%;">(PDF)</span> on August 21, 2010.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=2010+rheumatoid+arthritis+classification+criteria%3A+an+American+College+of+Rheumatology%2FEuropean+League+Against+Rheumatism+collaborative+initiative&amp;rft.au=Bingham%2C+CO&amp;rft.au=Birnbaum%2C+NS&amp;rft.au=Burmester%2C+GR&amp;rft.au=Bykerk%2C+VP&amp;rft.au=Cohen%2C+MD&amp;rft.au=Combe%2C+B&amp;rft.au=Costenbader%2C+KH&amp;rft.au=Dougados%2C+M&amp;rft.au=Emery%2C+P&amp;rft.au=Felson%2C+DT&amp;rft.au=Ferraccioli%2C+G&amp;rft.aufirst=D&amp;rft.au=Funovits%2C+J&amp;rft.au=Hawker%2C+G&amp;rft.au=Hazes%2C+JM&amp;rft.au=Hobbs%2C+K&amp;rft.au=Huizinga%2C+TW&amp;rft.au=Kavanaugh%2C+A&amp;rft.au=Kay%2C+J&amp;rft.au=Kvien%2C+TK&amp;rft.au=Laing%2C+T&amp;rft.aulast=Aletaha&amp;rft.au=M%C3%A9nard%2C+HA&amp;rft.au=Mease%2C+P&amp;rft.au=Moreland%2C+LW&amp;rft.au=Naden%2C+RL&amp;rft.au=Neogi%2C+T&amp;rft.au=Pincus%2C+T&amp;rft.au=Silman%2C+AJ&amp;rft.au=Smolen%2C+JS&amp;rft.au=Stanislawska-Biernat%2C+E&amp;rft.au=Symmons%2C+D&amp;rft.au=Tak%2C+PP&amp;rft.au=Upchurch%2C+KS&amp;rft.au=Vencovsky%2C+J&amp;rft.au=Wolfe%2C+F&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpractice%2Fclinical%2Fclassification%2Fra%2F2010_revised_criteria_classification_ra.pdf&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2010.138461&amp;rft_id=info%3Apmid%2F20699241&amp;rft.issue=9&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=1580-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><cite class="citation journal">Aletaha, Daniel; Neogi, Tuhina; Silman, Alan J.; Funovits, Julia; Felson, David T.; Bingham, Clifton O.; Birnbaum, Neal S.; Burmester, Gerd R.; Bykerk, Vivian P.; Cohen, Marc D.; Combe, Bernard; Costenbader, Karen H.; Dougados, Maxime; Emery, Paul; Ferraccioli, Gianfranco; Hazes, Johanna M. W.; Hobbs, Kathryn; Huizinga, Tom W. J.; Kavanaugh, Arthur; Kay, Jonathan; Kvien, Tore K.; Laing, Timothy; Mease, Philip; Ménard, Henri A.; Moreland, Larry W.; Naden, Raymond L.; Pincus, Theodore; Smolen, Josef S.; Stanislawska-Biernat, Ewa; Symmons, Deborah; Tak, Paul P.; Upchurch, Katherine S.; Vencovský, Jiří; Wolfe, Frederick; Hawker, Gillian. "2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative". <i>Arthritis &amp; Rheumatism</i>. <b>62</b> (9): 2569–2581. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.27584" rel="nofollow">10.1002/art.27584</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=2010+Rheumatoid+arthritis+classification+criteria%3A+An+American+College+of+Rheumatology%2FEuropean+League+Against+Rheumatism+collaborative+initiative&amp;rft.au=Bingham%2C+Clifton+O.&amp;rft.au=Birnbaum%2C+Neal+S.&amp;rft.au=Burmester%2C+Gerd+R.&amp;rft.au=Bykerk%2C+Vivian+P.&amp;rft.au=Cohen%2C+Marc+D.&amp;rft.au=Combe%2C+Bernard&amp;rft.au=Costenbader%2C+Karen+H.&amp;rft.au=Dougados%2C+Maxime&amp;rft.au=Emery%2C+Paul&amp;rft.au=Felson%2C+David+T.&amp;rft.au=Ferraccioli%2C+Gianfranco&amp;rft.aufirst=Daniel&amp;rft.au=Funovits%2C+Julia&amp;rft.au=Hawker%2C+Gillian&amp;rft.au=Hazes%2C+Johanna+M.+W.&amp;rft.au=Hobbs%2C+Kathryn&amp;rft.au=Huizinga%2C+Tom+W.+J.&amp;rft.au=Kavanaugh%2C+Arthur&amp;rft.au=Kay%2C+Jonathan&amp;rft.au=Kvien%2C+Tore+K.&amp;rft.au=Laing%2C+Timothy&amp;rft.aulast=Aletaha&amp;rft.au=M%C3%A9nard%2C+Henri+A.&amp;rft.au=Mease%2C+Philip&amp;rft.au=Moreland%2C+Larry+W.&amp;rft.au=Naden%2C+Raymond+L.&amp;rft.au=Neogi%2C+Tuhina&amp;rft.au=Pincus%2C+Theodore&amp;rft.au=Silman%2C+Alan+J.&amp;rft.au=Smolen%2C+Josef+S.&amp;rft.au=Stanislawska-Biernat%2C+Ewa&amp;rft.au=Symmons%2C+Deborah&amp;rft.au=Tak%2C+Paul+P.&amp;rft.au=Upchurch%2C+Katherine+S.&amp;rft.au=Vencovsk%C3%BD%2C+Ji%C5%99%C3&amp;rft.au=Wolfe%2C+Frederick&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.27584&amp;rft.issue=9&amp;rft.jtitle=Arthritis+%26+Rheumatism&amp;rft.pages=2569-2581&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=62"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><cite class="citation journal">Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N, Healey L, Kaplan S, Liang M, Luthra H (1988). <a class="external text" href="https://web.archive.org/web/20110124173431/http://www.rheumatology.org/practice/clinical/classification/ra/1987_revised_criteria_classification_ra.pdf" rel="nofollow">"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis"</a> <span style="font-size:85%;">(PDF)</span>. <i>Arthritis Rheum</i>. <b>31</b> (3): 315–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.1780310302" rel="nofollow">10.1002/art.1780310302</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3358796" rel="nofollow">3358796</a>. Archived from <a class="external text" href="http://www.rheumatology.org/practice/clinical/classification/ra/1987_revised_criteria_classification_ra.pdf" rel="nofollow">the original</a> <span style="font-size:85%;">(PDF)</span> on January 24, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">February 8,</span> 2011</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+American+Rheumatism+Association+1987+revised+criteria+for+the+classification+of+rheumatoid+arthritis&amp;rft.au=Bloch%2C+D&amp;rft.au=Cooper%2C+N&amp;rft.au=Edworthy%2C+S&amp;rft.aufirst=F&amp;rft.au=Fries%2C+J&amp;rft.au=Healey%2C+L&amp;rft.au=Kaplan%2C+S&amp;rft.aulast=Arnett&amp;rft.au=Liang%2C+M&amp;rft.au=Luthra%2C+H&amp;rft.au=McShane%2C+D&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpractice%2Fclinical%2Fclassification%2Fra%2F1987_revised_criteria_classification_ra.pdf&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780310302&amp;rft_id=info%3Apmid%2F3358796&amp;rft.issue=3&amp;rft.jtitle=Arthritis+Rheum&amp;rft.pages=315-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Merckmanual-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-Merckmanual_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Merckmanual_55-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Berkow R, ed. (1992). <i>The Merck Manual</i> (16th ed.). Merck Publishing Group. pp. 1307–08. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/0-911910-16-6" title="Special:BookSources/0-911910-16-6">0-911910-16-6</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=The+Merck+Manual&amp;rft.date=1992&amp;rft.edition=16th&amp;rft.genre=book&amp;rft.isbn=0-911910-16-6&amp;rft.pages=1307-08&amp;rft.pub=Merck+Publishing+Group&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation journal">Lovy MR, Starkebaum G, Uberoi S (1996). "Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis". <i><a class="mw-redirect" href="/wiki/J._Rheumatol." title="J. Rheumatol.">J. Rheumatol.</a></i> <b>23</b> (6): 1238–9. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8782126" rel="nofollow">8782126</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Hepatitis+C+infection+presenting+with+rheumatic+manifestations%3A+a+mimic+of+rheumatoid+arthritis&amp;rft.aufirst=MR&amp;rft.aulast=Lovy&amp;rft.au=Starkebaum%2C+G&amp;rft.au=Uberoi%2C+S&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8782126&amp;rft.issue=6&amp;rft.jtitle=J.+Rheumatol.&amp;rft.pages=1238-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text">Kelly, Janis (22 February 2005) <a class="external text" href="http://www.medscape.com/viewarticle/538134" rel="nofollow">DAS28 not always a reliable indicator of treatment effect in RA</a>, Medscape Medical News.</span></li>
<li id="cite_note-Prevoo1995-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-Prevoo1995_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Prevoo1995_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995). "Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis". <i>Arthritis Rheum</i>. <b>38</b> (1): 44–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.1780380107" rel="nofollow">10.1002/art.1780380107</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7818570" rel="nofollow">7818570</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Modified+disease+activity+scores+that+include+twenty-eight-joint+counts.+Development+and+validation+in+a+prospective+longitudinal+study+of+patients+with+rheumatoid+arthritis&amp;rft.aufirst=ML&amp;rft.au=Kuper%2C+HH&amp;rft.aulast=Prevoo&amp;rft.au=van+%27t+Hof%2C+MA&amp;rft.au=van+de+Putte%2C+LB&amp;rft.au=van+Leeuwen%2C+MA&amp;rft.au=van+Riel%2C+PL&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780380107&amp;rft_id=info%3Apmid%2F7818570&amp;rft.issue=1&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=44-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><cite class="citation journal">Yazici, Yusuf (2013). "Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring". <i><a href="/wiki/Arthritis_Research_%26_Therapy" title="Arthritis Research &amp; Therapy">Arthritis Research &amp; Therapy</a></i>. <b>15</b>: 104. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1186%2Far4139" rel="nofollow">10.1186/ar4139</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Tools+for+monitoring+remission+in+rheumatoid+arthritis%3A+any+will+do%2C+let%99s+just+pick+one+and+start+measuring&amp;rft.aufirst=Yusuf&amp;rft.aulast=Yazici&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1186%2Far4139&amp;rft.jtitle=Arthritis+Research+%26+Therapy&amp;rft.pages=104&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation journal">Bruce, Bonnie; Fries, James F. (2003-01-01). <a class="external text" href="http://dx.doi.org/10.1186/1477-7525-1-20" rel="nofollow">"The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications"</a>. <i>Health and Quality of Life Outcomes</i>. <b>1</b>: 20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1186%2F1477-7525-1-20" rel="nofollow">10.1186/1477-7525-1-20</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1477-7525" rel="nofollow">1477-7525</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC165587" rel="nofollow">165587</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12831398" rel="nofollow">12831398</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+Stanford+Health+Assessment+Questionnaire%3A+Dimensions+and+Practical+Applications&amp;rft.aufirst=Bonnie&amp;rft.au=Fries%2C+James+F.&amp;rft.aulast=Bruce&amp;rft.date=2003-01-01&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC165587&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.1186%2F1477-7525-1-20&amp;rft_id=info%3Adoi%2F10.1186%2F1477-7525-1-20&amp;rft_id=info%3Apmid%2F12831398&amp;rft.issn=1477-7525&amp;rft.jtitle=Health+and+Quality+of+Life+Outcomes&amp;rft.pages=20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Healthline-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Healthline_61-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Spriggs, Brenda B. <a class="external text" href="http://www.healthline.com/health/rheumatoid-arthritis-prevention#Overview1" rel="nofollow">"Rheumatoid Arthritis Prevention"</a>. Healthline Networks<span class="reference-accessdate">. Retrieved <span class="nowrap">September 16,</span> 2014</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.aufirst=Brenda+B&amp;rft.aulast=Spriggs&amp;rft.btitle=Rheumatoid+Arthritis+Prevention&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.healthline.com%2Fhealth%2Frheumatoid-arthritis-prevention%23Overview1&amp;rft.pub=Healthline+Networks&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-ACR2008-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACR2008_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACR2008_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Saag KG, Teng GG, Patkar NM, et al. (2008). "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis". <i>Arthritis Rheum</i>. <b>59</b> (6): 762–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.23721" rel="nofollow">10.1002/art.23721</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18512708" rel="nofollow">18512708</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=American+College+of+Rheumatology+2008+recommendations+for+the+use+of+nonbiologic+and+biologic+disease-modifying+antirheumatic+drugs+in+rheumatoid+arthritis&amp;rft.aufirst=KG&amp;rft.aulast=Saag&amp;rft.au=Patkar%2C+NM&amp;rft.au=Teng%2C+GG&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.23721&amp;rft_id=info%3Apmid%2F18512708&amp;rft.issue=6&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=762-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Wasserman-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wasserman_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wasserman_63-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wasserman_63-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wasserman_63-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Amy M. Wasserman (2011). "Diagnosis and Management of Rheumatoid Arthritis". <i>American Family Physician</i>. <b>84</b> (11): 1245–1252. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22150658" rel="nofollow">22150658</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Diagnosis+and+Management+of+Rheumatoid+Arthritis&amp;rft.au=Amy+M.+Wasserman&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F22150658&amp;rft.issue=11&amp;rft.jtitle=American+Family+Physician&amp;rft.pages=1245-1252&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-NICEguidelines-64"><span class="mw-cite-backlink">^ <a href="#cite_ref-NICEguidelines_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICEguidelines_64-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Chris Deighton; Rachel O’Mahony; Jonathan Tosh; Claire Turner; Michael Rudolf; Guideline Development Group (2009). "Management of rheumatoid arthritis: summary of NICE guidance". <i>British Medical Journal</i>. <b>338</b>: 710–712. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fbmj.b702" rel="nofollow">10.1136/bmj.b702</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Management+of+rheumatoid+arthritis%3A+summary+of+NICE+guidance&amp;rft.au=Chris+Deighton&amp;rft.au=Claire+Turner&amp;rft.au=Guideline+Development+Group&amp;rft.au=Jonathan+Tosh&amp;rft.au=Michael+Rudolf&amp;rft.au=Rachel+O%99Mahony&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.b702&amp;rft.jtitle=British+Medical+Journal&amp;rft.pages=710-712&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=338"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite class="citation journal">Richards BL, Whittle SL, Buchbinder R (Jan 18, 2012). Richards, Bethan L, ed. "Muscle relaxants for pain management in rheumatoid arthritis". <i>Cochrane database of systematic reviews (Online)</i>. <b>1</b>: CD008922. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008922.pub2" rel="nofollow">10.1002/14651858.CD008922.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22258993" rel="nofollow">22258993</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Muscle+relaxants+for+pain+management+in+rheumatoid+arthritis&amp;rft.au=Richards+BL%2C+Whittle+SL%2C+Buchbinder+R&amp;rft.date=2012-01-18&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008922.pub2&amp;rft_id=info%3Apmid%2F22258993&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008922&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (Oct 7, 2009). Hurkmans, Emalie, ed. "Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis". <i>Cochrane database of systematic reviews (Online)</i> (4): CD006853. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD006853.pub2" rel="nofollow">10.1002/14651858.CD006853.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821388" rel="nofollow">19821388</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Dynamic+exercise+programs+%28aerobic+capacity+and%2For+muscle+strength+training%29+in+patients+with+rheumatoid+arthritis&amp;rft.au=Hurkmans+E%2C+van+der+Giesen+FJ%2C+Vliet+Vlieland+TP%2C+Schoones+J%2C+Van+den+Ende+EC&amp;rft.date=2009-10-07&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006853.pub2&amp;rft_id=info%3Apmid%2F19821388&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD006853&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hagen KB, Byfuglien MG, Falzon L, Olsen SU, Smedslund G (Jan 21, 2009). Hagen, Kåre Birger, ed. "Dietary interventions for rheumatoid arthritis". <i>Cochrane database of systematic reviews (Online)</i> (1): CD006400. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD006400.pub2" rel="nofollow">10.1002/14651858.CD006400.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19160281" rel="nofollow">19160281</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Dietary+interventions+for+rheumatoid+arthritis&amp;rft.au=Hagen+KB%2C+Byfuglien+MG%2C+Falzon+L%2C+Olsen+SU%2C+Smedslund+G&amp;rft.date=2009-01-21&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006400.pub2&amp;rft_id=info%3Apmid%2F19160281&amp;rft.issue=1&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD006400&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation journal">Cramp, Fiona (2013). "Non-pharmacological interventions for fatigue in rheumatoid arthritis.". <i>Cochrane Database of Systematic Reviews</i> (8): Art. No.: CD008322. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008322.pub2" rel="nofollow">10.1002/14651858.CD008322.pub2</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Non-pharmacological+interventions+for+fatigue+in+rheumatoid+arthritis.&amp;rft.aufirst=Fiona&amp;rft.aulast=Cramp&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008322.pub2&amp;rft.issue=8&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=Art.+No.%3A+CD008322&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation journal">Steultjens, Esther EMJ (2004). "Occupational therapy for rheumatoid arthritis". <i>Cochrane Database of Systematic Reviews</i> (1). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD003114.pub2" rel="nofollow">10.1002/14651858.CD003114.pub2</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Occupational+therapy+for+rheumatoid+arthritis&amp;rft.aufirst=Esther+EMJ&amp;rft.aulast=Steultjens&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003114.pub2&amp;rft.issue=1&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gramling A, O'Dell JR (2012). "Initial management of rheumatoid arthritis". <i>Rheum. Dis. Clin. North Am</i>. <b>38</b> (2): 311–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.rdc.2012.05.003" rel="nofollow">10.1016/j.rdc.2012.05.003</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22819086" rel="nofollow">22819086</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Initial+management+of+rheumatoid+arthritis&amp;rft.aufirst=A&amp;rft.aulast=Gramling&amp;rft.au=O%27Dell%2C+JR&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rdc.2012.05.003&amp;rft_id=info%3Apmid%2F22819086&amp;rft.issue=2&amp;rft.jtitle=Rheum.+Dis.+Clin.+North+Am.&amp;rft.pages=311-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-chapter94-71"><span class="mw-cite-backlink">^ <a href="#cite_ref-chapter94_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-chapter94_71-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-chapter94_71-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-chapter94_71-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">DiPiro, Joseph T., Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, and L. Michael Posey (2008) Pharmacotherapy: a pathophysiologic approach. 7th ed. New York: McGraw-Hill, <a class="internal mw-magiclink-isbn" href="/wiki/Special:BookSources/9780071478991">ISBN 978-0-07-147899-1</a>.</span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation journal">Shea, B.; Swinden, M.V.; Tanjong Ghogomu, E.; Ortiz, Z.; Katchamart, W.; Rader, T.; Bombardier, C.; Wells, George A; Tugwell, Peter (May 31, 2013). "Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis". <i>The Cochrane database of systematic reviews</i>. <b>5</b> (5): CD000951. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD000951.pub2" rel="nofollow">10.1002/14651858.CD000951.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23728635" rel="nofollow">23728635</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Folic+acid+and+folinic+acid+for+reducing+side+effects+in+patients+receiving+methotrexate+for+rheumatoid+arthritis&amp;rft.au=Bombardier%2C+C.&amp;rft.aufirst=B.&amp;rft.au=Katchamart%2C+W.&amp;rft.aulast=Shea&amp;rft.au=Ortiz%2C+Z.&amp;rft.au=Rader%2C+T.&amp;rft.au=Swinden%2C+M.V.&amp;rft.au=Tanjong+Ghogomu%2C+E.&amp;rft.au=Tugwell%2C+Peter&amp;rft.au=Wells%2C+George+A&amp;rft.date=2013-05-31&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000951.pub2&amp;rft_id=info%3Apmid%2F23728635&amp;rft.issue=5&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD000951&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-ACR2002-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-ACR2002_73-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). "Guidelines for the management of rheumatoid arthritis: 2002 Update". <i>Arthritis &amp; Rheumatism</i>. <b>46</b> (2): 328–346. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.10148" rel="nofollow">10.1002/art.10148</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Guidelines+for+the+management+of+rheumatoid+arthritis%3A+2002+Update&amp;rft.au=American+College+of+Rheumatology+Subcommittee+on+Rheumatoid+Arthritis+Guidelines&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.10148&amp;rft.issue=2&amp;rft.jtitle=Arthritis+%26+Rheumatism&amp;rft.pages=328-346&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><cite class="citation journal">Singh, JA; Furst, DE; Bharat, A; Curtis, JR; Kavanaugh, AF; Kremer, JM; Moreland, LW; O'Dell, J; Winthrop, KL; Beukelman, T; Bridges SL, Jr; Chatham, WW; Paulus, HE; Suarez-Almazor, M; Bombardier, C; Dougados, M; Khanna, D; King, CM; Leong, AL; Matteson, EL; Schousboe, JT; Moynihan, E; Kolba, KS; Jain, A; Volkmann, ER; Agrawal, H; Bae, S; Mudano, AS; Patkar, NM; Saag, KG (May 2012). "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.". <i>Arthritis Care &amp; Research</i>. <b>64</b> (5): 625–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Facr.21641" rel="nofollow">10.1002/acr.21641</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22473917" rel="nofollow">22473917</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=2012+update+of+the+2008+American+College+of+Rheumatology+recommendations+for+the+use+of+disease-modifying+antirheumatic+drugs+and+biologic+agents+in+the+treatment+of+rheumatoid+arthritis.&amp;rft.au=Agrawal%2C+H&amp;rft.au=Bae%2C+S&amp;rft.au=Beukelman%2C+T&amp;rft.au=Bharat%2C+A&amp;rft.au=Bombardier%2C+C&amp;rft.au=Bridges+SL%2C+Jr&amp;rft.au=Chatham%2C+WW&amp;rft.au=Curtis%2C+JR&amp;rft.au=Dougados%2C+M&amp;rft.aufirst=JA&amp;rft.au=Furst%2C+DE&amp;rft.au=Jain%2C+A&amp;rft.au=Kavanaugh%2C+AF&amp;rft.au=Khanna%2C+D&amp;rft.au=King%2C+CM&amp;rft.au=Kolba%2C+KS&amp;rft.au=Kremer%2C+JM&amp;rft.aulast=Singh&amp;rft.au=Leong%2C+AL&amp;rft.au=Matteson%2C+EL&amp;rft.au=Moreland%2C+LW&amp;rft.au=Moynihan%2C+E&amp;rft.au=Mudano%2C+AS&amp;rft.au=O%27Dell%2C+J&amp;rft.au=Patkar%2C+NM&amp;rft.au=Paulus%2C+HE&amp;rft.au=Saag%2C+KG&amp;rft.au=Schousboe%2C+JT&amp;rft.au=Suarez-Almazor%2C+M&amp;rft.au=Volkmann%2C+ER&amp;rft.au=Winthrop%2C+KL&amp;rft.date=2012-05&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Facr.21641&amp;rft_id=info%3Apmid%2F22473917&amp;rft.issue=5&amp;rft.jtitle=Arthritis+Care+%26+Research&amp;rft.pages=625-39&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><cite class="citation journal">Singh, Jasvinder A; Cameron, Chris; Noorbaloochi, Shahrzad; Cullis, Tyler; Tucker, Matthew; Christensen, Robin; Ghogomu, Elizabeth Tanjong; Coyle, Doug; Clifford, Tammy; Tugwell, Peter; Wells, George A (May 2015). "Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis". <i>The Lancet</i>. <b>386</b> (9990): 258–265. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2814%2961704-9" rel="nofollow">10.1016/S0140-6736(14)61704-9</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Risk+of+serious+infection+in+biological+treatment+of+patients+with+rheumatoid+arthritis%3A+a+systematic+review+and+meta-analysis&amp;rft.au=Cameron%2C+Chris&amp;rft.au=Christensen%2C+Robin&amp;rft.au=Clifford%2C+Tammy&amp;rft.au=Coyle%2C+Doug&amp;rft.au=Cullis%2C+Tyler&amp;rft.aufirst=Jasvinder+A&amp;rft.au=Ghogomu%2C+Elizabeth+Tanjong&amp;rft.aulast=Singh&amp;rft.au=Noorbaloochi%2C+Shahrzad&amp;rft.au=Tucker%2C+Matthew&amp;rft.au=Tugwell%2C+Peter&amp;rft.au=Wells%2C+George+A&amp;rft.date=2015-05&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2814%2961704-9&amp;rft.issue=9990&amp;rft.jtitle=The+Lancet&amp;rft.pages=258-265&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=386"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><cite class="citation journal">Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T; Szczepanski; Szechinski; Filipowicz-Sosnowska; Emery; Close; Stevens; Shaw (2004). "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis". <i>N Engl J Med</i>. <b>350</b> (25): 2572–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1056%2FNEJMoa032534" rel="nofollow">10.1056/NEJMoa032534</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15201414" rel="nofollow">15201414</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Efficacy+of+B-cell-targeted+therapy+with+rituximab+in+patients+with+rheumatoid+arthritis&amp;rft.au=Close&amp;rft.au=Edwards+J%2C+Szczepanski+L%2C+Szechinski+J%2C+Filipowicz-Sosnowska+A%2C+Emery+P%2C+Close+D%2C+Stevens+R%2C+Shaw+T&amp;rft.au=Emery&amp;rft.au=Filipowicz-Sosnowska&amp;rft.au=Shaw&amp;rft.au=Stevens&amp;rft.au=Szczepanski&amp;rft.au=Szechinski&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa032534&amp;rft_id=info%3Apmid%2F15201414&amp;rft.issue=25&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=2572-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=350"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><cite class="citation journal">van Herwaarden, N; den Broeder, AA; Jacobs, W; van der Maas, A; Bijlsma, JW; van Vollenhoven, RF; van den Bemt, BH (Sep 29, 2014). "Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity". <i>The Cochrane database of systematic reviews</i>. <b>9</b> (9): CD010455. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD010455.pub2" rel="nofollow">10.1002/14651858.CD010455.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25264908" rel="nofollow">25264908</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Down-titration+and+discontinuation+strategies+of+tumor+necrosis+factor-blocking+agents+for+rheumatoid+arthritis+in+patients+with+low+disease+activity&amp;rft.au=Bijlsma%2C+JW&amp;rft.au=den+Broeder%2C+AA&amp;rft.aufirst=N&amp;rft.au=Jacobs%2C+W&amp;rft.aulast=van+Herwaarden&amp;rft.au=van+den+Bemt%2C+BH&amp;rft.au=van+der+Maas%2C+A&amp;rft.au=van+Vollenhoven%2C+RF&amp;rft.date=2014-09-29&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010455.pub2&amp;rft_id=info%3Apmid%2F25264908&amp;rft.issue=9&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD010455&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite class="citation journal">Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordström DC, Blom M; Virkki; Malmivaara; Konttinen; Nordström; Blom (2012). Hernandez, Adrian V, ed. <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264" rel="nofollow">"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis"</a>. <i>PLoS ONE</i>. <b>7</b> (1): e30275. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0030275" rel="nofollow">10.1371/journal.pone.0030275</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264" rel="nofollow">3260264</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22272322" rel="nofollow">22272322</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Systematic+review+and+meta-analysis+of+the+efficacy+and+safety+of+existing+TNF+blocking+agents+in+treatment+of+rheumatoid+arthritis&amp;rft.au=Aaltonen+KJ%2C+Virkki+LM%2C+Malmivaara+A%2C+Konttinen+YT%2C+Nordstr%C3%B6m+DC%2C+Blom+M&amp;rft.au=Blom&amp;rft.au=Konttinen&amp;rft.au=Malmivaara&amp;rft.au=Nordstr%C3%B6m&amp;rft.au=Virkki&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3260264&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3260264&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0030275&amp;rft_id=info%3Apmid%2F22272322&amp;rft.issue=1&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e30275&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation journal">Maxwell L, Singh JA; Singh (Oct 7, 2009). Maxwell, Lara, ed. "Abatacept for rheumatoid arthritis". <i>Cochrane database of systematic reviews (Online)</i> (4): CD007277. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD007277.pub2" rel="nofollow">10.1002/14651858.CD007277.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821401" rel="nofollow">19821401</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Abatacept+for+rheumatoid+arthritis&amp;rft.au=Maxwell+L%2C+Singh+JA&amp;rft.au=Singh&amp;rft.date=2009-10-07&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007277.pub2&amp;rft_id=info%3Apmid%2F19821401&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD007277&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation journal">Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P; Christensen; Wells; Suarez-Almazor; Buchbinder; Lopez-Olivo; Tanjong Ghogomu; Tugwell (Oct 7, 2009). Singh, Jasvinder A, ed. "Biologics for rheumatoid arthritis: an overview of Cochrane reviews". <i>Cochrane database of systematic reviews (Online)</i> (4): CD007848. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD007848.pub2" rel="nofollow">10.1002/14651858.CD007848.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821440" rel="nofollow">19821440</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Biologics+for+rheumatoid+arthritis%3A+an+overview+of+Cochrane+reviews&amp;rft.au=Buchbinder&amp;rft.au=Christensen&amp;rft.au=Lopez-Olivo&amp;rft.au=Singh+JA%2C+Christensen+R%2C+Wells+GA%2C+Suarez-Almazor+ME%2C+Buchbinder+R%2C+Lopez-Olivo+MA%2C+Tanjong+Ghogomu+E%2C+Tugwell+P&amp;rft.au=Suarez-Almazor&amp;rft.au=Tanjong+Ghogomu&amp;rft.au=Tugwell&amp;rft.au=Wells&amp;rft.date=2009-10-07&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007848.pub2&amp;rft_id=info%3Apmid%2F19821440&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD007848&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation journal">Tarp S, Bartels EM, Bliddal H, Furst DE, Boers M, Danneskiold-Samsøe B, Rasmussen M, Christensen R; Bartels; Bliddal; Furst; Boers; Danneskiold-Samsøe; Rasmussen; Christensen (November 2012). "Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials". <i>Arthritis and rheumatism</i>. <b>64</b> (11): 3511–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.34644" rel="nofollow">10.1002/art.34644</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22833186" rel="nofollow">22833186</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Effect+of+nonsteroidal+antiinflammatory+drugs+on+the+C-reactive+protein+level+in+rheumatoid+arthritis%3A+a+meta-analysis+of+randomized+controlled+trials&amp;rft.au=Bartels&amp;rft.au=Bliddal&amp;rft.au=Boers&amp;rft.au=Christensen&amp;rft.au=Danneskiold-Sams%C3%B8e&amp;rft.au=Furst&amp;rft.au=Rasmussen&amp;rft.au=Tarp+S%2C+Bartels+EM%2C+Bliddal+H%2C+Furst+DE%2C+Boers+M%2C+Danneskiold-Sams%C3%B8e+B%2C+Rasmussen+M%2C+Christensen+R&amp;rft.date=2012-11&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.34644&amp;rft_id=info%3Apmid%2F22833186&amp;rft.issue=11&amp;rft.jtitle=Arthritis+and+rheumatism&amp;rft.pages=3511-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation journal">Radner H, Ramiro S, Buchbinder R, Landewé RB, van der Heijde D, Aletaha D; Ramiro; Buchbinder; Landewé; Van Der Heijde; Aletaha (Jan 18, 2012). Radner, Helga, ed. "Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity". <i>Cochrane database of systematic reviews (Online)</i>. <b>1</b>: CD008951. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008951.pub2" rel="nofollow">10.1002/14651858.CD008951.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22258995" rel="nofollow">22258995</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Pain+management+for+inflammatory+arthritis+%28rheumatoid+arthritis%2C+psoriatic+arthritis%2C+ankylosing+spondylitis+and+other+spondylarthritis%29+and+gastrointestinal+or+liver+comorbidity&amp;rft.au=Aletaha&amp;rft.au=Buchbinder&amp;rft.au=Landew%C3%A9&amp;rft.au=Radner+H%2C+Ramiro+S%2C+Buchbinder+R%2C+Landew%C3%A9+RB%2C+van+der+Heijde+D%2C+Aletaha+D&amp;rft.au=Ramiro&amp;rft.au=Van+Der+Heijde&amp;rft.date=2012-01-18&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008951.pub2&amp;rft_id=info%3Apmid%2F22258995&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008951&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-pmid22141388-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22141388_83-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">McCormack PL (2011). "Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis". <i>Drugs</i>. <b>71</b> (18): 2457–89. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.2165%2F11208240-000000000-00000" rel="nofollow">10.2165/11208240-000000000-00000</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22141388" rel="nofollow">22141388</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Celecoxib%3A+a+review+of+its+use+for+symptomatic+relief+in+the+treatment+of+osteoarthritis%2C+rheumatoid+arthritis+and+ankylosing+spondylitis&amp;rft.au=McCormack+PL&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11208240-000000000-00000&amp;rft_id=info%3Apmid%2F22141388&amp;rft.issue=18&amp;rft.jtitle=Drugs&amp;rft.pages=2457-89&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=71"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation journal">Marks JL, Colebatch AN, Buchbinder R, Edwards CJ; Colebatch; Buchbinder; Edwards (Oct 5, 2011). Marks, Jonathan L, ed. "Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity". <i>Cochrane database of systematic reviews (Online)</i> (10): CD008952. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008952.pub2" rel="nofollow">10.1002/14651858.CD008952.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21975789" rel="nofollow">21975789</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Pain+management+for+rheumatoid+arthritis+and+cardiovascular+or+renal+comorbidity&amp;rft.au=Buchbinder&amp;rft.au=Colebatch&amp;rft.au=Edwards&amp;rft.au=Marks+JL%2C+Colebatch+AN%2C+Buchbinder+R%2C+Edwards+CJ&amp;rft.date=2011-10-05&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008952.pub2&amp;rft_id=info%3Apmid%2F21975789&amp;rft.issue=10&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008952&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation journal">Colebatch, AN; Marks, Jonathan L; Edwards, Christopher J (2011). "Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)". <i>Cochrane Database of Systematic Reviews</i> (11): CD008872. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008872.pub2" rel="nofollow">10.1002/14651858.CD008872.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22071858" rel="nofollow">22071858</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Safety+of+non-steroidal+anti-inflammatory+drugs%2C+including+aspirin+and+paracetamol+%28acetaminophen%29+in+people+receiving+methotrexate+for+inflammatory+arthritis+%28rheumatoid+arthritis%2C+ankylosing+spondylitis%2C+psoriatic+arthritis%2C+other+spondyloarthritis%29&amp;rft.au=Edwards%2C+Christopher+J&amp;rft.aufirst=AN&amp;rft.aulast=Colebatch&amp;rft.au=Marks%2C+Jonathan+L&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008872.pub2&amp;rft_id=info%3Apmid%2F22071858&amp;rft.issue=11&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=CD008872&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Job2008-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-Job2008_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Job2008_86-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS; Jobanputra; Barton; Bryan; Fry-Smith; Harris; Taylor (April 2008). "Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation". <i>Health technology assessment (Winchester, England)</i>. <b>12</b> (11): 1–278, iii. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.3310%2Fhta12110" rel="nofollow">10.3310/hta12110</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18405470" rel="nofollow">18405470</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Cyclooxygenase-2+selective+non-steroidal+anti-inflammatory+drugs+%28etodolac%2C+meloxicam%2C+celecoxib%2C+rofecoxib%2C+etoricoxib%2C+valdecoxib+and+lumiracoxib%29+for+osteoarthritis+and+rheumatoid+arthritis%3A+a+systematic+review+and+economic+evaluation&amp;rft.au=Barton&amp;rft.au=Bryan&amp;rft.au=Chen+YF%2C+Jobanputra+P%2C+Barton+P%2C+Bryan+S%2C+Fry-Smith+A%2C+Harris+G%2C+Taylor+RS&amp;rft.au=Fry-Smith&amp;rft.au=Harris&amp;rft.au=Jobanputra&amp;rft.au=Taylor&amp;rft.date=2008-04&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3310%2Fhta12110&amp;rft_id=info%3Apmid%2F18405470&amp;rft.issue=11&amp;rft.jtitle=Health+technology+assessment+%28Winchester%2C+England%29&amp;rft.pages=1-278%2C+iii&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation journal">Wang X, Tian HJ, Yang HK, Wanyan P, Peng YJ; Tian; Yang; Wanyan; Peng (October 2011). "Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis". <i>European journal of gastroenterology &amp; hepatology</i>. <b>23</b> (10): 876–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2FMEG.0b013e328349de81" rel="nofollow">10.1097/MEG.0b013e328349de81</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21900785" rel="nofollow">21900785</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Meta-analysis%3A+cyclooxygenase-2+inhibitors+are+no+better+than+nonselective+nonsteroidal+anti-inflammatory+drugs+with+proton+pump+inhibitors+in+regard+to+gastrointestinal+adverse+events+in+osteoarthritis+and+rheumatoid+arthritis&amp;rft.au=Peng&amp;rft.au=Tian&amp;rft.au=Wang+X%2C+Tian+HJ%2C+Yang+HK%2C+Wanyan+P%2C+Peng+YJ&amp;rft.au=Wanyan&amp;rft.au=Yang&amp;rft.date=2011-10&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMEG.0b013e328349de81&amp;rft_id=info%3Apmid%2F21900785&amp;rft.issue=10&amp;rft.jtitle=European+journal+of+gastroenterology+%26+hepatology&amp;rft.pages=876-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mallen SR, Essex MN, Zhang R; Essex; Zhang (July 2011). "Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs". <i>Current medical research and opinion</i>. <b>27</b> (7): 1359–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1185%2F03007995.2011.581274" rel="nofollow">10.1185/03007995.2011.581274</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21561397" rel="nofollow">21561397</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Gastrointestinal+tolerability+of+NSAIDs+in+elderly+patients%3A+a+pooled+analysis+of+21+randomized+clinical+trials+with+celecoxib+and+nonselective+NSAIDs&amp;rft.au=Essex&amp;rft.au=Mallen+SR%2C+Essex+MN%2C+Zhang+R&amp;rft.au=Zhang&amp;rft.date=2011-07&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1185%2F03007995.2011.581274&amp;rft_id=info%3Apmid%2F21561397&amp;rft.issue=7&amp;rft.jtitle=Current+medical+research+and+opinion&amp;rft.pages=1359-66&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation journal">"Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs". <i>Prescrire Int</i>. <b>20</b> (119): 216–9. 2011. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21954519" rel="nofollow">21954519</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Nonsteroidal+anti-inflammatory+drugs%3A+add+an+anti-ulcer+drug+for+patients+at+high+risk+only.+Always+limit+the+dose+and+duration+of+treatment+with+NSAIDs&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21954519&amp;rft.issue=119&amp;rft.jtitle=Prescrire+Int&amp;rft.pages=216-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Macfarlane-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-Macfarlane_90-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Macfarlane GJ, El-Metwally A, De Silva V, Ernst E, Dowds GL, Moots RJ; El-Metwally; De Silva; Ernst; Dowds; Moots; Arthritis Research UK Working Group on Complementary Alternative Medicines (2011). "Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review". <i>Rheumatology (Oxford)</i>. <b>50</b> (9): 1672–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2Fker119" rel="nofollow">10.1093/rheumatology/ker119</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21652584" rel="nofollow">21652584</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Evidence+for+the+efficacy+of+complementary+and+alternative+medicines+in+the+management+of+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.au=Arthritis+Research+UK+Working+Group+on+Complementary+Alternative+Medicines&amp;rft.au=De+Silva&amp;rft.au=Dowds&amp;rft.au=El-Metwally&amp;rft.au=Ernst&amp;rft.au=Macfarlane+GJ%2C+El-Metwally+A%2C+De+Silva+V%2C+Ernst+E%2C+Dowds+GL%2C+Moots+RJ&amp;rft.au=Moots&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fker119&amp;rft_id=info%3Apmid%2F21652584&amp;rft.issue=9&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=1672-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><cite class="citation journal">Brosseau L, Robinson V, Wells G, Debie R, Gam A, Harman K, Morin M, Shea B, Tugwell P (2005). "Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis". <i>Cochrane Database Syst Rev</i>. <b>4</b> (4): CD002049. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD002049.pub2" rel="nofollow">10.1002/14651858.CD002049.pub2</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16235295" rel="nofollow">16235295</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Low+level+laser+therapy+%28Classes+I%2C+II+and+III%29+for+treating+rheumatoid+arthritis&amp;rft.au=Debie%2C+R&amp;rft.aufirst=L&amp;rft.au=Gam%2C+A&amp;rft.au=Harman%2C+K&amp;rft.aulast=Brosseau&amp;rft.au=Morin%2C+M&amp;rft.au=Robinson%2C+V&amp;rft.au=Shea%2C+B&amp;rft.au=Tugwell%2C+P&amp;rft.au=Wells%2C+G&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002049.pub2&amp;rft_id=info%3Apmid%2F16235295&amp;rft.issue=4&amp;rft.jtitle=Cochrane+Database+Syst+Rev.&amp;rft.pages=CD002049&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><cite class="citation journal">Han, Alcie; Judd, Maria; Welch, Vivian; Wu, Taixiang; Tugwell, Peter; Wells, George A (2004). "Tai chi for treating rheumatoid arthritis". <i>Cochrane Database of Systematic Reviews</i> (3). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD004849" rel="nofollow">10.1002/14651858.CD004849</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Tai+chi+for+treating+rheumatoid+arthritis&amp;rft.aufirst=Alcie&amp;rft.au=Judd%2C+Maria&amp;rft.aulast=Han&amp;rft.au=Tugwell%2C+Peter&amp;rft.au=Welch%2C+Vivian&amp;rft.au=Wells%2C+George+A&amp;rft.au=Wu%2C+Taixiang&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004849&amp;rft.issue=3&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><cite class="citation journal">Lee MS, Shin B-C, Ernst E; Shin; Ernst (2008). "Acupuncture for rheumatoid arthritis: a systematic review". <i>Rheumatology</i>. <b>47</b> (12): 1747–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2Fken330" rel="nofollow">10.1093/rheumatology/ken330</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18710899" rel="nofollow">18710899</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Acupuncture+for+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.au=Ernst&amp;rft.au=Lee+MS%2C+Shin+B-C%2C+Ernst+E&amp;rft.au=Shin&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fken330&amp;rft_id=info%3Apmid%2F18710899&amp;rft.issue=12&amp;rft.jtitle=Rheumatology&amp;rft.pages=1747-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><cite class="citation journal">Macfarlane GJ, Paudyal P, Doherty M, Ernst E, Lewith G, MacPherson H, Sim J, Jones GT; Paudyal; Doherty; Ernst; Lewith; MacPherson; Sim; Jones; Arthritis Research UK Working Group on Complementary Alternative Therapies for the Management of the Rheumatic Diseases (2012). "A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis". <i>Rheumatology</i>. <b>51</b> (9): 1707–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Frheumatology%2Fkes133" rel="nofollow">10.1093/rheumatology/kes133</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22661556" rel="nofollow">22661556</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+systematic+review+of+evidence+for+the+effectiveness+of+practitioner-based+complementary+and+alternative+therapies+in+the+management+of+rheumatic+diseases%3A+rheumatoid+arthritis&amp;rft.au=Arthritis+Research+UK+Working+Group+on+Complementary+Alternative+Therapies+for+the+Management+of+the+Rheumatic+Diseases&amp;rft.au=Doherty&amp;rft.au=Ernst&amp;rft.au=Jones&amp;rft.au=Lewith&amp;rft.au=Macfarlane+GJ%2C+Paudyal+P%2C+Doherty+M%2C+Ernst+E%2C+Lewith+G%2C+MacPherson+H%2C+Sim+J%2C+Jones+GT&amp;rft.au=MacPherson&amp;rft.au=Paudyal&amp;rft.au=Sim&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkes133&amp;rft_id=info%3Apmid%2F22661556&amp;rft.issue=9&amp;rft.jtitle=Rheumatology&amp;rft.pages=1707-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation journal">Pirotta, M (September 2010). "Arthritis disease – the use of complementary therapies". <i>Australian family physician</i>. <b>39</b> (9): 638–40. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20877766" rel="nofollow">20877766</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Arthritis+disease+%93+the+use+of+complementary+therapies&amp;rft.aufirst=M&amp;rft.aulast=Pirotta&amp;rft.date=2010-09&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F20877766&amp;rft.issue=9&amp;rft.jtitle=Australian+family+physician&amp;rft.pages=638-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><cite class="citation journal">Miles EA, Calder PC; Calder (June 2012). "Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis". <i>The British journal of nutrition</i>. 107 Suppl 2 (S2): S171–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1017%2FS0007114512001560" rel="nofollow">10.1017/S0007114512001560</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22591891" rel="nofollow">22591891</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Influence+of+marine+n-3+polyunsaturated+fatty+acids+on+immune+function+and+a+systematic+review+of+their+effects+on+clinical+outcomes+in+rheumatoid+arthritis&amp;rft.au=Calder&amp;rft.au=Miles+EA%2C+Calder+PC&amp;rft.date=2012-06&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0007114512001560&amp;rft_id=info%3Apmid%2F22591891&amp;rft.issue=S2&amp;rft.jtitle=The+British+journal+of+nutrition&amp;rft.pages=S171-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107+Suppl+2"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><cite class="citation journal">Ruggiero C, Lattanzio F, Lauretani F, Gasperini B, Andres-Lacueva C, Cherubini A; Lattanzio; Lauretani; Gasperini; Andres-Lacueva; Cherubini (2009). <a class="external text" href="http://www.researchgate.net/publication/40818808_Omega-3_polyunsaturated_fatty_acids_and_immune-mediated_diseases_inflammatory_bowel_disease_and_rheumatoid_arthritis/file/d912f50eefc97a4450.pdf" rel="nofollow">"Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis"</a> <span style="font-size:85%;">(PDF)</span>. <i>Current pharmaceutical design</i>. <b>15</b> (36): 4135–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.2174%2F138161209789909746" rel="nofollow">10.2174/138161209789909746</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20041815" rel="nofollow">20041815</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Omega-3+polyunsaturated+fatty+acids+and+immune-mediated+diseases%3A+inflammatory+bowel+disease+and+rheumatoid+arthritis&amp;rft.au=Andres-Lacueva&amp;rft.au=Cherubini&amp;rft.au=Gasperini&amp;rft.au=Lattanzio&amp;rft.au=Lauretani&amp;rft.au=Ruggiero+C%2C+Lattanzio+F%2C+Lauretani+F%2C+Gasperini+B%2C+Andres-Lacueva+C%2C+Cherubini+A&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.researchgate.net%2Fpublication%2F40818808_Omega-3_polyunsaturated_fatty_acids_and_immune-mediated_diseases_inflammatory_bowel_disease_and_rheumatoid_arthritis%2Ffile%2Fd912f50eefc97a4450.pdf&amp;rft_id=info%3Adoi%2F10.2174%2F138161209789909746&amp;rft_id=info%3Apmid%2F20041815&amp;rft.issue=36&amp;rft.jtitle=Current+pharmaceutical+design&amp;rft.pages=4135-48&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web">Soeken, K L; Miller, S A; Ernst, E. <a class="external text" href="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?AccessionNumber=12003000980" rel="nofollow">"Herbal medicines for the treatment of rheumatoid arthritis: a systematic review"</a>. <i><a href="/wiki/Centre_for_Reviews_and_Dissemination" title="Centre for Reviews and Dissemination">Centre for Reviews and Dissemination</a></i>. <a href="/wiki/National_Institute_for_Health_Research" title="National Institute for Health Research">National Institute for Health Research</a><span class="reference-accessdate">. Retrieved <span class="nowrap">March 23,</span> 2013</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Herbal+medicines+for+the+treatment+of+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.au=Ernst%2C+E&amp;rft.aufirst=K+L&amp;rft.aulast=Soeken&amp;rft.au=Miller%2C+S+A&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.crd.york.ac.uk%2FCRDWeb%2FShowRecord.asp%3FAccessionNumber%3D12003000980&amp;rft.jtitle=Centre+for+Reviews+and+Dissemination&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-ACRCAM-99"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACRCAM_99-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACRCAM_99-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Herbal_Remedies,_Supplements_and_Acupuncture_for_Arthritis/" rel="nofollow">"Herbal Remedies, Supplements and Acupuncture for Arthritis"</a>. American College of Rheumatology<span class="reference-accessdate">. Retrieved <span class="nowrap">May 3,</span> 2013</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Herbal+Remedies%2C+Supplements+and+Acupuncture+for+Arthritis&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2FPractice%2FClinical%2FPatients%2FDiseases_And_Conditions%2FHerbal_Remedies%2C_Supplements_and_Acupuncture_for_Arthritis%2F&amp;rft.pub=American+College+of+Rheumatology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><cite class="citation journal">Abdel-Tawab M, Werz O, Schubert-Zsilavecz M; Werz; Schubert-Zsilavecz (June 2011). "Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data". <i>Clinical pharmacokinetics</i>. <b>50</b> (6): 349–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.2165%2F11586800-000000000-00000" rel="nofollow">10.2165/11586800-000000000-00000</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21553931" rel="nofollow">21553931</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Boswellia+serrata%3A+an+overall+assessment+of+in+vitro%2C+preclinical%2C+pharmacokinetic+and+clinical+data&amp;rft.au=Abdel-Tawab+M%2C+Werz+O%2C+Schubert-Zsilavecz+M&amp;rft.au=Schubert-Zsilavecz&amp;rft.au=Werz&amp;rft.date=2011-06&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11586800-000000000-00000&amp;rft_id=info%3Apmid%2F21553931&amp;rft.issue=6&amp;rft.jtitle=Clinical+pharmacokinetics&amp;rft.pages=349-69&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><cite class="citation journal">White B, Judkins DZ; Judkins (March 2011). "Clinical Inquiry. Does turmeric relieve inflammatory conditions?". <i>The Journal of family practice</i>. <b>60</b> (3): 155–6. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21369559" rel="nofollow">21369559</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Clinical+Inquiry.+Does+turmeric+relieve+inflammatory+conditions%3F&amp;rft.au=Judkins&amp;rft.au=White+B%2C+Judkins+DZ&amp;rft.date=2011-03&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21369559&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+family+practice&amp;rft.pages=155-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><cite class="citation journal">Wegener, T. (1999). "Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)". <i>Wiener medizinische Wochenschrift (1946)</i>. <b>149</b> (8–10): 254–257. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10483693" rel="nofollow">10483693</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Therapy+of+degenerative+diseases+of+the+musculoskeletal+system+with+South+African+devil%27s+claw+%28Harpagophytum+procumbens+DC%29&amp;rft.aufirst=T.&amp;rft.aulast=Wegener&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10483693&amp;rft.issue=8%9310&amp;rft.jtitle=Wiener+medizinische+Wochenschrift+%281946%29&amp;rft.pages=254-257&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=149"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid17627199-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17627199_103-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Denner SS (2007). "A review of the efficacy and safety of devil's claw for pain associated with degenerative musculoskeletal diseases, rheumatoid, and osteoarthritis". <i>Holist Nurs Pract</i>. <b>21</b> (4): 203–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2F01.HNP.0000280932.65581.72" rel="nofollow">10.1097/01.HNP.0000280932.65581.72</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17627199" rel="nofollow">17627199</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+review+of+the+efficacy+and+safety+of+devil%27s+claw+for+pain+associated+with+degenerative+musculoskeletal+diseases%2C+rheumatoid%2C+and+osteoarthritis&amp;rft.au=Denner+SS&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.HNP.0000280932.65581.72&amp;rft_id=info%3Apmid%2F17627199&amp;rft.issue=4&amp;rft.jtitle=Holist+Nurs+Pract&amp;rft.pages=203-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><cite class="citation journal">Zhang LF, Zhao JX; Zhao (December 2005). "The recent research situation of Euonymus alatus". <i>Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica</i>. <b>30</b> (24): 1895–8. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16494017" rel="nofollow">16494017</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+recent+research+situation+of+Euonymus+alatus&amp;rft.au=Zhang+LF%2C+Zhao+JX&amp;rft.au=Zhao&amp;rft.date=2005-12&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F16494017&amp;rft.issue=24&amp;rft.jtitle=Zhongguo+Zhong+yao+za+zhi+%3D+Zhongguo+zhongyao+zazhi+%3D+China+journal+of+Chinese+materia+medica&amp;rft.pages=1895-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid21365177-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21365177_105-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Bao J, Dai SM; Dai (2011). "A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety". <i>Rheumatol. Int</i>. <b>31</b> (9): 1123–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1007%2Fs00296-011-1841-y" rel="nofollow">10.1007/s00296-011-1841-y</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21365177" rel="nofollow">21365177</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+Chinese+herb+Tripterygium+wilfordii+Hook+F+in+the+treatment+of+rheumatoid+arthritis%3A+mechanism%2C+efficacy%2C+and+safety&amp;rft.au=Bao+J%2C+Dai+SM&amp;rft.au=Dai&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00296-011-1841-y&amp;rft_id=info%3Apmid%2F21365177&amp;rft.issue=9&amp;rft.jtitle=Rheumatol.+Int.&amp;rft.pages=1123-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><cite class="citation journal">Martí-Carvajal, Arturo J; Agreda-Pérez, Luis H; Solà, Ivan; Simancas-Racines, Daniel (2013). "Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis". <i>Cochrane Database of Systematic Reviews</i> (2): CD000332. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2F14651858.CD000332.pub3" rel="nofollow">10.1002/14651858.CD000332.pub3</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23450527" rel="nofollow">23450527</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Erythropoiesis-stimulating+agents+for+anemia+in+rheumatoid+arthritis&amp;rft.au=Agreda-P%C3%A9rez%2C+Luis+H&amp;rft.aufirst=Arturo+J&amp;rft.aulast=Mart%C3-Carvajal&amp;rft.au=Simancas-Racines%2C+Daniel&amp;rft.au=Sol%C3%A0%2C+Ivan&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000332.pub3&amp;rft_id=info%3Apmid%2F23450527&amp;rft.issue=2&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=CD000332&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><cite class="citation journal">Perry, Lisa M.; Winthrop, Kevin L.; Curtis, Jeffrey R. (13 June 2014). <a class="external text" href="http://link.springer.com/article/10.1007%2Fs11926-014-0431-x#" rel="nofollow">"Vaccinations for Rheumatoid Arthritis"</a>. <i>Current Rheumatology Reports</i>. <b>16</b> (8). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1007%2Fs11926-014-0431-x" rel="nofollow">10.1007/s11926-014-0431-x</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Vaccinations+for+Rheumatoid+Arthritis&amp;rft.au=Curtis%2C+Jeffrey+R.&amp;rft.aufirst=Lisa+M.&amp;rft.aulast=Perry&amp;rft.au=Winthrop%2C+Kevin+L.&amp;rft.date=2014-06-13&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%252Fs11926-014-0431-x%23&amp;rft_id=info%3Adoi%2F10.1007%2Fs11926-014-0431-x&amp;rft.issue=8&amp;rft.jtitle=Current+Rheumatology+Reports&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation journal">Grohskopf, LA; Olsen, SJ; Sokolow, LZ; Bresee, JS; Cox, NJ; Broder, KR; Karron, RA; Walter, EB; Centers for Disease Control and, Prevention (15 August 2014). "Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) – United States, 2014–15 influenza season". <i>MMWR. Morbidity and mortality weekly report</i>. <b>63</b> (32): 691–7. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25121712" rel="nofollow">25121712</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Prevention+and+control+of+seasonal+influenza+with+vaccines%3A+recommendations+of+the+Advisory+Committee+on+Immunization+Practices+%28ACIP%29+%93+United+States%2C+2014%9315+influenza+season&amp;rft.au=Bresee%2C+JS&amp;rft.au=Broder%2C+KR&amp;rft.au=Centers+for+Disease+Control+and%2C+Prevention&amp;rft.au=Cox%2C+NJ&amp;rft.aufirst=LA&amp;rft.au=Karron%2C+RA&amp;rft.aulast=Grohskopf&amp;rft.au=Olsen%2C+SJ&amp;rft.au=Sokolow%2C+LZ&amp;rft.au=Walter%2C+EB&amp;rft.date=2014-08-15&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F25121712&amp;rft.issue=32&amp;rft.jtitle=MMWR.+Morbidity+and+mortality+weekly+report&amp;rft.pages=691-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><cite class="citation journal">Black, CL; Yue, X; Ball, SW; Donahue, SM; Izrael, D; de Perio, MA; Laney, AS; Lindley, MC; Graitcer, SB; Lu, PJ; Williams, WW; Bridges, CB; DiSogra, C; Sokolowski, J; Walker, DK; Greby, SM (19 September 2014). "Influenza vaccination coverage among health care personnel – United States, 2013–14 influenza season.". <i>MMWR. Morbidity and mortality weekly report</i>. <b>63</b> (37): 805–11. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25233281" rel="nofollow">25233281</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Influenza+vaccination+coverage+among+health+care+personnel+%93+United+States%2C+2013%9314+influenza+season.&amp;rft.au=Ball%2C+SW&amp;rft.au=Bridges%2C+CB&amp;rft.au=de+Perio%2C+MA&amp;rft.au=DiSogra%2C+C&amp;rft.au=Donahue%2C+SM&amp;rft.aufirst=CL&amp;rft.au=Graitcer%2C+SB&amp;rft.au=Greby%2C+SM&amp;rft.au=Izrael%2C+D&amp;rft.au=Laney%2C+AS&amp;rft.aulast=Black&amp;rft.au=Lindley%2C+MC&amp;rft.au=Lu%2C+PJ&amp;rft.au=Sokolowski%2C+J&amp;rft.au=Walker%2C+DK&amp;rft.au=Williams%2C+WW&amp;rft.au=Yue%2C+X&amp;rft.date=2014-09-19&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F25233281&amp;rft.issue=37&amp;rft.jtitle=MMWR.+Morbidity+and+mortality+weekly+report&amp;rft.pages=805-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hales, CM; Harpaz, R; Ortega-Sanchez, I; Bialek, SR; Centers for Disease Control and Prevention, (CDC) (22 August 2014). "Update on recommendations for use of herpes zoster vaccine.". <i>MMWR. Morbidity and mortality weekly report</i>. <b>63</b> (33): 729–31. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25144544" rel="nofollow">25144544</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Update+on+recommendations+for+use+of+herpes+zoster+vaccine.&amp;rft.au=Bialek%2C+SR&amp;rft.au=Centers+for+Disease+Control+and+Prevention%2C+%28CDC%29&amp;rft.aufirst=CM&amp;rft.au=Harpaz%2C+R&amp;rft.aulast=Hales&amp;rft.au=Ortega-Sanchez%2C+I&amp;rft.date=2014-08-22&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F25144544&amp;rft.issue=33&amp;rft.jtitle=MMWR.+Morbidity+and+mortality+weekly+report&amp;rft.pages=729-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html" rel="nofollow">"WHO Disease and injury country estimates"</a>. <i>World Health Organization</i>. 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">November 11,</span> 2009</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=WHO+Disease+and+injury+country+estimates&amp;rft.date=2009&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html&amp;rft.jtitle=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text">Kitas, George (4 April 2006) <a class="external text" href="http://web.archive.org/web/20060924153339/http://www.rheumatoid.org.uk/article.php?article_id=112" rel="nofollow">Why is life span shortened by Rheumatoid Arthritis?</a> National Rheumatoid Arthritis Society</span></li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><a class="external text" href="http://web.archive.org/web/20050306030726/http://mayoclinic.org/news2005-rst/2654.html" rel="nofollow">Rheumatoid Arthritis Patients Have Double the Risk of Heart Failure</a>. mayoclinic.org (3 February 2005).</span></li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20061009112820/http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html" rel="nofollow">"Cardiac disease in rheumatoid arthritis"</a>. Johns Hopkins University. 2002. Archived from <a class="external text" href="http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html" rel="nofollow">the original</a> on October 9, 2006.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Cardiac+disease+in+rheumatoid+arthritis&amp;rft.date=2002&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.hopkins-arthritis.org%2Fnews-archive%2F2002%2Fcardiac.html&amp;rft.pub=Johns+Hopkins+University&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid20678592-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20678592_115-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Atzeni F, Turiel M, Caporali R, Cavagna L, Tomasoni L, Sitia S, Sarzi-Puttini P; Turiel; Caporali; Cavagna; Tomasoni; Sitia; Sarzi-Puttini (2010). "The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases". <i>Autoimmun Rev</i>. <b>9</b> (12): 835–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.autrev.2010.07.018" rel="nofollow">10.1016/j.autrev.2010.07.018</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20678592" rel="nofollow">20678592</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+effect+of+pharmacological+therapy+on+the+cardiovascular+system+of+patients+with+systemic+rheumatic+diseases&amp;rft.au=Atzeni+F%2C+Turiel+M%2C+Caporali+R%2C+Cavagna+L%2C+Tomasoni+L%2C+Sitia+S%2C+Sarzi-Puttini+P&amp;rft.au=Caporali&amp;rft.au=Cavagna&amp;rft.au=Sarzi-Puttini&amp;rft.au=Sitia&amp;rft.au=Tomasoni&amp;rft.au=Turiel&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2010.07.018&amp;rft_id=info%3Apmid%2F20678592&amp;rft.issue=12&amp;rft.jtitle=Autoimmun+Rev&amp;rft.pages=835-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-biologics_cv_effects.2F_cancer-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-biologics_cv_effects.2F_cancer_116-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Damjanov, N; Nurmohamed, MT; Szekanecz, Z (Mar 18, 2014). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3984692" rel="nofollow">"Biologics, cardiovascular effects and cancer."</a>. <i>BMC medicine</i>. <b>12</b> (1): 48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1186%2F1741-7015-12-48" rel="nofollow">10.1186/1741-7015-12-48</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3984692" rel="nofollow">3984692</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24642038" rel="nofollow">24642038</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Biologics%2C+cardiovascular+effects+and+cancer.&amp;rft.aufirst=N&amp;rft.aulast=Damjanov&amp;rft.au=Nurmohamed%2C+MT&amp;rft.au=Szekanecz%2C+Z&amp;rft.date=2014-03-18&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3984692&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3984692&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-12-48&amp;rft_id=info%3Apmid%2F24642038&amp;rft.issue=1&amp;rft.jtitle=BMC+medicine&amp;rft.pages=48&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Loz2012-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-Loz2012_117-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Lozano, 1R; Naghavi, M; Foreman, K; Lim, S; Shibuya, K; Aboyans, V; Abraham, J; Adair, T; et al. (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". <i>Lancet</i>. <b>380</b> (9859): 2095–128. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2812%2961728-0" rel="nofollow">10.1016/S0140-6736(12)61728-0</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23245604" rel="nofollow">23245604</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Global+and+regional+mortality+from+235+causes+of+death+for+20+age+groups+in+1990+and+2010%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2010&amp;rft.au=Abdulhak%2C+Aref+Bin&amp;rft.au=Aboyans%2C+V&amp;rft.au=Abraham%2C+J&amp;rft.au=Adair%2C+T&amp;rft.au=Aggarwal%2C+R&amp;rft.au=Ahn%2C+Stephanie+Y&amp;rft.au=Almazroa%2C+Mohammad+A&amp;rft.au=Alvarado%2C+Miriam&amp;rft.au=Anderson%2C+H+Ross&amp;rft.au=Anderson%2C+Laurie+M&amp;rft.au=Andrews%2C+Kathryn+G&amp;rft.au=Atkinson%2C+Charles&amp;rft.au=Baddour%2C+Larry+M&amp;rft.au=Barker-Collo%2C+Suzanne&amp;rft.au=Bartels%2C+David+H&amp;rft.au=Bell%2C+Michelle+L&amp;rft.au=Benjamin%2C+Emelia+J&amp;rft.au=Bennett%2C+Derrick&amp;rft.au=Bhalla%2C+Kavi&amp;rft.au=Bikbov%2C+Boris&amp;rft.au=Birbeck%2C+Gretchen&amp;rft.au=Blyth%2C+Fiona&amp;rft.au=Bolliger%2C+Ian&amp;rft.au=Boufous%2C+Soufiane&amp;rft.au=Bucello%2C+Chiara&amp;rft.aufirst=1R&amp;rft.au=Foreman%2C+K&amp;rft.aulast=Lozano&amp;rft.au=Lim%2C+S&amp;rft.au=Naghavi%2C+M&amp;rft.au=Shibuya%2C+K&amp;rft.date=2012-12-15&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2961728-0&amp;rft_id=info%3Apmid%2F23245604&amp;rft.issue=9859&amp;rft.jtitle=Lancet&amp;rft.pages=2095-128&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=380"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><cite class="citation journal">Alamanos Y, Voulgari PV, Drosos AA; Voulgari; Drosos (2006). "Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review". <i>Semin. Arthritis Rheum</i>. <b>36</b> (3): 182–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.semarthrit.2006.08.006" rel="nofollow">10.1016/j.semarthrit.2006.08.006</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17045630" rel="nofollow">17045630</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Incidence+and+prevalence+of+rheumatoid+arthritis%2C+based+on+the+1987+American+College+of+Rheumatology+criteria%3A+a+systematic+review&amp;rft.au=Alamanos+Y%2C+Voulgari+PV%2C+Drosos+AA&amp;rft.au=Drosos&amp;rft.au=Voulgari&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2006.08.006&amp;rft_id=info%3Apmid%2F17045630&amp;rft.issue=3&amp;rft.jtitle=Semin.+Arthritis+Rheum.&amp;rft.pages=182-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><cite class="citation web">Rothschild, Bruce M. <a class="external text" href="https://web.archive.org/web/20120202085715/http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm" rel="nofollow">"Tennessee Origins of Rheumatoid Arthritis"</a>. Mcclungmuseum.utk.edu. Archived from <a class="external text" href="http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm" rel="nofollow">the original</a> on February 2, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">March 3,</span> 2011</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Rothschild%2C+Bruce+M.&amp;rft.btitle=Tennessee+Origins+of+Rheumatoid+Arthritis&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fmcclungmuseum.utk.edu%2Fresearch%2Frenotes%2Frn-05txt.htm&amp;rft.pub=Mcclungmuseum.utk.edu&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20030219095659/http://www.arc.org.uk/newsviews/arctdy/104/bones.htm" rel="nofollow">"Bones of contention"</a>. <i>Arthritis Research UK</i>. April 1999. Archived from <a class="external text" href="http://www.arc.org.uk/newsviews/arctdy/104/bones.htm" rel="nofollow">the original</a> on February 19, 2003<span class="reference-accessdate">. Retrieved <span class="nowrap">February 5,</span> 2013</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Bones+of+contention&amp;rft.date=1999-04&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.arc.org.uk%2Fnewsviews%2Farctdy%2F104%2Fbones.htm&amp;rft.jtitle=Arthritis+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><cite class="citation book">Garrod AB (1859). <i>The Nature and Treatment of Gout and Rheumatic Gout</i>. London: Walton and Maberly.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Garrod+AB&amp;rft.btitle=The+Nature+and+Treatment+of+Gout+and+Rheumatic+Gout&amp;rft.date=1859&amp;rft.genre=book&amp;rft.place=London&amp;rft.pub=Walton+and+Maberly&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid14528501-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14528501_122-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Rothschild BM, Rothschild C, Helbling M; Rothschild; Helbling (2003). "Unified theory of the origins of erosive arthritis: conditioning as a protective/directing mechanism?". <i><a class="mw-redirect" href="/wiki/J._Rheumatol." title="J. Rheumatol.">J. Rheumatol.</a></i> <b>30</b> (10): 2095–102. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14528501" rel="nofollow">14528501</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Unified+theory+of+the+origins+of+erosive+arthritis%3A+conditioning+as+a+protective%2Fdirecting+mechanism%3F&amp;rft.au=Helbling&amp;rft.au=Rothschild&amp;rft.au=Rothschild+BM%2C+Rothschild+C%2C+Helbling+M&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14528501&amp;rft.issue=10&amp;rft.jtitle=J.+Rheumatol.&amp;rft.pages=2095-102&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-pmid7005475-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7005475_123-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Appelboom T, de Boelpaepe C, Ehrlich GE, Famaey JP; De Boelpaepe; Ehrlich; Famaey (1981). "Rubens and the question of antiquity of rheumatoid arthritis". <i>JAMA</i>. <b>245</b> (5): 483–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1001%2Fjama.245.5.483" rel="nofollow">10.1001/jama.245.5.483</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7005475" rel="nofollow">7005475</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rubens+and+the+question+of+antiquity+of+rheumatoid+arthritis&amp;rft.au=Appelboom+T%2C+de+Boelpaepe+C%2C+Ehrlich+GE%2C+Famaey+JP&amp;rft.au=De+Boelpaepe&amp;rft.au=Ehrlich&amp;rft.au=Famaey&amp;rft.date=1981&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.245.5.483&amp;rft_id=info%3Apmid%2F7005475&amp;rft.issue=5&amp;rft.jtitle=JAMA&amp;rft.pages=483-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245"><span style="display:none;"> </span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><cite class="citation web">Kelly, Janis (14 June 2005). <a class="external text" href="http://www.medscape.com/viewarticle/538251" rel="nofollow">"Did RA travel from New World to Old? The Rubens connection"</a>. Medscape<span class="reference-accessdate">. Retrieved <span class="nowrap">March 3,</span> 2011</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Kelly%2C+Janis&amp;rft.btitle=Did+RA+travel+from+New+World+to+Old%3F+The+Rubens+connection&amp;rft.date=2005-06-14&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F538251&amp;rft.pub=Medscape&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dequeker J.; Rico H. (1992). "Rheumatoid arthritis-like deformities in an early 16th-century painting of the Flemish-Dutch school". <i>JAMA</i>. <b>268</b> (2): 249–251. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1001%2Fjama.268.2.249" rel="nofollow">10.1001/jama.268.2.249</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1608144" rel="nofollow">1608144</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis-like+deformities+in+an+early+16th-century+painting+of+the+Flemish-Dutch+school&amp;rft.au=Dequeker+J.&amp;rft.au=Rico+H.&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.268.2.249&amp;rft_id=info%3Apmid%2F1608144&amp;rft.issue=2&amp;rft.jtitle=JAMA&amp;rft.pages=249-251&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=268"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hart FD (1976). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1639217" rel="nofollow">"History of the treatment of rheumatoid arthritis"</a>. <i>Br Med J</i>. <b>1</b> (6012): 763–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1136%2Fbmj.1.6012.763" rel="nofollow">10.1136/bmj.1.6012.763</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1639217" rel="nofollow">1639217</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/177148" rel="nofollow">177148</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=History+of+the+treatment+of+rheumatoid+arthritis&amp;rft.au=Hart+FD&amp;rft.date=1976&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1639217&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1639217&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.1.6012.763&amp;rft_id=info%3Apmid%2F177148&amp;rft.issue=6012&amp;rft.jtitle=Br+Med+J&amp;rft.pages=763-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text">Fresenius HemoCare, Inc., "New Hope for Rheumatoid Arthritis Patients," press release, September 17, 1999.</span></li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://arthritis.about.com/od/arthqa/f/prosorba.htm" rel="nofollow">"Prosorba Column – Which Rheumatoid Arthritis Patients Are Good Candidates for the Prosorba Column?"</a>. Arthritis.about.com<span class="reference-accessdate">. Retrieved <span class="nowrap">March 3,</span> 2011</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Prosorba+Column+%93+Which+Rheumatoid+Arthritis+Patients+Are+Good+Candidates+for+the+Prosorba+Column%3F&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Farthritis.about.com%2Fod%2Farthqa%2Ff%2Fprosorba.htm&amp;rft.pub=Arthritis.about.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hajishengallis, George (2015-01-01). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4276050" rel="nofollow">"Periodontitis: from microbial immune subversion to systemic inflammation"</a>. <i>Nature Reviews. Immunology</i>. <b>15</b> (1): 30–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1038%2Fnri3785" rel="nofollow">10.1038/nri3785</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1474-1741" rel="nofollow">1474-1741</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4276050" rel="nofollow">4276050</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25534621" rel="nofollow">25534621</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Periodontitis%3A+from+microbial+immune+subversion+to+systemic+inflammation&amp;rft.aufirst=George&amp;rft.aulast=Hajishengallis&amp;rft.date=2015-01-01&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4276050&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4276050&amp;rft_id=info%3Adoi%2F10.1038%2Fnri3785&amp;rft_id=info%3Apmid%2F25534621&amp;rft.issn=1474-1741&amp;rft.issue=1&amp;rft.jtitle=Nature+Reviews.+Immunology&amp;rft.pages=30-44&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><cite class="citation journal">Farquharson, D.; Butcher, J. P.; Culshaw, S. (2012-03-01). <a class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/22274780" rel="nofollow">"Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis"</a>. <i>Mucosal Immunology</i>. <b>5</b> (2): 112–120. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1038%2Fmi.2011.66" rel="nofollow">10.1038/mi.2011.66</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1935-3456" rel="nofollow">1935-3456</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22274780" rel="nofollow">22274780</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Periodontitis%2C+Porphyromonas%2C+and+the+pathogenesis+of+rheumatoid+arthritis&amp;rft.au=Butcher%2C+J.+P.&amp;rft.au=Culshaw%2C+S.&amp;rft.aufirst=D.&amp;rft.aulast=Farquharson&amp;rft.date=2012-03-01&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F22274780&amp;rft_id=info%3Adoi%2F10.1038%2Fmi.2011.66&amp;rft_id=info%3Apmid%2F22274780&amp;rft.issn=1935-3456&amp;rft.issue=2&amp;rft.jtitle=Mucosal+Immunology&amp;rft.pages=112-120&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fuggle, Nicholas R.; Smith, Toby O.; Kaul, Arvind; Sofat, Nidhi (2016-01-01). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4774606" rel="nofollow">"Hand to Mouth: A Systematic Review and Meta-Analysis of the Association between Rheumatoid Arthritis and Periodontitis"</a>. <i>Frontiers in Immunology</i>. <b>7</b>: 80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.3389%2Ffimmu.2016.00080" rel="nofollow">10.3389/fimmu.2016.00080</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="plainlinks"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4774606" rel="nofollow">4774606</a><span style="margin-left:0.1em"><img alt="Freely accessible" data-file-height="813" data-file-width="512" height="14" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x" title="Freely accessible" width="9"/></span></span>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/26973655" rel="nofollow">26973655</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Hand+to+Mouth%3A+A+Systematic+Review+and+Meta-Analysis+of+the+Association+between+Rheumatoid+Arthritis+and+Periodontitis&amp;rft.aufirst=Nicholas+R.&amp;rft.au=Kaul%2C+Arvind&amp;rft.aulast=Fuggle&amp;rft.au=Smith%2C+Toby+O.&amp;rft.au=Sofat%2C+Nidhi&amp;rft.date=2016-01-01&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4774606&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4774606&amp;rft_id=info%3Adoi%2F10.3389%2Ffimmu.2016.00080&amp;rft_id=info%3Apmid%2F26973655&amp;rft.jtitle=Frontiers+in+Immunology&amp;rft.pages=80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><cite class="citation journal">Tang, Qingqin; Fu, Haitao; Qin, Baodong; Hu, Zhide; Liu, Yaoting; Liang, Yan; Zhou, Lin; Yang, Zaixing; Zhong, Renqian (2017-02-01). <a class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/27977821" rel="nofollow">"A Possible Link Between Rheumatoid Arthritis and Periodontitis: A Systematic Review and Meta-analysis"</a>. <i>The International Journal of Periodontics &amp; Restorative Dentistry</i>. <b>37</b> (1): 79–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.11607%2Fprd.2656" rel="nofollow">10.11607/prd.2656</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1945-3388" rel="nofollow">1945-3388</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/27977821" rel="nofollow">27977821</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+Possible+Link+Between+Rheumatoid+Arthritis+and+Periodontitis%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.aufirst=Qingqin&amp;rft.au=Fu%2C+Haitao&amp;rft.au=Hu%2C+Zhide&amp;rft.aulast=Tang&amp;rft.au=Liang%2C+Yan&amp;rft.au=Liu%2C+Yaoting&amp;rft.au=Qin%2C+Baodong&amp;rft.au=Yang%2C+Zaixing&amp;rft.au=Zhong%2C+Renqian&amp;rft.au=Zhou%2C+Lin&amp;rft.date=2017-02-01&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F27977821&amp;rft_id=info%3Adoi%2F10.11607%2Fprd.2656&amp;rft_id=info%3Apmid%2F27977821&amp;rft.issn=1945-3388&amp;rft.issue=1&amp;rft.jtitle=The+International+Journal+of+Periodontics+%26+Restorative+Dentistry&amp;rft.pages=79-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid23370372-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23370372_133-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gatenby P, Lucas R, Swaminathan A (2013). "Vitamin D deficiency and risk for rheumatic diseases: an update". <i>Curr Opin Rheumatol</i>. <b>25</b> (2): 184–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2FBOR.0b013e32835cfc16" rel="nofollow">10.1097/BOR.0b013e32835cfc16</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23370372" rel="nofollow">23370372</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Vitamin+D+deficiency+and+risk+for+rheumatic+diseases%3A+an+update&amp;rft.aufirst=P&amp;rft.aulast=Gatenby&amp;rft.au=Lucas%2C+R&amp;rft.au=Swaminathan%2C+A&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FBOR.0b013e32835cfc16&amp;rft_id=info%3Apmid%2F23370372&amp;rft.issue=2&amp;rft.jtitle=Curr+Opin+Rheumatol&amp;rft.pages=184-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Wen2011-134"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wen2011_134-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wen2011_134-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Wen H, Baker JF (March 2011). "Vitamin D, immunoregulation, and rheumatoid arthritis". <i>Journal of Clinical Rheumatology</i>. <b>17</b> (2): 102–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1097%2FRHU.0b013e31820edd18" rel="nofollow">10.1097/RHU.0b013e31820edd18</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21364350" rel="nofollow">21364350</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Vitamin+D%2C+immunoregulation%2C+and+rheumatoid+arthritis&amp;rft.au=Baker%2C+JF&amp;rft.aufirst=H&amp;rft.aulast=Wen&amp;rft.date=2011-03&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FRHU.0b013e31820edd18&amp;rft_id=info%3Apmid%2F21364350&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Clinical+Rheumatology&amp;rft.pages=102-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-pmid21067953-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21067953_135-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC (2010). "Vitamin D and inflammation". <i>Joint Bone Spine</i>. <b>77</b> (6): 552–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.jbspin.2010.09.018" rel="nofollow">10.1016/j.jbspin.2010.09.018</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21067953" rel="nofollow">21067953</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Vitamin+D+and+inflammation&amp;rft.au=Boissier%2C+MC&amp;rft.au=Falgarone%2C+G&amp;rft.aufirst=X&amp;rft.aulast=Guillot&amp;rft.au=Saidenberg-Kermanac%27h%2C+N&amp;rft.au=Semerano%2C+L&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jbspin.2010.09.018&amp;rft_id=info%3Apmid%2F21067953&amp;rft.issue=6&amp;rft.jtitle=Joint+Bone+Spine&amp;rft.pages=552-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><cite class="citation journal">St-Arnaud R (2008). "The direct role of vitamin D on bone homeostasis". <i>Arch Biochem Biophys</i>. <b>473</b> (2): 225–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1016%2Fj.abb.2008.03.038" rel="nofollow">10.1016/j.abb.2008.03.038</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18424254" rel="nofollow">18424254</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+direct+role+of+vitamin+D+on+bone+homeostasis&amp;rft.au=St-Arnaud+R&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.abb.2008.03.038&amp;rft_id=info%3Apmid%2F18424254&amp;rft.issue=2&amp;rft.jtitle=Arch+Biochem+Biophys&amp;rft.pages=225-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=473"><span style="display:none;"> </span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=34" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="mbox-small plainlinks sistersitebox" role="presentation" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><a class="image" href="/wiki/File:Commons-logo.svg"><img alt="" class="noviewer" data-file-height="1376" data-file-width="1024" height="40" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" width="30"/></a></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a class="extiw" href="https://commons.wikimedia.org/wiki/Category:Rheumatoid_arthritis" title="commons:Category:Rheumatoid arthritis">Rheumatoid arthritis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Arthritis/Rheumatoid" rel="nofollow">Rheumatoid arthritis</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
<li><cite class="citation web">Charles Weber. <a class="external text" href="http://charles_w.tripod.com/arthritis2.html" rel="nofollow">"History of rheumatoid arthritis"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Charles+Weber&amp;rft.btitle=History+of+rheumatoid+arthritis&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fcharles_w.tripod.com%2Farthritis2.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></li>
<li><cite class="citation journal">Singh, JA; Saag, KG; Bridges SL, Jr; Akl, EA; Bannuru, RR; Sullivan, MC; Vaysbrot, E; McNaughton, C; Osani, M; Shmerling, RH; Curtis, JR; Furst, DE; Parks, D; Kavanaugh, A; O'Dell, J; King, C; Leong, A; Matteson, EL; Schousboe, JT; Drevlow, B; Ginsberg, S; Grober, J; St Clair, EW; Tindall, E; Miller, AS; McAlindon, T (January 2016). "2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.". <i>Arthritis &amp; rheumatology (Hoboken, N.J.)</i>. <b>68</b> (1): 1–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1002%2Fart.39480" rel="nofollow">10.1002/art.39480</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/26545940" rel="nofollow">26545940</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=2015+American+College+of+Rheumatology+Guideline+for+the+Treatment+of+Rheumatoid+Arthritis.&amp;rft.au=Akl%2C+EA&amp;rft.au=Bannuru%2C+RR&amp;rft.au=Bridges+SL%2C+Jr&amp;rft.au=Curtis%2C+JR&amp;rft.au=Drevlow%2C+B&amp;rft.aufirst=JA&amp;rft.au=Furst%2C+DE&amp;rft.au=Ginsberg%2C+S&amp;rft.au=Grober%2C+J&amp;rft.au=Kavanaugh%2C+A&amp;rft.au=King%2C+C&amp;rft.aulast=Singh&amp;rft.au=Leong%2C+A&amp;rft.au=Matteson%2C+EL&amp;rft.au=McAlindon%2C+T&amp;rft.au=McNaughton%2C+C&amp;rft.au=Miller%2C+AS&amp;rft.au=O%27Dell%2C+J&amp;rft.au=Osani%2C+M&amp;rft.au=Parks%2C+D&amp;rft.au=Saag%2C+KG&amp;rft.au=Schousboe%2C+JT&amp;rft.au=Shmerling%2C+RH&amp;rft.au=St+Clair%2C+EW&amp;rft.au=Sullivan%2C+MC&amp;rft.au=Tindall%2C+E&amp;rft.au=Vaysbrot%2C+E&amp;rft.date=2016-01&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.39480&amp;rft_id=info%3Apmid%2F26545940&amp;rft.issue=1&amp;rft.jtitle=Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29&amp;rft.pages=1-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68"><span style="display:none;"> </span></span></li>
</ul>
<div aria-labelledby="Diseases_of_joints_.28M00.E2.80.93M19.2C_711.E2.80.93719.29" class="navbox" role="navigation" style="padding:3px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th class="navbox-title" colspan="2" scope="col">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions"><abbr style=";;background:none transparent;border:none;" title="View this template">v</abbr></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Arthropathies_and_related_conditions" title="Template talk:Arthropathies and related conditions"><abbr style=";;background:none transparent;border:none;" title="Discuss this template">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Arthropathies_and_related_conditions&amp;action=edit"><abbr style=";;background:none transparent;border:none;" title="Edit this template">e</abbr></a></li>
</ul>
</div>
<div id="Diseases_of_joints_.28M00.E2.80.93M19.2C_711.E2.80.93719.29" style="font-size:114%"><a href="/wiki/Arthropathy" title="Arthropathy">Diseases of joints</a> (<a href="/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#.28M00.E2.80.93M25.29_Arthropathies" title="ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue">M00–M19</a>, <a href="/wiki/List_of_ICD-9_codes_710%E2%80%93739:_diseases_of_the_musculoskeletal_system_and_connective_tissue#Arthropathies_and_related_disorders_.28710.E2.80.93719.29" title="List of ICD-9 codes 710–739: diseases of the musculoskeletal system and connective tissue">711–719</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a><br/>
(<a href="/wiki/Monoarthritis" title="Monoarthritis">one joint</a> /<br/>
<a href="/wiki/Polyarthritis" title="Polyarthritis">multiple</a>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Septic_arthritis" title="Septic arthritis">Infectious</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis arthritis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (indirectly)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Noninfectious</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>1. <a class="mw-redirect" href="/wiki/Seronegative_spondyloarthropathy" title="Seronegative spondyloarthropathy">Seronegative spondyloarthropathy</a>:
<ul>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a>*<a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a>*<a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a>*<a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a></li>
</ul>
</li>
</ul>
<ul>
<li>2.<i><strong class="selflink">Rheumatoid arthritis</strong>:</i></li>
<li><a href="/wiki/Adult-onset_Still%27s_disease" title="Adult-onset Still's disease">Adult-onset Still's disease</a></li>
<li><a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a></li>
</ul>
<ul>
<li>3.<i><a href="/wiki/Crystal_arthropathy" title="Crystal arthropathy">Crystal arthropathy</a>:</i> <a href="/wiki/Gout" title="Gout">Gout</a></li>
<li><a href="/wiki/Chondrocalcinosis" title="Chondrocalcinosis">Chondrocalcinosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Noninflammatory</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a>:</i> <a href="/wiki/Heberden%27s_node" title="Heberden's node">Heberden's node</a></li>
<li><a href="/wiki/Bouchard%27s_nodes" title="Bouchard's nodes">Bouchard's nodes</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Other</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hemarthrosis" title="Hemarthrosis">Bleeding</a></li>
<li><a href="/wiki/Arthralgia" title="Arthralgia">pain</a></li>
<li><a href="/wiki/Osteophyte" title="Osteophyte">Osteophyte</a></li>
<li><i><a href="/wiki/Villonodular_synovitis" title="Villonodular synovitis">villonodular synovitis</a></i>
<ul>
<li><a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a></li>
</ul>
</li>
<li><a href="/wiki/Joint_stiffness" title="Joint stiffness">stiffness</a></li>
</ul>
</div>
</td>
</tr>
</table>
</div>
<div aria-labelledby="Hypersensitivity_and_autoimmune_diseases_.28279.5.E2.80.936.29" class="navbox" role="navigation" style="padding:3px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th class="navbox-title" colspan="2" scope="col">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases"><abbr style=";;background:none transparent;border:none;" title="View this template">v</abbr></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Hypersensitivity_and_autoimmune_diseases" title="Template talk:Hypersensitivity and autoimmune diseases"><abbr style=";;background:none transparent;border:none;" title="Discuss this template">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit"><abbr style=";;background:none transparent;border:none;" title="Edit this template">e</abbr></a></li>
</ul>
</div>
<div id="Hypersensitivity_and_autoimmune_diseases_.28279.5.E2.80.936.29" style="font-size:114%"><a href="/wiki/Hypersensitivity" title="Hypersensitivity">Hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a> (<a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">279.5–6</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br/>
(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a class="mw-redirect" href="/wiki/Atopic_eczema" title="Atopic eczema">Atopic eczema</a></li>
<li><a class="mw-redirect" href="/wiki/Urticaria" title="Urticaria">Allergic urticaria</a></li>
<li><a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">Allergic rhinitis</a> (Hay fever)</li>
<li><a href="/wiki/Asthma" title="Asthma">Allergic asthma</a></li>
<li><a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a></li>
<li><a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a>
<ul>
<li>common allergies include: <a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a></li>
<li><a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a></li>
<li><a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a></li>
<li><a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a></li>
<li><a class="mw-redirect" href="/wiki/Seafood_allergy" title="Seafood allergy">Seafood</a></li>
<li><a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a></li>
<li><a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a></li>
</ul>
</li>
<li><a class="mw-redirect" href="/wiki/Penicillin_drug_reaction" title="Penicillin drug reaction">Penicillin allergy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Eosinophilic_esophagitis" title="Eosinophilic esophagitis">Eosinophilic esophagitis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cell-mediated_cytotoxicity" title="Antibody-dependent cell-mediated cytotoxicity">ADCC</a><br/>
<ul>
<li>
<ul>
<li><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></li>
<li><a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a></li>
</ul>
</li>
</ul>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Cytotoxicity" title="Cytotoxicity">Cytotoxic</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a></li>
<li><a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura">Immune thrombocytopenic purpura</a></li>
<li><a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a></li>
<li><a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a></li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li><a class="mw-redirect" href="/wiki/Goodpasture%27s_syndrome" title="Goodpasture's syndrome">Goodpasture's syndrome</a></li>
<li><a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="Guillain–Barré syndrome">Guillain–Barré syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">"<a href="/wiki/Hypersensitivity#Type_V" title="Hypersensitivity">Type V</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a></li>
<li><a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></li>
<li><a class="mw-redirect" href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br/>
(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Henoch%E2%80%93Sch%C3%B6nlein_purpura" title="Henoch–Schönlein purpura">Henoch–Schönlein purpura</a></li>
<li><a href="/wiki/Cutaneous_small-vessel_vasculitis" title="Cutaneous small-vessel vasculitis">Hypersensitivity vasculitis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
<li><a href="/wiki/Farmer%27s_lung" title="Farmer's lung">Farmer's lung</a></li>
<li><a href="/wiki/Acute_proliferative_glomerulonephritis" title="Acute proliferative glomerulonephritis">Post-streptococcal glomerulonephritis</a></li>
<li><a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a></li>
<li><a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a></li>
<li><a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></li>
<li><strong class="selflink">Rheumatoid arthritis</strong></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br/>
(<a href="/wiki/T_cell" title="T cell">T cells</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Allergic_contact_dermatitis" title="Allergic contact dermatitis">Allergic contact dermatitis</a></li>
<li><a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a></li>
<li><a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's thyroiditis</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li><a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a></li>
<li><a href="/wiki/Giant-cell_arteritis" title="Giant-cell arteritis">Giant-cell arteritis</a></li>
<li><a href="/wiki/Postorgasmic_illness_syndrome" title="Postorgasmic illness syndrome">Postorgasmic illness syndrome</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Transfusion-associated_graft_versus_host_disease" title="Transfusion-associated graft versus host disease">Transfusion-associated graft versus host disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Unknown/<br/>
multiple</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th class="navbox-group" scope="row">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a>
<ul>
<li><a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a></li>
</ul>
</li>
<li><a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a></li>
<li><a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th class="navbox-group" scope="row">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a>
<ul>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a></li>
</ul>
</li>
<li><a href="/wiki/Addison%27s_disease" title="Addison's disease">Autoimmune adrenalitis</a></li>
<li><a href="/wiki/Autoimmune_disease" title="Autoimmune disease">Systemic autoimmune disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
<div aria-label="Navbox" class="navbox" role="navigation" style="padding:3px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th class="navbox-group" scope="row"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><span style="white-space:nowrap;"><a href="/wiki/Integrated_Authority_File" title="Integrated Authority File">GND</a>: <span class="uid"><a class="external text" href="http://d-nb.info/gnd/4076708-5" rel="nofollow">4076708-5</a></span></span></li>
<li><span style="white-space:nowrap;"><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a class="external text" href="http://id.ndl.go.jp/auth/ndlna/00564944" rel="nofollow">00564944</a></span></span></li>
</ul>
</div>
</td>
</tr>
</table>
</div>
<!-- 
NewPP limit report
Parsed by mw1164
Cached time: 20170126183907
Cache expiry: 86400
Dynamic content: true
CPU time usage: 1.768 seconds
Real time usage: 1.894 seconds
Preprocessor visited node count: 10673/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 418451/2097152 bytes
Template argument size: 9256/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 7/500
Lua time usage: 1.026/10.000 seconds
Lua memory usage: 7.19 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1643.039      1 -total
 56.20%  923.406      1 Template:Reflist
 36.68%  602.612    108 Template:Cite_journal
 16.81%  276.159     15 Template:Citation_needed
 15.41%  253.200     15 Template:Fix
 11.49%  188.803      1 Template:Infobox_medical_condition
 10.20%  167.614      1 Template:Infobox
  9.64%  158.451     15 Template:Delink
  6.10%  100.202     17 Template:Cite_web
  5.08%   83.471     30 Template:Category_handler
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:25875-0!*!0!!en!4!*!math=5 and timestamp 20170126183905 and revision id 762110407
 -->
<noscript><img alt="" height="1" src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" style="border: none; position: absolute;" title="" width="1"/></noscript></div> <div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;oldid=762110407">https://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;oldid=762110407</a>"					</div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Connective_tissue_diseases" title="Category:Connective tissue diseases">Connective tissue diseases</a></li><li><a href="/wiki/Category:Arthritis" title="Category:Arthritis">Arthritis</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Disorders_of_fascia" title="Category:Disorders of fascia">Disorders of fascia</a></li><li><a href="/wiki/Category:Steroid-responsive_inflammatory_conditions" title="Category:Steroid-responsive inflammatory conditions">Steroid-responsive inflammatory conditions</a></li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Uses_editors_parameter" title="Category:CS1 maint: Uses editors parameter">CS1 maint: Uses editors parameter</a></li><li><a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">CS1 maint: Multiple names: authors list</a></li><li><a href="/wiki/Category:Pages_using_ISBN_magic_links" title="Category:Pages using ISBN magic links">Pages using ISBN magic links</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2016" title="Category:Articles with unsourced statements from July 2016">Articles with unsourced statements from July 2016</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2014" title="Category:Articles with unsourced statements from October 2014">Articles with unsourced statements from October 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_January_2017" title="Category:Articles with unsourced statements from January 2017">Articles with unsourced statements from January 2017</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2008" title="Category:Articles with unsourced statements from July 2008">Articles with unsourced statements from July 2008</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_September_2010" title="Category:Articles with unsourced statements from September 2010">Articles with unsourced statements from September 2010</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2015" title="Category:Articles with unsourced statements from December 2015">Articles with unsourced statements from December 2015</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2015" title="Category:Articles with unsourced statements from July 2015">Articles with unsourced statements from July 2015</a></li><li><a href="/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata" title="Category:Commons category with local link same as on Wikidata">Commons category with local link same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_GND_identifiers" title="Category:Wikipedia articles with GND identifiers">Wikipedia articles with GND identifiers</a></li><li><a href="/wiki/Category:RTT" title="Category:RTT">RTT</a></li></ul></div></div> <div class="visualClear"></div>
</div>
</div>
<div id="mw-navigation">
<h2>Navigation menu</h2>
<div id="mw-head">
<div aria-labelledby="p-personal-label" class="" id="p-personal" role="navigation">
<h3 id="p-personal-label">Personal tools</h3>
<ul>
<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a accesskey="n" href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]">Talk</a></li><li id="pt-anoncontribs"><a accesskey="y" href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Rheumatoid+arthritis" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a accesskey="o" href="/w/index.php?title=Special:UserLogin&amp;returnto=Rheumatoid+arthritis" title="You're encouraged to log in; however, it's not mandatory. [o]">Log in</a></li> </ul>
</div>
<div id="left-navigation">
<div aria-labelledby="p-namespaces-label" class="vectorTabs" id="p-namespaces" role="navigation">
<h3 id="p-namespaces-label">Namespaces</h3>
<ul>
<li class="selected" id="ca-nstab-main"><span><a accesskey="c" href="/wiki/Rheumatoid_arthritis" title="View the content page [c]">Article</a></span></li>
<li id="ca-talk"><span><a accesskey="t" href="/wiki/Talk:Rheumatoid_arthritis" rel="discussion" title="Discussion about the content page [t]">Talk</a></span></li>
</ul>
</div>
<div aria-labelledby="p-variants-label" class="vectorMenu emptyPortlet" id="p-variants" role="navigation">
<h3 id="p-variants-label">
<span>Variants</span><a href="#"></a>
</h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
</div>
<div id="right-navigation">
<div aria-labelledby="p-views-label" class="vectorTabs" id="p-views" role="navigation">
<h3 id="p-views-label">Views</h3>
<ul>
<li class="selected" id="ca-view"><span><a href="/wiki/Rheumatoid_arthritis">Read</a></span></li>
<li id="ca-edit"><span><a accesskey="e" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" title="Edit this page [e]">Edit</a></span></li>
<li class="collapsible" id="ca-history"><span><a accesskey="h" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=history" title="Past revisions of this page [h]">View history</a></span></li>
</ul>
</div>
<div aria-labelledby="p-cactions-label" class="vectorMenu emptyPortlet" id="p-cactions" role="navigation">
<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
<div id="p-search" role="search">
<h3>
<label for="searchInput">Search</label>
</h3>
<form action="/w/index.php" id="searchform">
<div id="simpleSearch">
<input accesskey="f" id="searchInput" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" type="search"/><input name="title" type="hidden" value="Special:Search"/><input class="searchButton mw-fallbackSearchButton" id="mw-searchButton" name="fulltext" title="Search Wikipedia for this text" type="submit" value="Search"/><input class="searchButton" id="searchButton" name="go" title="Go to a page with this exact name if it exists" type="submit" value="Go"/> </div>
</form>
</div>
</div>
</div>
<div id="mw-panel">
<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page" title="Visit the main page"></a></div>
<div aria-labelledby="p-navigation-label" class="portal" id="p-navigation" role="navigation">
<h3 id="p-navigation-label">Navigation</h3>
<div class="body">
<ul>
<li id="n-mainpage-description"><a accesskey="z" href="/wiki/Main_Page" title="Visit the main page [z]">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a accesskey="x" href="/wiki/Special:Random" title="Load a random article [x]">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-interaction-label" class="portal" id="p-interaction" role="navigation">
<h3 id="p-interaction-label">Interaction</h3>
<div class="body">
<ul>
<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a accesskey="r" href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-tb-label" class="portal" id="p-tb" role="navigation">
<h3 id="p-tb-label">Tools</h3>
<div class="body">
<ul>
<li id="t-whatlinkshere"><a accesskey="j" href="/wiki/Special:WhatLinksHere/Rheumatoid_arthritis" title="List of all English Wikipedia pages containing links to this page [j]">What links here</a></li><li id="t-recentchangeslinked"><a accesskey="k" href="/wiki/Special:RecentChangesLinked/Rheumatoid_arthritis" rel="nofollow" title="Recent changes in pages linked from this page [k]">Related changes</a></li><li id="t-upload"><a accesskey="u" href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]">Upload file</a></li><li id="t-specialpages"><a accesskey="q" href="/wiki/Special:SpecialPages" title="A list of all special pages [q]">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;oldid=762110407" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a accesskey="g" href="https://www.wikidata.org/wiki/Q187255" title="Link to connected data repository item [g]">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Rheumatoid_arthritis&amp;id=762110407" title="Information on how to cite this page">Cite this page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-coll-print_export-label" class="portal" id="p-coll-print_export" role="navigation">
<h3 id="p-coll-print_export-label">Print/export</h3>
<div class="body">
<ul>
<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Rheumatoid+arthritis">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Rheumatoid+arthritis&amp;returnto=Rheumatoid+arthritis&amp;oldid=762110407&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a accesskey="p" href="/w/index.php?title=Rheumatoid_arthritis&amp;printable=yes" title="Printable version of this page [p]">Printable version</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-wikibase-otherprojects-label" class="portal" id="p-wikibase-otherprojects" role="navigation">
<h3 id="p-wikibase-otherprojects-label">In other projects</h3>
<div class="body">
<ul>
<li class="wb-otherproject-link wb-otherproject-commons"><a href="https://commons.wikimedia.org/wiki/Category:Rheumatoid_arthritis" hreflang="en">Wikimedia Commons</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-lang-label" class="portal" id="p-lang" role="navigation">
<h3 id="p-lang-label">Languages</h3>
<div class="body">
<ul>
<li class="interlanguage-link interwiki-ar"><a class="interlanguage-link-target" href="https://ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%85%D9%81%D8%A7%D8%B5%D9%84_%D8%A7%D9%84%D8%B1%D9%88%D9%85%D8%A7%D8%AA%D9%88%D9%8A%D8%AF%D9%8A" hreflang="ar" lang="ar" title="التهاب المفاصل الروماتويدي – Arabic">العربية</a></li><li class="interlanguage-link interwiki-az"><a class="interlanguage-link-target" href="https://az.wikipedia.org/wiki/Revmatoid_artrit" hreflang="az" lang="az" title="Revmatoid artrit – Azerbaijani">Azərbaycanca</a></li><li class="interlanguage-link interwiki-bg"><a class="interlanguage-link-target" href="https://bg.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%B5%D0%BD_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" hreflang="bg" lang="bg" title="Ревматоиден артрит – Bulgarian">Български</a></li><li class="interlanguage-link interwiki-bs"><a class="interlanguage-link-target" href="https://bs.wikipedia.org/wiki/Reumatoidni_artritis" hreflang="bs" lang="bs" title="Reumatoidni artritis – Bosnian">Bosanski</a></li><li class="interlanguage-link interwiki-ca"><a class="interlanguage-link-target" href="https://ca.wikipedia.org/wiki/Artritis_reumatoide" hreflang="ca" lang="ca" title="Artritis reumatoide – Catalan">Català</a></li><li class="interlanguage-link interwiki-cs"><a class="interlanguage-link-target" href="https://cs.wikipedia.org/wiki/Revmatoidn%C3%AD_artritida" hreflang="cs" lang="cs" title="Revmatoidní artritida – Czech">Čeština</a></li><li class="interlanguage-link interwiki-da"><a class="interlanguage-link-target" href="https://da.wikipedia.org/wiki/Leddegigt" hreflang="da" lang="da" title="Leddegigt – Danish">Dansk</a></li><li class="interlanguage-link interwiki-de"><a class="interlanguage-link-target" href="https://de.wikipedia.org/wiki/Rheumatoide_Arthritis" hreflang="de" lang="de" title="Rheumatoide Arthritis – German">Deutsch</a></li><li class="interlanguage-link interwiki-et"><a class="interlanguage-link-target" href="https://et.wikipedia.org/wiki/Reumatoidartriit" hreflang="et" lang="et" title="Reumatoidartriit – Estonian">Eesti</a></li><li class="interlanguage-link interwiki-el"><a class="interlanguage-link-target" href="https://el.wikipedia.org/wiki/%CE%A1%CE%B5%CF%85%CE%BC%CE%B1%CF%84%CE%BF%CE%B5%CE%B9%CE%B4%CE%AE%CF%82_%CE%B1%CF%81%CE%B8%CF%81%CE%AF%CF%84%CE%B9%CE%B4%CE%B1" hreflang="el" lang="el" title="Ρευματοειδής αρθρίτιδα – Greek">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a class="interlanguage-link-target" href="https://es.wikipedia.org/wiki/Artritis_reumatoide" hreflang="es" lang="es" title="Artritis reumatoide – Spanish">Español</a></li><li class="interlanguage-link interwiki-eu"><a class="interlanguage-link-target" href="https://eu.wikipedia.org/wiki/Artritis_erreumatoide" hreflang="eu" lang="eu" title="Artritis erreumatoide – Basque">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a class="interlanguage-link-target" href="https://fa.wikipedia.org/wiki/%D8%B1%D9%88%D9%85%D8%A7%D8%AA%DB%8C%D8%B3%D9%85_%D9%85%D9%81%D8%B5%D9%84%DB%8C" hreflang="fa" lang="fa" title="روماتیسم مفصلی – Persian">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a class="interlanguage-link-target" href="https://fr.wikipedia.org/wiki/Polyarthrite_rhumato%C3%AFde" hreflang="fr" lang="fr" title="Polyarthrite rhumatoïde – French">Français</a></li><li class="interlanguage-link interwiki-ga"><a class="interlanguage-link-target" href="https://ga.wikipedia.org/wiki/Airtr%C3%ADteas_r%C3%A9amat%C3%B3ideach" hreflang="ga" lang="ga" title="Airtríteas réamatóideach – Irish">Gaeilge</a></li><li class="interlanguage-link interwiki-gl"><a class="interlanguage-link-target" href="https://gl.wikipedia.org/wiki/Artrite_reumatoide" hreflang="gl" lang="gl" title="Artrite reumatoide – Galician">Galego</a></li><li class="interlanguage-link interwiki-ko"><a class="interlanguage-link-target" href="https://ko.wikipedia.org/wiki/%EB%A5%98%EB%A7%88%ED%8B%B0%EC%8A%A4_%EA%B4%80%EC%A0%88%EC%97%BC" hreflang="ko" lang="ko" title="류마티스 관절염 – Korean">한국어</a></li><li class="interlanguage-link interwiki-hy"><a class="interlanguage-link-target" href="https://hy.wikipedia.org/wiki/%D5%8C%D6%87%D5%B4%D5%A1%D5%BF%D5%B8%D5%AB%D5%A4_%D5%A1%D6%80%D5%A9%D6%80%D5%AB%D5%BF" hreflang="hy" lang="hy" title="Ռևմատոիդ արթրիտ – Armenian">Հայերեն</a></li><li class="interlanguage-link interwiki-hi"><a class="interlanguage-link-target" href="https://hi.wikipedia.org/wiki/%E0%A4%86%E0%A4%AE%E0%A4%B5%E0%A4%BE%E0%A4%A4%E0%A5%80%E0%A4%AF_%E0%A4%B8%E0%A4%82%E0%A4%A7%E0%A4%BF%E0%A4%B6%E0%A5%8B%E0%A4%A5" hreflang="hi" lang="hi" title="आमवातीय संधिशोथ – Hindi">हिन्दी</a></li><li class="interlanguage-link interwiki-hr"><a class="interlanguage-link-target" href="https://hr.wikipedia.org/wiki/Reumatoidni_artritis" hreflang="hr" lang="hr" title="Reumatoidni artritis – Croatian">Hrvatski</a></li><li class="interlanguage-link interwiki-id"><a class="interlanguage-link-target" href="https://id.wikipedia.org/wiki/Artritis_reumatoid" hreflang="id" lang="id" title="Artritis reumatoid – Indonesian">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-is"><a class="interlanguage-link-target" href="https://is.wikipedia.org/wiki/Li%C3%B0agigt" hreflang="is" lang="is" title="Liðagigt – Icelandic">Íslenska</a></li><li class="interlanguage-link interwiki-it"><a class="interlanguage-link-target" href="https://it.wikipedia.org/wiki/Artrite_reumatoide" hreflang="it" lang="it" title="Artrite reumatoide – Italian">Italiano</a></li><li class="interlanguage-link interwiki-he"><a class="interlanguage-link-target" href="https://he.wikipedia.org/wiki/%D7%93%D7%9C%D7%A7%D7%AA_%D7%9E%D7%A4%D7%A8%D7%A7%D7%99%D7%9D_%D7%A9%D7%99%D7%92%D7%A8%D7%95%D7%A0%D7%99%D7%AA" hreflang="he" lang="he" title="דלקת מפרקים שיגרונית – Hebrew">עברית</a></li><li class="interlanguage-link interwiki-kk"><a class="interlanguage-link-target" href="https://kk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D1%82%D1%8B%D2%9B_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" hreflang="kk" lang="kk" title="Ревматоидтық артрит – Kazakh">Қазақша</a></li><li class="interlanguage-link interwiki-ku"><a class="interlanguage-link-target" href="https://ku.wikipedia.org/wiki/Artr%C3%AEta_rumato%C3%AEd" hreflang="ku" lang="ku" title="Artrîta rumatoîd – Kurdish">Kurdî</a></li><li class="interlanguage-link interwiki-lv"><a class="interlanguage-link-target" href="https://lv.wikipedia.org/wiki/Reimato%C4%ABdais_artr%C4%ABts" hreflang="lv" lang="lv" title="Reimatoīdais artrīts – Latvian">Latviešu</a></li><li class="interlanguage-link interwiki-ln"><a class="interlanguage-link-target" href="https://ln.wikipedia.org/wiki/Mingayi_na_articulation" hreflang="ln" lang="ln" title="Mingayi na articulation – Lingala">Lingála</a></li><li class="interlanguage-link interwiki-hu"><a class="interlanguage-link-target" href="https://hu.wikipedia.org/wiki/Rheumatoid_arthritis" hreflang="hu" lang="hu" title="Rheumatoid arthritis – Hungarian">Magyar</a></li><li class="interlanguage-link interwiki-mk"><a class="interlanguage-link-target" href="https://mk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%B5%D0%BD_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82%D0%B8%D1%81" hreflang="mk" lang="mk" title="Ревматоиден артритис – Macedonian">Македонски</a></li><li class="interlanguage-link interwiki-nl"><a class="interlanguage-link-target" href="https://nl.wikipedia.org/wiki/Reumato%C3%AFde_artritis" hreflang="nl" lang="nl" title="Reumatoïde artritis – Dutch">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a class="interlanguage-link-target" href="https://ja.wikipedia.org/wiki/%E9%96%A2%E7%AF%80%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81" hreflang="ja" lang="ja" title="関節リウマチ – Japanese">日本語</a></li><li class="interlanguage-link interwiki-no"><a class="interlanguage-link-target" href="https://no.wikipedia.org/wiki/Leddgikt" hreflang="no" lang="no" title="Leddgikt – Norwegian">Norsk bokmål</a></li><li class="interlanguage-link interwiki-or"><a class="interlanguage-link-target" href="https://or.wikipedia.org/wiki/%E0%AC%B0%E0%AC%BF%E0%AC%89%E0%AC%AE%E0%AC%BE%E0%AC%9F%E0%AC%8F%E0%AC%A1_%E0%AC%86%E0%AC%B0%E0%AD%8D%E0%AC%A5%E0%AD%8D%E0%AC%B0%E0%AC%BE%E0%AC%87%E0%AC%9F%E0%AC%BF%E0%AC%B8" hreflang="or" lang="or" title="ରିଉମାଟଏଡ ଆର୍ଥ୍ରାଇଟିସ – Odia">ଓଡ଼ିଆ</a></li><li class="interlanguage-link interwiki-pl"><a class="interlanguage-link-target" href="https://pl.wikipedia.org/wiki/Reumatoidalne_zapalenie_staw%C3%B3w" hreflang="pl" lang="pl" title="Reumatoidalne zapalenie stawów – Polish">Polski</a></li><li class="interlanguage-link interwiki-pt"><a class="interlanguage-link-target" href="https://pt.wikipedia.org/wiki/Artrite_reumatoide" hreflang="pt" lang="pt" title="Artrite reumatoide – Portuguese">Português</a></li><li class="interlanguage-link interwiki-ru"><a class="interlanguage-link-target" href="https://ru.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D1%8B%D0%B9_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" hreflang="ru" lang="ru" title="Ревматоидный артрит – Russian">Русский</a></li><li class="interlanguage-link interwiki-simple"><a class="interlanguage-link-target" href="https://simple.wikipedia.org/wiki/Rheumatoid_arthritis" hreflang="simple" lang="simple" title="Rheumatoid arthritis – Simple English">Simple English</a></li><li class="interlanguage-link interwiki-sl"><a class="interlanguage-link-target" href="https://sl.wikipedia.org/wiki/Revmatoidni_artritis" hreflang="sl" lang="sl" title="Revmatoidni artritis – Slovenian">Slovenščina</a></li><li class="interlanguage-link interwiki-ckb"><a class="interlanguage-link-target" href="https://ckb.wikipedia.org/wiki/%D8%A8%D8%A7%D8%AF%D8%A7%D8%B1%DB%8C%DB%8C_%D8%AC%D9%88%D9%85%DA%AF%DB%95%DA%A9%D8%A7%D9%86" hreflang="ckb" lang="ckb" title="باداریی جومگەکان – Central Kurdish">کوردیی ناوەندی</a></li><li class="interlanguage-link interwiki-sr"><a class="interlanguage-link-target" href="https://sr.wikipedia.org/wiki/%D0%A0%D0%B5%D1%83%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D0%B8_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82%D0%B8%D1%81" hreflang="sr" lang="sr" title="Реуматоидни артритис – Serbian">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a class="interlanguage-link-target" href="https://sh.wikipedia.org/wiki/Reumatoidni_artritis" hreflang="sh" lang="sh" title="Reumatoidni artritis – Serbo-Croatian">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a class="interlanguage-link-target" href="https://fi.wikipedia.org/wiki/Nivelreuma" hreflang="fi" lang="fi" title="Nivelreuma – Finnish">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a class="interlanguage-link-target" href="https://sv.wikipedia.org/wiki/Reumatoid_artrit" hreflang="sv" lang="sv" title="Reumatoid artrit – Swedish">Svenska</a></li><li class="interlanguage-link interwiki-ta"><a class="interlanguage-link-target" href="https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AF%81%E0%AE%9F%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%81_%E0%AE%B5%E0%AE%BE%E0%AE%A4%E0%AE%AE%E0%AF%8D" hreflang="ta" lang="ta" title="முடக்கு வாதம் – Tamil">தமிழ்</a></li><li class="interlanguage-link interwiki-th"><a class="interlanguage-link-target" href="https://th.wikipedia.org/wiki/%E0%B8%82%E0%B9%89%E0%B8%AD%E0%B8%AD%E0%B8%B1%E0%B8%81%E0%B9%80%E0%B8%AA%E0%B8%9A%E0%B8%A3%E0%B8%B9%E0%B8%A1%E0%B8%B2%E0%B8%95%E0%B8%AD%E0%B8%A2%E0%B8%94%E0%B9%8C" hreflang="th" lang="th" title="ข้ออักเสบรูมาตอยด์ – Thai">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a class="interlanguage-link-target" href="https://tr.wikipedia.org/wiki/Romatoid_artrit" hreflang="tr" lang="tr" title="Romatoid artrit – Turkish">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a class="interlanguage-link-target" href="https://uk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D1%97%D0%B4%D0%BD%D0%B8%D0%B9_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" hreflang="uk" lang="uk" title="Ревматоїдний артрит – Ukrainian">Українська</a></li><li class="interlanguage-link interwiki-vi"><a class="interlanguage-link-target" href="https://vi.wikipedia.org/wiki/Vi%C3%AAm_kh%E1%BB%9Bp_d%E1%BA%A1ng_th%E1%BA%A5p" hreflang="vi" lang="vi" title="Viêm khớp dạng thấp – Vietnamese">Tiếng Việt</a></li><li class="interlanguage-link interwiki-zh"><a class="interlanguage-link-target" href="https://zh.wikipedia.org/wiki/%E9%A1%9E%E9%A2%A8%E6%BF%95%E6%80%A7%E9%97%9C%E7%AF%80%E7%82%8E" hreflang="zh" lang="zh" title="類風濕性關節炎 – Chinese">中文</a></li> </ul>
<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a class="wbc-editpage" href="https://www.wikidata.org/wiki/Q187255#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></span></div> </div>
</div>
</div>
</div>
<div id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last modified on 26 January 2017, at 18:39.</li>
<li id="footer-info-copyright">Text is available under the <a href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License" rel="license">Creative Commons Attribution-ShareAlike License</a><a href="//creativecommons.org/licenses/by-sa/3.0/" rel="license" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy"><a class="extiw" href="https://wikimediafoundation.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
<li id="footer-places-cookiestatement"><a href="https://wikimediafoundation.org/wiki/Cookie_statement">Cookie statement</a></li>
<li id="footer-places-mobileview"><a class="noprint stopMobileRedirectToggle" href="//en.m.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;mobileaction=toggle_view_mobile">Mobile view</a></li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico">
<a href="https://wikimediafoundation.org/"><img alt="Wikimedia Foundation" height="31" src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88"/></a> </li>
<li id="footer-poweredbyico">
<a href="//www.mediawiki.org/"><img alt="Powered by MediaWiki" height="31" src="/static/images/poweredby_mediawiki_88x31.png" srcset="/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x" width="88"/></a> </li>
</ul>
<div style="clear:both"></div>
</div>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.768","walltime":"1.894","ppvisitednodes":{"value":10673,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":418451,"limit":2097152},"templateargumentsize":{"value":9256,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":7,"limit":500},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 1643.039      1 -total"," 56.20%  923.406      1 Template:Reflist"," 36.68%  602.612    108 Template:Cite_journal"," 16.81%  276.159     15 Template:Citation_needed"," 15.41%  253.200     15 Template:Fix"," 11.49%  188.803      1 Template:Infobox_medical_condition"," 10.20%  167.614      1 Template:Infobox","  9.64%  158.451     15 Template:Delink","  6.10%  100.202     17 Template:Cite_web","  5.08%   83.471     30 Template:Category_handler"]},"scribunto":{"limitreport-timeusage":{"value":"1.026","limit":"10.000"},"limitreport-memusage":{"value":7541464,"limit":52428800}},"cachereport":{"origin":"mw1164","timestamp":"20170126183907","ttl":86400,"transientcontent":true}}});});</script><script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":65,"wgHostname":"mw1255"});});</script>
</body>
</html>
